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Abstract 
Coinfection with bacteria and viruses is an understudied area of microbiology, 
despite its potential to modulate pathogen abundance and host survival. We 
investigated the effect of bacteria on virus infection and developed an in vitro system 
to study the first step: viral internalization. Our studies show that multiple bacterial 
species promote the entry of a diverse panel of viruses into lung and gut epithelial 
cells. Bacteria expressing the toll-like receptor (TLR)5 agonist, flagellin, are most 
efficient at inducing viral uptake and studies using recombinant flagellin or aflagellate 
bacterial strains confirm that flagellin has pro-viral activity. Flagellin promotes 
epithelial cells to support virus entry via TLR5-dependent activation of NF-κB. To 
extend these observations and study the role of flagellin in the complete viral 
replicative lifecycle, we studied human immunodeficiency virus (HIV)-1 replication in 
T cells.  Flagellin augments HIV-1 entry and promoter activity and increases the 
production of extracellular virus. The data presented in this thesis highlight a new role 
for bacterial flagellin to promote diverse virus infection of epithelial barriers and 
enhance the spread of HIV-1. This has significant implications for understanding how 
exposure to multiple pathogens can alter susceptibility to infection and its associated 
pathogenesis.  
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1. INTRODUCTION 
 
1.1 The importance of coinfection 
The human body hosts a variety of microbes: including bacteria, viruses, fungi and 
parasites. However, the majority of publications report on the mechanisms underlying 
a single infectious agent causing disease. Coinfection, also called polymicrobial or 
dual-species infection, refers to the occurrence of two or more microbes that interact 
synergistically. Coinfections are more likely to increase pathogen abundance and 
have a negative effect on host health, than the inverse (Griffiths et al., 2011). 
Interestingly, one infection can affect the outcome of a secondary infection even after 
the first has resolved, due to changes in host immunity (Didierlaurent et al., 2007; 
Goulding et al., 2007). It is important that we understand coinfection and other 
interactions between microbes, to better prevent and treat infections that are likely to 
have increased mortality rates.  
 
Global infectious disease mortality data only report a single cause of death, even if 
other causes were known, preventing researchers from tracking the prevalence of 
coinfection (Griffiths et al., 2011). The importance of studying coinfection is 
evidenced when reading clinical reports of pulmonary and gastrointestinal infections, 
which often report that 20-30% of cases involve two or more pathogenic microbes 
(Bhavnani et al., 2012; Hoffmann et al., 2012; Sambe-Ba et al., 2013; Obasi et al., 
2014). Analysis of all publications describing coinfections in 2009 determined that the 
most commonly reported pathogen type was bacterial. However, the most studied 
coinfecting pairs were virus-virus combinations, such as human immunodeficiency 
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virus (HIV)-hepatitis C virus (HCV; (Griffiths et al., 2011). There is a need to study the 
interactions of bacterial pathogens with other microbes. 
 
While virus-virus coinfections often occur though shared transmission routes, many 
bacterial species able to cause disease are carried by the host and require an 
opportunity to cause infection. This often occurs following viral infection, when 
immune cell responses can be altered and immunosuppressive cytokines are present 
(Didierlaurent et al., 2007). Concurrent and successive infections can be more 
difficult to treat and have increased mortality rates (Gordon et al., 2002; Karlström et 
al., 2009; Aaron, 2014). Some coinfection combinations include bacterial species 
already known to interact synergistically with other microbes, such as respiratory 
viruses promoting bacterial infection (Bosch et al., 2013) or HIV-induced 
immunosuppression potentiaing opportunistic infections (Furrer, 2016). There are 
also disease states known to be associated with coinfection, for example, acute otitis 
media in children, caused by bacterial-bacterial, viral-viral or viral-bacterial 
coinfection (Marom et al., 2012).  
 
The transkingdom interactions that have been well characterized will be discussed 
below. However, further research is required to identify coinfecting pathogens that 
are frequently understudied, to increase our understanding of microbial interactions. 
This can aid treatment, or ideally increase preventative strategies, to decrease the 
high mortality rates associated with coinfection. 
 3 
1.2 Influenza leads to secondary bacterial infection  
The influenza virus is an enveloped, negative sense RNA virus that can be classified 
as type A, B or C. The majority of human infections are caused by type A (Short et 
al., 2012). Influenza induces a cytolytic infection that reduces the epithelial barrier 
function, through necrosis of epithelial cells and apoptosis of inflammatory cells 
(Hussell and Cavanagh, 2009). Influenza interacts with host cells via two envelope 
glycoproteins; hemagglutinin (HA) binds to its receptor on host cells, sialic acids, to 
facilitate entry, and neuraminidase (NA) cleaves sialic acids to allow release of new 
progeny virus from the infected cell in the late steps of the viral life cycle (Short et al., 
2012). Influenza infection has long been known to associate with bacterial 
pneumonia and the majority of deaths caused by the 1918-1919 influenza pandemic, 
the most recent pandemic without access to antimicrobial agents, were due to 
secondary bacterial infections (Morens et al., 2008).  
 
Following the discovery of antimicrobial agents and the introduction of vaccines to 
some common bacterial pathogens in the lung, secondary bacterial infections are still 
detected after influenza infection. However, the range of species involved has 
changed (Morens et al., 2008). Bacterial infection usually occurs between four and 
14 days after resolution of an influenza infection, when fever reappears. Although 
influenza is not associated with one specific bacterial species, secondary infection is 
most often caused by Haemophilus influenzae, Staphylococcus aureus and 
Streptococcus pneumoniae (Hussell et al., 2009).  
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The time between influenza resolution and onset of bacterial pneumonia suggests 
that the interplay is not mediated via direct interactions between the microbes, but an 
alteration of the host environment following resolution of the viral Infection. One 
exception to this occurs in coinfections with influenza and S. pneumoniae, which both 
express NA. S. pneumoniae encoded NA cleaves host cell sialic acid and thereby 
promotes bacterial adhesion. However, following influenza virus exit from epithelial 
cells, the sialic acid has already been modified and can independently augment 
bacterial adhesion (Peltola and McCullers, 2004). This shared use of NA helps 
explain the synergy observed when the two microbes infect the lung epithelia at the 
same time. Interestingly, administration of the influenza NA inhibitor oseltamivir to 
influenza-infected individuals can decrease the risk of secondary complications 
(Viasus et al., 2011; Vardakas et al., 2016). 
 
The species of bacteria most frequently associated with secondary infection often 
colonize the nasopharynx in healthy individuals. Remodeling of the lung immune 
environment during influenza infection allows bacteria to colonize the lower lung 
causing pneumonia (Short et al., 2012). In children, influenza and other respiratory 
viral infections can lead to otitis media, when bacteria such as S. pneumoniae infect 
the middle ear (Marom et al., 2012). This remodeling has been reported to increase 
the concentration of interleukin (IL)-10 in the lungs of mice to 20 times higher than 
mice without influenza infection, allowing increased bacterial growth, as the addition 
of neutralizing anti-IL-10 monoclonal antibody decreased the bacterial burden (van 
der Sluijs et al., 2004). This study indicates that the presence of an anti-inflammatory 
cytokines following virus resolution can allow bacteria to colonize the lung.  
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Influenza A virus infection prior to S. aureus challenge in mice reduces the clearance 
of either microbe from the lung, despite increased macrophage and neutrophil 
accumulation and interferon (IFN) expression (Kudva et al., 2011). Kudva et al., 
2011, reported that type I IFN produced during the virus infection decreases the 
ability of dendritic cells (DC) to induce Th17 CD4+ T cells that are major players in 
bacterial clearance. Th17 cells express high levels of the pro-inflammatory cytokines 
IL-17 and IL-22 that recruit neutrophils and induce antimicrobial peptide (AMP) 
expression, respectively (Aujla et al., 2007). Further effects on immune cells include 
desensitization of alveolar macrophages to bacterial products following influenza 
infection and decreased pro-inflammatory activity upon secondary challenge 
(Didierlaurent et al., 2008). 
 
Bacterial pneumonia following influenza infection is more difficult to treat than 
pneumonia caused by a primary bacterial infection and it has been demonstrated that 
treatment with different types of antibiotic can improve or worsen the outcome 
(Karlström et al., 2009). The use of β-lactam antibiotics that are bacteriocidal caused 
greater inflammation and higher mortality than clindamycin, a bacteriostatic antibiotic 
that leaves cells intact, in a mouse model of influenza A virus and S. pneumoniae 
coinfection (Karlström et al., 2009). This study suggests a need for bacterial testing 
following influenza infection, before prescription of antibiotics, if the mortality rate of 
secondary bacterial infection is to be lowered.  
 
The combination of this respiratory virus with certain bacterial species worsens 
pneumonia outcome compared to that caused by bacteria alone (Hussell and 
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Cavanagh, 2009). There are many ways that influenza can lead to enhanced 
bacterial infection (Fig.1.1), including those discussed above: decreased integrity of 
the lung epithelium caused by the cytopathic effects of the virus but also increased 
expression of bacterial adhesion molecules on influenza infected cells, decreased 
immune cells that can control bacterial growth such as alveolar macrophages and 
neutrophils and upregulation of immune suppressant cytokines following the creation 
of apoptotic cells. Importantly, it has been found that influenza vaccination can 
decrease the likelihood of bacterial coinfection (Lee et al., 2015) as well as antiviral 
drugs also targeting the bacterial neuraminidase to reduce bacterial infection (Viasus 
et al., 2011; Vardakas et al., 2016). In contrast, there is evidence that S. pneumoniae 
exposure prior to influenza can reduce the viral infection (Short et al., 2012). 
However, the mechanisms for this are yet to be determined. 
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Figure 1.1 Influenza virus infection predisposes the lung epithelia to secondary 
bacterial infection. 
Adapted from (Cauley and Vella, 2015) 1. Virus infection of lung epithelia can lead to 
cell death and damage. 2. Bacteria spread into damaged areas of the lung and 
replicate. 3. Prolonged pro-inflammatory responses to the virus infection can become 
toxic and have a negative effect. 4. Phagocytic cells are recruited to clear dying 
epithelial cells and are less able to phagocytose bacteria. 5. Regulatory T cells can 
be recruited to dampen the anti-viral response by producing anti-inflammatory 
cytokines. The combination of steps 3, 4 and 5 allow bacterial growth to continue 
leading to a secondary infection. 
1 2 
3 
4 
5 
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1.3 HIV and opportunistic infections  
HIV is a lentivirus and part of the Retroviridae family. There are two types of HIV and 
the majority of HIV-associated deaths are caused by HIV-1, whereas HIV-2 has a 
lower mortality rate (Prince et al., 2014). HIV is transmitted by sexual intercourse, 
contaminated blood and vertically from mother-to-child before or during birth, or 
through breast milk (Cohen et al., 2008). The virus targets CD4+ T cells for depletion, 
leading to immunodeficiency, which can progress to acquired immune deficiency 
syndrome (AIDS; (Pantaleo et al., 1993). However, it is now known that the effects 
are not limited to T cells and there is chronic immune activation that is not reversed 
by antiretroviral therapy (ART; (Mudd and Brenchley, 2016). Transmission and 
infection of a new host is dependent on the amount of infectious virus in the bodily 
fluid transferred. This varies from high levels during the acute infection to 
undetectable levels from individuals on ART, which is suppressive so does not cure 
HIV (Cohen et al., 2008). While HIV infection can be controlled to prevent 
progression to AIDS, it is important to understand factors that can increase HIV 
transmission to uninfected individuals.  
 
Due to the immunocompromised status of HIV-infected individuals not treated with 
ART, secondary infections are common. However, they can also occur during ART 
(Hooshyar et al., 2007). These infections can be bacterial, viral, fungal or parasitic 
and are often opportunistic pathogens that would not cause disease in a healthy 
individual. For HIV-infected individuals undergoing treatment in North America, the 
risk of opportunistic infection is now low (fewer than two in 100 per year) and the 
main risks are candidiasis, Pneumocystis jirovecii pneumonia, mycobacterial 
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infections including Mycobacterium tuberculosis (Mtb), cytomegalovirus, 
toxoplasmosis and cryptococcosis (Buchacz et al., 2016). In resource-limited 
settings, tuberculosis is attributable for 40% of HIV-associated deaths (Gupta et al., 
2015). The incidence of any opportunistic infection in these settings, even with ART, 
can be as high as 50%, but is linked to lower T cell numbers due to reduced ART 
availability (Mitiku et al., 2015). 
 
1.3.1 HIV and Mtb 
One third of the global population is reported to encounter Mtb and tuberculosis is the 
second most common cause of death by an infectious agent (Shankar et al., 2014). 
Mtb primarily infects the respiratory tract and is detected by innate immune cells such 
as alveolar macrophages, which phagocytose the bacterium, where it halts lysosomal 
breakdown to replicate in the immune cell. This infected cell is surrounded by other 
immune cells that form a granuloma to limit the infection and allow Mtb to establish 
latency (reviewed by (Ernst, 2012). The bacterium can persist for years in this state, 
only to be reactivated by alteration of the immune status. As Mtb has an intracellular 
lifecycle, cell-mediated immunity is necessary for clearance from the host and this 
allows for interactions with HIV-infected cells (Fig.1.2). HIV coinfection can increase 
the chance of Mtb reactivation by 20-fold and exacerbate associated pathologies 
(Pawlowski et al., 2012). Conversely, the presence of Mtb increases HIV RNA levels 
through pro-inflammatory signaling that can augment HIV transcription in infected T 
cells and macrophages (Deffur et al., 2013). 
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Figure 1.2 Interactions between HIV and Mtb that can exacerbate both 
infections. 
Adapted from Shankar et al., 2014. 1. Macrophages (MΦ) infected with 
Mycobacterium tuberculosis (MTB) can upregulate expression of an HIV co-receptor, 
CXCR4, allowing increased virus infection. 2. Altered cytokine secretion from MTB-
infected macrophages also has effects on immune cell functionality and prevents 
apoptosis of infected cells. Furthermore, HIV-infected T cells have increased 
expression of immune activation markers (3), reduced anti-viral and anti-bacterial 
responses and less IFNγ release (4), which is one of the responses required for 
maintaining a granuloma around MTB-infected cells. 
	   
	   
	   	   
	   	   
	   	   
1 
2 
3 
4 
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Deffur et al., 2013, reported that HIV infection can deplete Mtb specific T cells and 
thereby increase the risk of reactivation. Furthermore, both microbes can infect 
macrophages, and Mtb has a greater growth rate in HIV infected macrophages 
through increased tumour necrosis factor (TNF) signaling (Imperiali et al., 2001). This 
pro-inflammatory signaling increases HIV replication and, interestingly, Mtb can 
increase expression of a viral co-receptor, CXCR4, which promotes infection of naïve 
target cells (Shankar et al., 2014). A humanized mouse model of HIV-Mtb coinfection 
has identified that the microbes can act synergistically and this is dependent on the 
timing of infection. HIV-infected cells localized to Mtb replication sites and pro-
inflammatory signaling led to granuloma breakdown (Nusbaum et al., 2016). 
 
1.3.2 HIV and fungal infections  
While fungal infections are rare in the immunocompetent host (Schmiedel and 
Zimmerli, 2016), they are some of the most prevalent infections in HIV-infected hosts 
(Mitiku et al., 2015; Buchacz et al., 2016). A major opportunistic fungal infection 
associated with HIV is candidiasis, caused by Candida spp. Candida spp. are 
commensal organisms found on the skin and in the oral cavity, gastrointestinal tract 
and female genital tract that can cause infection upon reaching the bloodstream or 
deep tissue (Schmiedel and Zimmerli, 2016).  
 
Although increased susceptibility could be solely due to immune suppression, HIV- 
infected macrophages show a reduced ability to phagocytose Candida albicans 
(Crowe et al., 1994). Furthermore, studies have identified that HIV, through its 
envelope glycoproteins, can bind to Candida spp. cells, which increases their uptake 
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into HIV-infected host cells (Gruber et al., 2003). Mouse studies have also shown 
that reduced IL-17 and IL-22 responses during HIV infection lead to decreased innate 
defences in the oral mucosa (de Repentigny et al., 2015). These mechanisms are 
similar to those reported for Mtb, indicating that broad effects from one microbe can 
impact on the outcome of other infections.  
 
Interestingly, Candida albicans has been reported to reduce HIV replication in 
macrophages by promoting the anti-viral response and triggering expression of 
interferon-stimulated genes such as tetherin (Rodriguez Rodrigues et al., 2013). This 
interaction highlights the complexity of studying coinfections in more detail. We need 
to determine whether the microbes in question are likely to meet and act 
synergistically, and identify whether there’s a need for more potent or specific 
treatments. 
 
1.3.3 Bacterial translocation during HIV infection 
HIV infection causes immune activation and inflammation, which is linked to damage 
to the intestinal tract and gastrointestinal symptoms (reviewed by (Marchetti et al., 
2013). CD4+ T cells specific to the gut are lost early in HIV infection, 
disproportionately to the loss of circulating CD4+ T cells, likely due to increased 
expression of the HIV-1 co-receptor CCR5 on the gut-resident cells (Mudd and 
Brenchley, 2016). Other changes associated with gut damage include loss of IL-17 
and IL-22 producing cells and enterocyte apoptosis (Shan and Siliciano, 2014). This 
damage allows bacteria and their products to pass through the epithelial barrier into 
the local area and beyond to the bloodstream, which is termed microbial 
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translocation. Furthermore, the immunocompromised status that can occur during 
HIV infection may reduce phagocytosis of any bacteria breaching the barrier. During 
translocation of bacteria and their microbial associated molecular patterns (MAMP), 
inflammation is increased, which may also contribute to breakdown of the barrier 
(Marchetti et al., 2013). 
 
Although ART can reduce viral RNA in the periphery to undetectable levels, HIV-
infected individuals still have increased mortality compared to uninfected individuals. 
This is most likely explained by chronic immune activation and inflammatory 
responses induced by microbial translocation, as gastrointestinal damage is not 
rapidly reversed by ART (Lozupone et al., 2013; Mudd and Brenchley, 2016). 
Microbial translocation can be detected by measuring levels of bacterial MAMPs 
such as lipopolysaccharide (LPS) and flagellin in the blood and by levels of antibody 
to these antigens (Marchetti et al., 2013). Soluble CD14 is a useful marker of 
monocyte activation that correlates with LPS levels, but may also indicate the 
presence of Gram-positive bacteria (Shan and Siliciano, 2014). Microbial 
translocation can affect HIV pathogenesis by increasing inflammation, including T cell 
activation, potentiating immunodeficiency but also through direct effects on the viral 
lifecycle. Activation of NF-κB by bacterial products such as flagellin can increase HIV 
replication (Brichacek et al., 2010; Ferreira et al., 2011), cell-cell transmission (Côté 
et al., 2013) and reactivation of latent HIV in T cells (Thibault et al., 2009).  
 
Recent studies show that HIV infection can cause profound changes in the virome 
and bacterial and fungal microbiomes and these changes can contribute to 
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immunodeficiency, which is only now being realized (Palmer et al., 2016). The most 
dramatic changes in the intestinal microbiome composition are observed in 
individuals with low CD4+ T cell counts. Interestingly, expansion of other viruses 
such as adenovirus may also cause epithelial damage and contribute to microbial 
translocation (Monaco et al., 2016).  
 
1.3.4 Non-HIV infections can enhance HIV transmission 
While HIV can increase the likelihood of opportunistic infections or microbial 
translocation, there is also evidence for HIV as a secondary infection. Bacterial 
vaginosis is a condition where the female lower genital tract has an altered 
microbiome, often with no symptoms. Although the bacterial species involved can 
vary between individuals, there is an association with increased transmission of HIV 
and other sexually transmitted infections (Mirmonsef et al., 2012), for which the 
mechanisms are yet to be determined. It is possible that an increasingly pro-
inflammatory environment leads to epithelial damage, allowing HIV easier entry into 
the host. Chlamydia trachomatis is the most common bacterial STI. (Buckner et al., 
2016), found that migration of T cells infected with HIV was more successful when 
the epithelial cells were infected with C. trachomatis.  
 
Clinical studies suggest that schistosome infection, a parasitic worm, can increase 
HIV transmission and progression to AIDS, suggesting that increased used of low-
cost treatments for this infection could reduce HIV transmission as well as 
schistosomiasis (Secor, 2012). Trichomonas vaginalis is another parasite associated 
with increased HIV infection and is the most common non-viral STI in the world 
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(Mirmonsef et al., 2012). While there is clinical evidence for increased HIV 
transmission in the presence of other STIs and genital infections, there is little 
experimental investigation into these interactions. These reports highlight the 
importance of STI screening, as the most common organisms are largely 
asymptomatic but can increase the risk of HIV transmission. 
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1.4 Bacteria can predispose the host to viral infections  
The majority of research into coinfection focuses on viral infection preceding bacterial 
infection. Interactions such as the increased susceptibility to HIV infection when other 
STIs are present (Mirmonsef et al., 2012) have promoted research to study the 
effect(s) of bacterial carriage predisposing to viral infections. One interesting and 
expanding area is the impact of the microbiome on the outcome of viral infections. 
Two groups reported differences in poliovirus, reovirus and mouse mammary tumour 
virus (MMTV) infection of germ-free mice, or after pre-treating mice with antibiotics, 
suggesting a pro-viral role for the microbiome (Fig.1.3; (Kane et al., 2011; Kuss et 
al., 2011). Furthermore, norovirus infection is augmented by the presence of bacterial 
products (Karst, 2015). However, there are also viruses for which the microbiome 
exerts an inhibitory effect (Wilks et al., 2013). Several in vitro studies have reported 
that bacterial infection can potentiate virus infection and these studies will be 
discussed below (Sajjan et al., 2006; Chattoraj et al., 2011a; Verkaik et al., 2011). 
 
1.4.1 Microbiome-viral interactions 
The intestinal tract is the most heavily colonized organ in the body and its 
microbiome is one of the protective mechanisms present to prevent disease, by 
competing for space and nutrients with potentially pathogenic organisms (Sekirov et 
al., 2010). However, recent studies suggest that the microbiome can facilitate viral 
infection. Kuss et al., 2011, reported that antibiotic depletion of intestinal bacteria 
decreased mortality associated with oral poliovirus and reovirus infection. Further 
studies showed that Gram-negative bacterial surface expressed LPS binds poliovirus 
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Figure 1.3 The intestinal microbiome can augment virus infection in mouse 
models. 
Adapted from (Wilks et al., 2013) 1. Reduction in the intestinal microbiome using 
antibiotics (Abx) can decrease poliovirus and reovirus infections, improving mouse 
survival. Addition of Abx resistant bacteria rescues viral pathogenesis. 2. Infection of 
germ-free mice with murine leukemia virus (MuLV), which in conventionally reared 
mice causes leukemia and death, leads to increased viremia without leukemia 
generation. Addition of sheep red blood cells (SRBC) increases mortality for germ-
free mice infected with MuLV to the level seen with conventionally reared mice, 
however without leukemia development. 3. Mouse mammary tumor virus (MMTV) 
causes a persistent infection in mice. In those treated with Abx or raised germ-free, 
the infection is eliminated. Germ-free mice without the MyD88 gene infected with 
MMTV are not able to clear the virus, suggesting a role for TLR signaling. 
	   1 2 
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and this interaction promotes viral stability at higher temperatures, and attachment to 
host cells via the poliovirus receptor (Kuss et al., 2011; Robinson et al., 2014). 
Moreover, bacterially expressed peptidoglycan (PGN) was independently reported to 
increase the stability of poliovirus (Robinson et al., 2014), identifying a direct 
interaction between poliovirus and a wide range of bacterial species. Rotavirus 
infection can also be reduced when the microbiota is depleted and the effect is 
suggested be at the viral entry stage, rather than replication, but further investigation 
is needed to determine the mechanism (Uchiyama et al., 2014). 
 
MMTV, which is frequently transmitted through milk from mothers to their offspring, 
can also utilize LPS on mucosal surfaces to its advantage (Wilks et al., 2013). Kane 
et al., 2011, reported that adult mice exposed to MMTV in milk as neonates failed to 
mount an anti-MMTV response later in life. However, when neonates were infected 
with MMTV intraperitoneally, they produced antibody upon subsequent challenge 
with viral antigens. This occurs through MMTV binding LPS in the stomach of 
neonates, which induces toll-like receptor (TLR)4 signaling and leads to increased 
expression of IL-10. The IL-10 produced reduces the anti-viral response to MMTV 
and potentiates tolerance (Kane et al., 2011). MMTV binds LPS via the incorporation 
of LPS-specific host cell receptors, TLR4, CD14 and MD-2, into virus particles (Wilks 
et al., 2015). This study highlights a role for MMTV incorporation of host immune 
receptors to allow the virus to evade the immune system. In contrast, influenza virus 
infection in mice is enhanced when the microbiome is depleted with antibiotics (Wilks 
et al., 2013), which introduces another factor to consider when treating secondary 
bacterial infections causing pneumonia as discussed earlier. 
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1.4.2 Noroviruses 
Human noroviruses are non-enveloped, positive sense RNA viruses that cause 
gastroenteritis and are amongst the most prevalent causes of pediatric diarrhea (Koo 
et al., 2013). However, until recently it has been difficult to study human noroviruses 
due to a lack of in vitro cell culture models that allow virus replication. Murine 
noroviruses infect macrophages and DCs. However, efforts to infect these cell types 
with human noroviruses have been unsuccessful and the same is true of intestinal 
epithelial cells, which would be the logical first point of infection for a gastrointestinal 
pathogen (Karst, 2015).  
 
(Jones et al., 2014) showed that human noroviruses infect B cells and this can be 
augmented by bacteria, or bacterial products. Initial experiments identified that 
murine noroviruses could infect B cells in vitro and in vivo. To assess this using a 
human norovirus; filtered and unfiltered stool samples positive for the virus were 
incubated with B cells and the unfiltered samples supported higher levels of viral 
replication. Subsequent experiments showed an interaction between the virus and 
histo-blood group antigens (HBGAs) that are expressed by the host, but also by 
certain bacterial species present in the gut. Although this mechanism still requires 
more research, it is hypothesized that the virus particles are coated with HBGAs 
allowing immune evasion (Karst, 2015). 
 
1.4.3 Bacterial species in the lung predispose to viral infection 
In vitro studies have investigated interactions between viruses and bacteria isolated 
from individuals with chronic obstructive pulmonary disease (COPD) and cystic 
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fibrosis (CF), as well as pediatric patients with acute respiratory tract infections. 
Human metapneumovirus (HMPV) antibodies are detected in children by the age of 
5, but not all children develop respiratory tract infections from this virus, and the 
factors responsible for this are not yet understood (Panda et al., 2014). Verkaik et al., 
2011, hypothesized that respiratory bacteria could exacerbate HMPV infection. They 
report an association between HMPV seroconversion and S. pneumoniae carriage in 
young children, which led them to test the interaction in vitro. Human bronchial 
epithelial cells pre-exposed to S. pneumoniae support increased levels of HMPV 
infection by up to 10-fold, whereas S. aureus, Moraxella catarrhalis and H. influenzae 
have no effect on virus infection (Verkaik et al., 2011). Further investigations are 
needed to determine the mechanism of increased HMPV infection following S. 
pneumoniae exposure.  
 
COPD is a chronic condition that can be exacerbated by acute viral and bacterial 
infections that lead to increased mortality (Aaron, 2014). Coinfection has been 
identified in 25% of hospitalized patients and is frequently associated with more 
severe symptoms and outcomes (Papi et al., 2006). Sajjan et al., 2006, investigated 
the effect of coinfection with H. influenzae and rhinovirus, two microbes commonly 
isolated from COPD patients with clinical symptoms. Primary airway epithelial cells 
infected with H. influenzae prior to rhinovirus secrete higher levels of the pro-
inflammatory chemokine IL-8, than when infected with either pathogen alone. 
Interestingly, heat-killed bacteria do not replicate this effect. Increased IL-8 
expression occurs via an upregulation of TLR3 by H. influenzae, potentiating the host 
response to detect viral dsRNA. Furthermore, bacterial exposure upregulates the 
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viral receptor ICAM-1; allowing more virus particles to bind to host cells. This 
provides an explanation for the reported increase in the susceptibility of individuals 
with COPD to rhinovirus infection. 
 
Lung epithelial cells from individuals with CF have impaired innate defenses and, like 
COPD, CF predisposes to acute episodes of inflammation and viral and bacterial 
exacerbations (Elborn, 2016). Rhinovirus is associated with up to 60% of CF 
exacerbations (Chattoraj et al., 2011b). Individuals with CF have increased 
susceptibility to Gram-negative bacteria and P. aeruginosa is the predominant 
infection (Elborn, 2016). Chattoraj et al., 2011a, infected airway cells with P. 
aeruginosa and allowed the bacteria to form a biofilm to replicate the bacterial burden 
in vivo, rhinovirus was then added and they reported an increased release of 
bacterial cells from the biofilm in the presence of virus. Further studies identified a 
role for rhinovirus to disrupt the biofilm via oxidative stress dependent mechanisms. 
The free bacterial cells then migrate across the epithelial barrier and disrupt tight 
junctions (TJ) when the virus is coinfected.  
 
Chattoraj et al., 2011b, assessed the potential interactions of P. aeruginosa and 
rhinovirus in epithelial cells isolated from individuals diagnosed with CF. They report 
that IFN responses to rhinovirus are reduced by the presence of P. aeruginosa when 
CF epithelial cells are coinfected, while the reverse occurs in normal epithelial cells. 
The reduced IFN response increased virus replication in CF epithelial cells co-
infected with P. aeruginosa. Together, these data identify a complex interaction 
between rhinovirus and P. aeruginosa that may contribute to the exacerbations seen 
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in individuals with CF, whose lungs often contain P. aeruginosa biofilms even after 
antibiotic therapy (Rybtke et al., 2015). 
 
Collectively, these studies suggest that the role of bacteria in promoting viral 
infections may be varied and underreported. We were therefore interested to develop 
an in vitro model system to investigate this further and this required identification of a 
common niche that bacteria and viruses could interact in. 
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1.5 Epithelial barriers  
Epithelial barriers are one of the first defenses against infection. They are often 
colonized by bacteria and are the first point of infection for many viruses. To prevent 
infection they form both a physical and biochemical barrier. Polarization of epithelial 
cells creates a network of cells that are held together by junctional proteins (Fig.1.4a; 
reviewed by (Bergelson, 2009). There are two types of junctional complex between 
epithelial cells: TJs and adherens junctions (AJ) that prevent the movement of 
molecules between the apical and basolateral surfaces of the cell (Fig.1.4b). They 
also limit invasion of pathogens, together with mucous layers and antimicrobial 
peptides (Gallo and Hooper, 2012).  
 
Polarized epithelial surfaces include the respiratory, digestive and reproductive 
tracts. These sites are frequently exposed to foreign material, including microbial 
antigens and required to develop a tolerance these antigens whilst retaining the 
ability to recognize pathogens and mount an inflammatory response (Wissinger et al., 
2009). When studying epithelial cells in vitro, it is important to remember that unless 
cells are grown under the correct circumstances to facilitate polarization, there will be 
less distinction between apically- and basally-localized molecules as found in vivo 
and this may alter the interaction of microbes with the host cell. 
 
1.5.1 The gut epithelium 
The intestinal tract is the largest epithelial surface in the body and forms a 
biochemical barrier at the apical surface of epithelial cells (enterocytes) with mucosal  
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Figure 1.4 The structure of polarized epithelial cells. 
Adapted from Bergelson, 2009. a) Tight junctions (TJ) and adherens junctions (AJ) 
are protein complexes that separate the apical and basolateral membranes when 
epithelial cells are polarized and facilitate the formation of a barrier. b) TJs are 
composed of four types of protein; claudin, occludin, members of the junction 
adhesion molecule family including JAM and CAR, and members of the zonula 
occludens (ZO) protein family, they also interact with the actin network. AJs are 
composed of cadherin and nectin.  
a)  b) 
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layer(s) that can vary between different sites (Fig.1.5; reviewed by (Peterson and 
Artis, 2014). This allows commensal bacteria to grow and ideally prevents the 
disruption of homeostasis by pathogenic microbes. While immune cells are present, 
they are largely localized to the basal side of the epithelia. However, epithelial cells 
have pattern recognition receptors (PRR) to recognize MAMPs and contribute to 
inflammatory responses when necessary. They also transport secretory 
immunoglobulin A (sIgA) that can prevent bacterial-host cell receptor interactions and 
aid clearance. Secretory goblet cells produce mucins and Paneth cells also 
contribute to the anti-bacterial environment by secreting AMPs. AMPs, including 
defensins and cathelicidins, are broadly effective against a variety of bacterial strains 
and disrupt bacterial membranes. Immune sensing of the apical environment is 
performed by tissue resident macrophages that form dendrites to sample antigens, 
goblet cells and microfold (M) cells that can transport antigens to DCs on the 
basolateral surface. 
 
The bacterial community in the gut is estimated to comprise 70% of the total human 
microbiome and is supported by the nutrient rich environment, where it is involved in 
both health and disease (reviewed by (Sekirov et al., 2010). Two phyla are dominant, 
the Bacteroidetes and the Firmicutes, but the total number of species can be over 
1000. Studies using germ-free mice have determined that the gut microbiome is 
necessary for the development of the immune system, including two contrasting 
functions; tolerance to the microbiome to prevent continuous inflammation and 
detection of pathogenic microbes with the induction of inflammation to clear them.  
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Figure 1.5 Intestinal epithelial barriers. 
The composition of the epithelial barrier differs along the intestinal tract, from 
(Peterson and Artis, 2014) 1. In the small intestine there is a thick layer of mucus 
between villi that contains secretions such as antibody (sIgA), antimicrobial proteins 
(AMP) and trefoil factor 3 (TFF3), which contribute to the physical and chemical 
barrier required to regulate bacterial growth. While, apoptotic intestinal epithelial cells 
(IEC) are shed from the top of villi, intestinal epithelial stem cells (IESC) in the crypts 
renew many of the cell types present in the epithelium. Immune cells such as 
macrophages and dendritic cells are present to sample antigens present. 2. The 
follicle associated epithelial sites contain microfold (M) cells that can sample luminal 
antigens and present them to underlying immune cells. This requires a thinner 
mucosal layer. 3. The mucosal layer in the colon is much thicker and comprised of 
two different layers, as well as AMPs and sIgA. While commensal bacteria can 
penetrate the outer layer, the inner layer still forms a barrier. 
1 2 3 
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The presence of commensal bacteria also helps to control overgrowth of pathogenic 
bacterial species by competitive exclusion, which includes competition for nutrients 
and space. However, if homeostasis is altered then commensal bacteria can cause 
opportunistic infections or inflammation due to the presence of MAMPs, such as LPS 
and PGN, as seen during HIV infection. 
 
1.5.2 The lung epithelium 
The respiratory tract forms a biochemical barrier that comprises the apical surface of 
epithelial cells using mucous and AMPs. However, it also uses cilia to move any 
incoming microbes away from the lungs (Fig.1.6; reviewed by (Whitsett and 
Alenghat, 2015). The respiratory tract is constantly exposed to the environment and 
requires mucociliary clearance to keep the alveoli, where gas exchange occurs, 
almost completely sterile. The airways comprise ciliated epithelial cells that can 
detect MAMPs and secretory cell types such as serous and goblet cells that produce 
mucous, AMPs and fluids to aid bacterial clearance. To further monitor the 
environment; DCs and macrophages sample antigens, induce inflammation and 
phagocytose pathogens. Interestingly, alveolar macrophages can inhibit inflammation 
to control damage and maintain tissue homeostasis. Of note these macrophages 
express lower levels of major histocompatibility complex (MHC)II, which allows 
antigen presentation, compared to non-resident cells, and constitutively express IL-
10 (Wissinger et al., 2009). Both functions contribute to the tolerance necessary at 
epithelial surfaces. 
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Figure 1.6 The lung epithelial barrier. 
The composition of the lung epithelial barrier, adapted from (Whitsett and Alenghat, 
2015) Both ciliated and mucous-producing goblet epithelial cells form the apical 
barrier, with serous cells contributing host defense proteins in pericellular fluid. Fluid 
production and cilial beating are coordinated by the submucosal gland to move 
mucous and inhaled materials along the epithelium and away from areas of gas 
exchange. Basal cells are progenitors for ciliated and goblet cells. 
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The lungs can contain commensal bacteria, at low levels compared to the gut, which 
can contribute to immune education. Disruption of mucociliary clearance alters the 
lung microbiome and contributes to exacerbation in conditions including as COPD 
and CF, where commensal bacteria can cause opportunistic infections (Whitsett and 
Alenghat, 2015). 
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1.6 Effects of bacteria on epithelia 
Bacterial pathogens adhere to human cells to colonize or invade them. Many 
bacterial strains can adhere to epithelial monolayers and reduce their barrier 
function, to aid their cellular invasion or cross the barrier. To achieve this, bacteria 
commonly secrete effector proteins that interact with TJ proteins or the actin 
cytoskeleton (Kazmierczak et al., 2001). Examples of the mechanisms used to 
achieve this alteration in epithelial permeability are discussed below. 
 
Clostridium perfringens expresses an enterotoxin that binds to occludin and claudin 
TJ proteins and induces their degradation, to disrupt the polarized monolayer 
(Sonoda et al., 1999; Singh et al., 2000b). This leads to diarrheal symptoms and 
potentiates bacterial spread to spread to new hosts. A similar mechanism occurs for 
Vibrio cholerae, which uses its toxin to bind and degrade occludin (Wu et al., 2000). 
Helicobacter pylori uses a type IV secretion system to inject an effector protein, 
CagA, into gastric epithelial cells, where it associates with the TJ protein ZO-1. CagA 
then recruits the TJ proteins to the site of bacterial attachment, disrupting TJ contacts 
with neighbouring cells (Amieva et al., 2003).  
 
Enteropathogenic (EP) and enterohemorrhagic strains of Escherichia coli encode two 
proteins that perturb the host actin cytoskeleton and disrupt barrier function to allow 
bacteria to pass between epithelial cells. This is important for their pathogenicity, 
unlike other serotypes of E. coli that are not associated with pathologies. To disrupt 
actin structures, the translocated intimin receptor (Tir) is inserted into the host cell 
membrane where it binds the effector protein, intimin. Upon binding, Tir can 
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potentiate host tyrosine kinase signaling cascades to bring actin structures towards 
the bacterial cell and form a pedestal (Campellone, 2010). Interestingly, TJ disruption 
is well characterized for intestinal pathogens but not respiratory pathogens. However, 
P. aeruginosa is an opportunistic pathogen of the lung that is reported to take 
advantage of an already disrupted epithelium to initiate infection (Engel and Eran, 
2011). 
 
1.6.1 STm perturbs TJs 
Salmonella enterica serovar Typhimurium (STm) is a facultative intracellular, Gram-
negative bacterium and is associated with a self-limiting gastroenteritis in immune 
competent hosts (Zhang et al., 2003). However, it can cross the intestine and cause 
systemic disease. In sub-Saharan Africa, STm is the most common cause of 
bloodstream infections presenting with fever, with up to 25% mortality (Feasey et al., 
2012). In HIV-infected individuals not on ART, this mortality rate can reach 47% 
(Gordon et al., 2002).  
 
STm can infect epithelial cells, through TJ disruption (Fàbrega and Vila, 2013). It also 
infects M cells to reach innate immune cells across the epithelial barrier and DCs can 
form dendrites to capture STm on the apical surface of the epithelia (Fig.1.7; (Santos 
and Bäumler, 2004). These interactions can all lead to inflammation. Of the MAMPs 
secreted by STm, flagellin, a component of the bacterial flagella, is the major pro-
inflammatory determinant that activates NF-κB signalling in host cells (Zeng et al., 
2003).  
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Figure 1.7 STm crosses gut epithelial cells. 
Salmonella Typhimurium (STm) can invade its host through different pathways, 
adapted from (Garai et al., 2012) 1. The bacterium adheres to epithelial cells and 
induces membrane ruffling to facilitate uptake into a vacuole and subsequently 
release from the basal membrane (4) or apoptosis of the host cell (5), allowing 
dissemination and phagocytosis by immune cells. 2. Interactions with M cells lead to 
endocytosis and transport to immune cells on the basal side of the epithelium. 3. 
Dendrites from dendritic cells can reach between epithelial cells and phagocytose 
bacteria.  
	   	   	   	   	   
1 
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STm uses two type III secretion systems to invade and replicate within host cells that 
are encoded by Salmonella pathogenicity islands (SPI). These type III secretion 
systems are composed of needle-like protein structures that ‘inject’ effector proteins 
into the host cell. SPI-1 effector proteins can augment entry into non-phagocytic cells 
and SPI-2 effector proteins promote bacterial replication in the Salmonella containing 
vacuole (SCV;(Velge et al., 2012). The SPI-1 type III secretion system injects effector 
proteins SopB, SopE, SopE2 and SipA to decrease barrier function of polarized 
epithelia. These proteins alter the localization of TJ proteins ZO-1 and occludin by 
activation of Rho family GTPases, leading to actin remodelling, as well as decreasing 
the levels of ZO-1 and occludin in the cell (Boyle et al., 2006; Velge et al., 2012). 
Additionally, it has recently been reported that Salmonella can upregulate TJ protein 
claudin-2, referred to as the ‘leaky’ TJ protein. This was determined in vitro and in a 
mouse model of infection to augment bacterial invasion through increased cell 
permeability (Zhang et al., 2013). 
 
Further interactions between the SPI-1 effector proteins modulate host cell actin to 
induce ruffling of the cell membrane and allow the bacterium to enter the cell 
(McGhie et al., 2009). Once entered, STm induces the SCV to survive in host cells 
and evade immune responses (reviewed by (Steele-Mortimer, 2008). It is a modified 
phagosome, with SPI-2 effectors preventing lysosomal fusion and destruction of the 
bacterium. 
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1.7 Viral entry pathways  
Viruses must enter the host cell to replicate and produce new particles. Virus entry is 
initiated by attachment to specific host cell receptors via the viral glycoprotein(s). This 
allows internalization and the majority of viruses utilize the host cell endocytic 
machinery to enter the cell (reviewed by (Yamauchi and Helenius, 2013). This may 
be either clathrin-dependent or -independent, or via macropinocytosis. The virus 
particles can then escape into the cytoplasm to replicate (most RNA viruses) or gain 
transport to the nucleus where they can start replication (most DNA viruses). Escape 
from endocytic vesicles can occur in the early to late compartments, but also from the 
endoplasmic reticulum or the macropinosome. Furthermore, viruses can enter the 
host cell via direct fusion with the plasma membrane to deliver their genome. There 
is involvement of diverse host cell processes in viral entry mechanisms and some 
viruses can engage more than one pathway. 
 
1.7.1 Vesicular stomatitis virus (VSV) entry 
VSV, although not a common human pathogen, is the prototypic virus in the order 
Mononegavirales, which includes rabies, Ebola and mumps viruses (Bukreyev et al., 
2006). VSV entry into host cells has been well characterized and it can enter varied 
cell types, making it an attractive virus for gene therapy (Lévy et al., 2015). Entry is 
mediated by the VSV glycoprotein (G), which associates with clathrin-coated pits on 
the plasma membrane and is rapidly trafficked to early endosomes, also co-opting 
actin, where low pH causes fusion either in early or late endosomes (Fig.1.8;  
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Figure 1.8 VSV entry. 
From (Albertini et al., 2012) Vesicular stomatitis virus (VSV) particles attach to the 
host cell via LDL receptor family members and undergo clathrin-mediated 
endocytosis, which also requires dynamin and actin for efficient entry. Two pathways 
are proposed for escape from the endosome. 1. As the early endosome becomes a 
multivesicular body (MVB), particles can fuse with internal vesicles. This fusion 
releases the viral nucleocapsid. Once the MVB has matured to a late endosome, 
identified by increased presence of Rab 7 and decreased presence of Rab 5 found 
earlier in the pathway, vesicle fusion releases the nucleocapsid into the cytoplasm. 2. 
VSV particles fuse rapidly in early endosomes to release the nucleocapsid into the 
cytoplasm. 
1 
2 
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(Cureton et al., 2009; Hastie et al., 2013). It was recently reported that the entry 
receptor is the low-density lipoprotein (LDL) receptor and family members 
(Finkelshtein et al., 2013), which elucidates its broad cell tropism. Once VSV enters a 
host cell and produces new virions it can induce apoptosis, this has allowed it to be 
developed as an oncolytic virus for cancer therapy in cells without a robust IFN 
response (Hastie and Grdzelishvili, 2012). 
 
1.7.2 Other virus entry routes of interest  
Lassa virus fusion occurs in endosomes and is pH sensitive much like VSV (Cosset 
et al., 2009). However, entry is via multivesicular bodies as opposed to clathrin-
mediated (Pasqual et al., 2011) and α-dystroglycan is the main receptor (Cao et al., 
1998), although more entry factors have recently been identified (Shimojima et al., 
2012). MeV requires two glycoproteins, hemagglutinin (H) for entry and fusion (F) for 
fusion of virus-host and host-host membranes. The wild-type virus uses the receptors 
signalling lymphocyte activation molecule (SLAM)F1 and nectin-4 to enter cells 
(Mühlebach et al., 2011; Noyce et al., 2011). However, the Edmonston vaccine strain 
has an altered tropism for CD46 as opposed to nectin-4 (Dörig et al., 1993; Naniche 
et al., 1993). Fusion of MeV with the host cell surface is poorly defined, but it is 
reported to occur at neutral pH (Nakatsu et al., 2006). The pro-inflammatory cytokine 
TNF can promote the entry of MeV, Lassa and VSV pseudoparticles into polarized 
liver epithelial cells (Fletcher et al., 2014). 
 
The Ebola virus glycoprotein associates with C-type lectins on the host cell 
membrane, while host phosphatidylserine receptors can interact with 
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phosphatidylserine in the viral envelope, and the virion enters primarily through 
macropinocytosis (reviewed by (Moller-Tank and Maury, 2015). Interestingly, Ebola 
has another receptor in endosomes, Neimann-Pick disease, type C1 (NPC1), which 
assists virus fusion and release into the cytoplasm. Influenza HA binding to sialic 
acids has been reported to facilitate entry via various pathways including clathrin-
dependent and -independent endocytosis and more recently, macropinocytosis. 
Irrespective of initial entry pathway, fusion occurs in late endosomes at low pH 
(Edinger et al., 2014). HIV binds to cells via the receptor CD4 using glycoprotein 
gp120. Plasma membrane fusion is triggered by HIV gp41 using one of its host cell 
co-receptors, CCR5 or CXCR4 (Klasse, 2012).  
 
1.7.3 Modelling viral infection of epithelia  
Many viruses must cross epithelial barriers to enter the body, and some have been 
discovered to use TJ proteins as entry receptors (Bergelson, 2009; Fletcher et al., 
2012). This route translates into lower infection levels in polarized cells compared to 
non-polarized cells, due to inaccessibility of receptors. To maximize entry, viruses 
can alter the permeability of epithelial barriers directly, or by inducing inflammation. 
 
Coxsackievirus B3 and Adenovirus 5 (Ad5) both show limited infection of polarized 
gut cells via the apical or basal surface, unless ethylenediaminetetraacetic acid 
(EDTA) is included to disrupt the barrier function. This is due to localization of the 
coxsackievirus and adenovirus receptor in TJs (Cohen et al., 2001). Coxsackie 
viruses can induce their own movement to TJs, through interaction with the host cell 
membrane protein decay-accelerating factor and downstream signaling pathways to 
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induce actin cytoskeleton rearrangements (Coyne and Bergelson, 2006). Ad5 also 
shows restricted entry into polarized lung cells, compared to non-polarized cells, with 
a further decrease when the virus is administered apically rather than basolaterally. 
Interestingly, Ad5 can successfully infect polarized cells in the presence of 
macrophages, via induction of IL-8, which relocates the viral co-receptor from TJs to 
the apical surface (Lütschg et al., 2011). 
 
In a similar mechanism, cytokines secreted by macrophages can promote viral 
infection of polarized liver cells. Conditioned medium from macrophages stimulated 
by various agonists, including bacterial LPS, enhances HCV, measles (MeV), Lassa 
and VSV infection. TNF and IL-1β were determined to be the main effectors (Fletcher 
et al., 2014). This study used lentiviral pseudoparticles to determine the level of viral 
entry, without the presence of fully replicating virus. Lentiviral pseudoparticles are 
formed of an HIV core that packages a luciferase reporter gene, enveloped by host 
cell membrane containing the viral glycoprotein(s) of interest (Hsu et al., 2003). This 
allows investigation of viral entry without replication, distribution of new virions and 
secondary infections.  
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1.8 Aims  
The aim of this study was to further our understanding of bacterial-viral coinfection. 
Initially, by developing a model system to determine the effect of bacteria on virus 
infection, as the majority of research currently focuses on viral infection preceding 
bacterial. Bacteria and viruses both enter the body through epithelial surfaces and we 
chose to model this in vitro. Virus entry is often restricted on polarized epithelia and 
considering that certain bacteria can affect TJ integrity, we hypothesized that 
bacterial species able to increase epithelial permeability would increase virus entry. 
This stage of the viral lifecycle is easily modeled with lentiviral pseudoparticles, which 
were utilized for this study. Using this model system, we aimed to test various viruses 
and bacteria, to determine whether certain combinations can act synergistically or 
there are common interactions that would enable us to define the mechanism(s) 
leading to increased virus entry. Following the development of this model system 
using pseudoparticles, we were interested in assessing the role of bacterial stimuli in 
full-length virus infection. 
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2. MATERIALS & METHODS 
 
2.1 Cell culture 
All cell lines used in this study are described in Table 2.1. Unless otherwise stated, 
cells were maintained at 37°C (20% O2 and 5% CO2) in growth medium 
supplemented with 10% foetal bovine serum (FBS; Thermo Fisher Scientific, USA), 
1% non-essential amino acids (Thermo Fisher Scientific), 1% L-glutamine (Thermo 
Fisher Scientific) and 50 units/mL penicillin and streptomycin (P/S; Thermo Fisher 
Scientific). To facilitate polarization A549, Caco-2 and Calu-3 cells seeded at 9x104 
cells/cm2 in sterile TC-treated plates or 1x105 cells/transwell (12 mm diameter, 0.4 
µm pore size inserts; Corning, USA) for 7-14 days were fed with fresh medium 3x per 
week, both apically and basolaterally. In case of non-polarized culture, the cells were 
seeded at 1x105-3x105 cells/mL one day before use.  
 
2.2 Dextran flux assay 
To assess barrier integrity using the permeability coefficient, a protocol previously 
reported by (Glod et al., 2006), was modified. A549 and Caco-2 cells were grown on 
transwells for 1, 7 and 14 days as described above. Dulbecco’s modified Eagle’s 
medium (DMEM, phenol red-free; Thermo Fisher Scientific) containing 2% FBS and 2 
mg/mL 70 kDa Fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich) was added 
at time 0 to the apical side and the insert was moved to a well with fresh medium 
without FITC-dextran. Subsequent to incubation for 5 min at 37°C, the cells were 
moved again to a new well and this process was repeated for 30 min. The 
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basolateral medium was measured with excitation at 485 nm for emission at 520 nm 
using a microplate reader (Wallac Victor 1420) and compared to a standard curve of 
dextran movement through an empty transwell, using 2 µg/mL–80 ng/mL. The rate of 
dextran movement (mg/min) was determined for each cell type at each day post 
seeding. Rates were compared by calculating the permeability coefficient (cm/min) 
using the equation (1/((1/sample rate)/(1/standard curve rate)))/transwell surface 
area. 
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Name Tissue of origin Growth medium Source 
1G5 HIV reporter cell derived from the Jurkat T 
cell line (Human peripheral blood). Contain 
a luciferase reporter under transcriptional 
control of the HIV-1 LTR promoter and 
express CXCR4 (Aguilar-Cordova et al., 
1994) 
Roswell Park 
Memorial Institute 
(RPMI)-1640 
Professor Ariberto Fassati,  
University College London,  
London,  
UK 
293T Human embryonic kidney DMEM American Type Culture 
Collection (ATCC)  
A549 Human lung carcinoma DMEM ATCC 
A549-SLAM A549 cells stably transfected with human 
SLAMF1 by HIV-1 based transduction 
using a puromycin resistant bi-cistronic 
transcriptional cassette  
DMEM 
supplemented with 
1 µg/mL puromycin 
(Thermo Fisher 
Scientific) 
Dr Dalan Bailey,  
University of Birmingham, 
Birmingham,  
UK 
Caco-2 Human colon adenocarcinoma DMEM ATCC 
Calu-3 Human lung adenocarcinoma Eagle’s minimum 
essential medium 
(EMEM; Thermo 
Fisher Scientific) 
ATCC 
Detroit 562 Human pharyngeal carcinoma EMEM Dr Andrea Mitchell, 
University of Birmingham, 
Birmingham,  
UK 
Huh-7 Human hepatoma DMEM Dr Charles Rice, 
Rockerfeller University,  
New York, 
USA  
PM1 Derivative of HuT 78 human cutaneous T 
cells RPMI-1640 NIBSC Centre for AIDS Reagents, UK 
SupT1 Human T cell lymphoblastic lymphoma RPMI-1640 ATCC 
TZM-bl HIV reporter cell derived from HeLa human 
cervical epithelial cells. Contain a luciferase 
reporter under transcriptional control of the 
HIV-1 LTR promoter and express the HIV-1 
co-receptors CXCR4 and CCR5 (Wei et al., 
2002) 
DMEM Professor Bill Paxton, 
University of Liverpool,  
Liverpool, 
UK 
 
Table 2.1 Characteristics of the cell lines used in this study. 
The name used throughout this work, tissue of origin, growth medium and source for 
each cell line cultured. 
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2.3 Pseudoparticle (pp) generation and infection 
Ebola pp, influenza pp, Lassa pp, MeVpp, VSV-Gpp and non-enveloped (NE)pp were 
produced as described previously (Hsu et al., 2003). 293T cells were plated on poly-
L-lysine (Sigma-Aldrich) coated plates and transfected with equal quantities of 
pNL4.3e-r-luciferase and envelope construct plasmids (see Table 2.2) using fugene 6 
(Promega, USA). To make green fluorescent protein (GFP)-tagged pseudoparticles 
(GFPpp), cells were transfected with plasmids containing the viral glycoprotein of 
interest, gag-pol and CSGW in optimem medium that was subsequently replaced 
with 3% FBS/DMEM without P/S 6h post-transfection. Pseudoparticles were 
collected at 48h and 60h post-transfection, the stocks were pooled, clarified by 
centrifugation at 2500 rpm for 10 min and passed through 0.22 µM filters before 
storing at -80°C. Cells were infected in triplicate and incubated for 48h. The 
supernatant was removed (in some cases used for cytotoxicity assay as described 
later), cells were lysed and an equal volume of luciferase substrate added (Promega, 
UK) to be read for 10 s/well in a Centro LB 960 microplate luminometer (Berthold 
Technologies, UK). Values are plotted as relative light units (RLU), dilution factors 
removed and where NEpp is not shown it has been subtracted from all samples. 
 44 
 
Plasmid name used in text Description  Reference 
pNL4.3e
-
r
-
luciferase HIV-1 replication-deficient core that 
packages the luciferase gene  Hsu et al., 2003 
For GFPpp: 
Gag-pol 
CSGW 
 
HIV-1 replication-deficient core  
HIV-1 vector that packages the GFP 
gene 
 (Hatziioannou et al., 
2005) 
Ebola Glycoprotein from the Zaire Mayinga 
strain  (Long et al., 2015) 
HIV-1 Glycoprotein from the LAI strain  Professor Bill Paxton,  
 University of Liverpool,  
 Liverpool, 
 UK 
For influenza: 
Hemagglutinin 
Neuraminidase 
Glycoproteins from the H7N1 strain  (Ohuchi et al., 1994) 
Lassa Glycoprotein from the AV strain  Cosset et al., 2009 
For MeV: 
Hemagglutinin 
Fusion 
Glycoproteins from the Edmonston 
strain  (Schoenhals et al., 2012) 
  
VSV Glycoprotein from the Indiana strain  Hsu et al., 2003 
Control Empty vector for NEpp  Hsu et al., 2003 
 
Table 2.2 Plasmids used for pseudoparticle generation in this study. 
The name used throughout this study, description of genes encoded and reference 
for each plasmid used to generate lentiviral pseudoparticles.
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2.4 Lactate dehydrogenase (LDH) cytotoxicity assay 	  
To determine the effect of drug treatments or bacterial exposure on epithelial cell 
viability, the CytoTox 96 non-radioactive cytotoxicity assay (Promega) was used to 
detect LDH release according to manufacturer’s instructions. Cell supernatants were 
collected, clarified and incubated with an equal volume of CytoTox 96 reagent for 30 
min at room temperature (r.t.). An equal volume of stop solution was added and the 
absorbance was measured at 490 nm using a Multiskan Ascent platereader (Thermo 
Electron Corporation). To determine 100% cell lysis, a positive control was obtained 
by freeze-thaw lysing untreated cells and measuring released LDH. 
 
2.5 Bacterial culture 
Bacterial strains used in this study are described in Table 2.3. Bacteria were stored 
as glycerol stocks in 20% glycerol (v/v) at -80°C or on Luria-Bertani (LB; Thermo 
Fisher Scientific) agar plates at 4°C. When needed for infection, bacteria were grown 
overnight in LB broth or DMEM (supplemented with 25 mM HEPES; Thermo Fisher 
Scientific) containing appropriate antibiotics at 37°C with aeration (200 rpm), 
inoculated into fresh broth or medium at a ratio of 1:50 and allowed to grow to mid-
logarithmic phase (OD600 of 0.5). Bacteria grown in LB were washed 3x with 
phosphate buffered saline (PBS; Thermo Fisher Scientific) and resuspended in 10% 
FBS/DMEM for addition to epithelial cells. To enumerate the colony forming units 
(CFU) of the bacterial stock added to epithelial cells, which was then used to 
determine multiplicity of infection (MOI), the samples were diluted in PBS x10-1 to 
x10-6 and 5 µL of each dilution added in triplicate to LB plates. After overnight  
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Species and strain Reference and/or source 
Bacillus subtilis  
(NCTC 3610) Professor Laura Piddock, University of Birmingham,  
Birmingham,  
UK 
EP E. coli  
(O127:H6 E2348/69) Professor Laura Piddock 
Klebsiella pneumoniae 
(NCTC 9633) Professor Laura Piddock 
P. aeruginosa  
(PA14) Professor Ian Henderson, University of Birmingham,  
Birmingham,  
UK 
Aflagellate P. aeruginosa  
(PA14 fliC::Tn Gm15) Professor Ian Henderson (Liberati et al., 2006) 
STm  
(SL1344) (Hoiseth and Stocker, 1981) 
Aflagellate STm  
(SL1344 fliC::cat fljB::aph) Dr Robert Kingsley, Institute of Food Research. 
Norwich, 
UK 
Attenuated STm 
(SL3261) (Hoiseth and Stocker, 1981) 
STm ΔSPI-1  
(SL1344 SPI-1::aph) Professor Laura Piddock 
STm ΔSPI-2  
(SL1344 ssaV::aph) (Guy et al., 2000) 
S. aureus 
(NCTC 8532) Professor Laura Piddock  
 
Table 2.3 Bacterial strains used in this study. 
The strain details and reference and/or source for each bacterial species assessed. 
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incubation at 37°C, the colonies were counted for one dilution and multiplied by 
dilution factors to determine CFU/mL. Bacteria were heat killed at 100°C for 20 min 
and the absence of viable bacterial cells was verified by overnight culture on LB 
plates. 
 
Aflagellate STm was constructed by allelic exchange using the method previously 
described (Datsenko and Wanner, 2000) using primers 
taacgcagtaaagagaggacgttttgcggaacctggttcgcctgcgccagaacggaCATATGAATATCCTCCT  
and ggcacaagtcattaatacaaacagcctgtcgctgttgacccagaataacctgaacaaTGTGTAGGCTGGAGCTGCTTC 
specific for fliC and  
ttaacgtaacagagacagcacgttctgcgggacctggttagcctgcgccagaacgCATATGAATATCCTCCTTAG  
and ggcacaagtaatcaacactaacagtctgtcgctgctgacccagaataacctgaacaaTGTGTAGGCTGGAGCTGCTTC  
for amplification of cat (chloramphenicol resistance) and aph (kanamycin resistance) 
genes, respectively. Specific replacement of each gene was tested by PCR 
amplification of the chromosomal region using specific primers flanking the mutation 
sites. The resultant strain with double gene replacement of fliC and fljB was 
confirmed as non-motile.  
 
To determine the adhesion and invasion of bacteria into epithelial cells, bacteria were 
added to cells in 24-well plate and incubated for 1h. Adhered bacteria were quantified 
by washing epithelial cells 3x with phosphate buffered saline (PBS) and lysing with 
1% triton X-100 (Sigma-Aldrich) for 10 min. Lysate was serially diluted and plated to 
count CFU. Internalized bacteria were quantified by washing the cells and incubating 
them in 100 µg/mL gentamicin (Thermo Fisher Scientific) for 30 min to kill external 
bacteria. The cells were lysed and plated to determine CFU as described above. 
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2.6 Bacterial-viral infection studies 
Cells were treated with bacteria, conditioned medium (CM), STm TLR grade LPS 
(Enzo Life Sciences, UK) or flagellin (STm FliC purified as previously described by 
Flores-Langarica et al., 2015; P. aeruginosa PA-Fla, InvivoGen, USA) for 1h using 
medium without P/S throughout the assay when bacteria were present. 
Pseudoparticles were added with 34 µg/mL chloramphenicol or 40 µg/mL tobramycin 
(Sigma-Aldrich) and the cells incubated for 48h prior to lysis and measurement of 
luciferase activity. When using gentamicin, 30 min post-STm addition the bacteria 
were removed and antibiotic was added at 50 µg/mL with VSV-Gpp. Cells were 
incubated for 30 min with the virus and high concentration of antibiotic, washed 1x 
with medium, and then incubated for 48h with medium containing a low concentration 
of gentamicin (5 µg/mL). To determine virus entry, cells were lysed and an equal 
volume of luciferase substrate added (Promega, UK) to be read for 10 s/well in a 
Centro LB 960 microplate luminometer (Berthold Technologies, UK). Relative 
pseudoparticle entry was calculated by subtracting the NEpp signal and expressing 
the treated signal relative to the untreated control.  
 
To determine the rate of virus entry, cells were treated with STm for 1h, VSV-Gpp 
was added for 1h and the cells were washed three times with medium to remove 
external virus at time points specified, then incubated with fresh medium for 24h. 
Cells were lysed to quantify luciferase. 
 
To test GFPpp, cells were treated with bacteria for 1h. Pseudoparticles were added 
with chloramphenicol and the cells were incubated for 48h. For flow cytometry, cells 
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were PBS washed, trypsinized and fixed with 4% paraformaldehyde (PFA; TAAB, 
UK). Fluorescence at 488 nm was measured using a CyAn ADP Analyzer (Beckman 
Coulter, USA). Using FlowJo 7.6.1 software, the live cell population was selected and 
the GFP+ population analyzed to determine virus infected cells. 
 
2.7 Confocal microscopy  
TJ protein localization: Cells were grown on coverslips overnight and incubated with 
STm (MOI 10) at 37°C for 1h before fixing with 4% PFA. Cells were permeabilized 
with 0.1% Triton X-100 and incubated with 2 ug/mL rabbit α-ZO-1 or mouse α-
occludin (Thermo Fisher Scientific) followed by goat α-rabbit Alexa fluor 594 or goat 
α-mouse Alexa fluor 488 (Thermo Fisher Scientific). Nuclei were counterstained with 
4′,6-diamidino-2-phenylindole (DAPI; Thermo Fisher Scientific) and coverslips were 
mounted with ProLong Gold (Thermo Fisher Scientific). Cells were imaged using a 
Zeiss 510 META confocal microscope with 63x objective and LSM software. 
 
STm and GFPpp coinfection: Cells were grown on coverslips overnight and 
incubated with STm (MOI 10) at 37°C for 1h before addition of VSV-Gpp containing a 
GFP reporter and chloramphenicol. After 48h incubation, cells were fixed with PFA 
and permeabilized. To visualize STm, cells were incubated with mouse α-LPS (1E6; 
Thermo Fisher Scientific) followed by goat α-mouse Alexa fluor 633 and DAPI. 
Coverslips were mounted with ProLong Gold and cells were imaged using a Zeiss 
510 META confocal microscope with 40x objective and LSM software. 
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Transferrin or dextran uptake: Cells were grown on coverslips overnight and 
incubated with 1 µg/mL human transferrin-Alexa Fluor 488 conjugate (Thermo Fisher 
Scientific) or 250 µg/mL 10 kDa dextran Oregon green 488 (Thermo Fisher Scientific) 
in serum free medium for 1h. Cells were fixed with PFA, permeabilized and incubated 
with mouse α-CD81 (2s131, in house) followed by goat α-mouse Alexa fluor 594 
(Thermo Fisher Scientific) and DAPI. Coverslips were mounted with ProLong Gold 
and cells were imaged using a Zeiss 510 META confocal microscope with 100x 
objective and LSM software. 
 
2.8 IL-8 enzyme linked immunosorbent assay (ELISA) 
Supernatants were collected from infected cells and stored at -20°C. IL-8 was 
measured by ELISA using the manufacturer’s instructions (Thermo Fisher Scientific) 
and absorbance measured at 450 nm using an Multiskan Ascent platereader. 
 
2.9 Luciferase reporter gene transfection 
Two protocols were used to test promoter activity of the luciferase plasmid following 
addition of bacteria. (1) A549 cells seeded in a 6-well plate and transfected with 1.6 
µg pNL4.3env-rev-luciferase using fugene 6 were incubated for 24 hr. The cells were 
trypsinized, re-seeded in a 96-well plate and incubated for a further 24h. Bacteria 
were prepared as detailed in 2.5 and added in triplicate before incubation at 37°C for 
1h when chloramphenicol was added in 10% FBS/DMEM at final concentration of 34 
µg/mL and the cells were incubated for a final 24h. The cells were lysed and 
measured for luciferase signal as detailed earlier. (2) A549 cells were seeded in a 
24-well plate, bacteria were added for 1h, 10% FBS/DMEM was removed and 
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optimem medium with 34 µg/mL chloramphenicol was added for fugene 6 
transfection of pNL4.3env-rev-luciferase. Transfection mix was incubated for 6h and 
removed to culture the cells in 10% FBS/DMEM containing chloramphenicol for the 
remaining 18h. Cells were lysed to determine luciferase activity. 
 
2.10 Generation of CM 
Bacteria were cultured in DMEM overnight, medium was spin clarified and filtered 
through 0.22 µm. Absence of bacterial cells was verified by overnight culture on LB 
plates. Proteinase K (PrK) treatment of CM involved incubation of CM with PrK (50 
µg/mL; Sigma-Aldrich) for 30 min and heat inactivation of PrK at 100°C for 5 min 
prior to addition to epithelial cells. CM was prepared for sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) by concentrating with trichloroacetic 
acid (TCA) from 30 mL to 100 µL and 10 µL and running in a 12% gel with a 
prestained protein ladder (Geneflow, UK). Proteins present in the gel were detected 
by Coomassie staining (Sigma-Aldrich). Size fractionation was achieved using 
Vivaspin centrifugal concentrators (Sartorius, Germany). CM was added to the top of 
molecular weight cut-off columns of various pore sizes, spun at 4000 g for 20 min 
and samples collected from the top and bottom were added to cells for 1h prior to 
VSV-Gpp. To deplete flagellin from CM, STm was grown in RPMI, spin clarified and 
filtered through 0.22 µm for affinity chromatography using α-FliC monoclonal 
antibody by Dr Margaret Goodall at the Monoclonal Production Unit, University of 
Birmingham.  
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To prepare CM for mass spectrometry, 50 mL STm CM produced using phenol red 
free DMEM was centrifuged in a 100 kDa Vivaspin, the top fraction was dialysed in a 
10 kDa Slide-A-Lyzer cassette (Thermo Fisher Scientific) in ddH2O and tested on 
A549 cells with VSV-Gpp to ensure activity. Samples were sent to the Advanced 
Mass Spectrometry Facility, University of Birmingham, to assess protein fragments 
present using an Orbitrap mass spectrometer. The Sequest algorithm was used to 
determine STm specific proteins. 
 
2.11 Addition of antibody to flagellin and VSV-Gpp 
Mouse sera from four PBS-immunized and four STm FliC-immunized mice, and 
flagellin ELISA data, were provided by Dr Adriana Flores-Langarica, University of 
Birmingham. The sera were pooled and heat inactivated at 56°C for 20 min. Flagellin 
was incubated with serially diluted sera for 30 min and added to cells for 1h prior to 
VSV-Gpp addition. 
 
2.12 Addition of MLN4924 to flagellin and VSV-Gpp 
To determine the effect on NF-κB activation, A549 cells were transfected using 
fugene 6 with plasmid pConA-luciferase (Andrew MacDonald, University of Leeds), 
which contains a luciferase reporter under the control of NF-κB binding sites. At 24h 
post-transfection cells were treated with STm, CM or flagellin for 1h and 
chloramphenicol added. Cells were incubated for 24h prior to lysis and measurement 
of luciferase activity.  To find the optimal concentration of MLN4924 (R&D Systems, 
USA), A549 cells were transfected with pConA-luc and 24h post-transfection were 
pre-treated with MLN4924 for 15 min prior to inoculation with STm. To determine the 
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effect of MLN4924 on pseudoparticle infection studies cells were pretreated with 
MLN4924 prior to addition of STm, CM or flagellin and pseudoparticle or HIV-1 
infection. 
 
2.13 Silencing with siRNA  
A549 cells were transfected according to manufacturer’s instructions (Dharmafect 1; 
Thermo Fisher Scientific) with ON-TARGETplus smart pool siRNA to human TLR5, 
RelA or non-targeting control (Dharmacon, USA) 24h prior to treatment with flagellin 
and pseudoparticle infection. Subsequently, the cells were incubated for 48h and 
lysed for luciferase assay, RNA preparation for PCR or western blotting. 
 
PCR: RNA was prepared using the Qiagen RNeasy kit and amplified for TLR5 using 
human TLR5 primer pair Hs01019558_m1 (Thermo Fisher Scientific) in a quantitative 
reverse-transcription PCR (qRT-PCR) in accordance with the manufacturer’s 
guidelines (CellsDirect kit; Thermo Fisher Scientific) and fluorescence was monitored 
in a 7500 real-time PCR machine (Thermo Fisher Scientific). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was included as an endogenous control for 
amplification efficiency, and TLR5 amplification normalized to GAPDH using the 
ΔΔCt method. Western blotting: Proteins were separated using an 8% SDS-PAGE 
gel, transferred to PVDF membrane (Merck Millipore, USA) and probed using primary 
rabbit α-RelA (Cell Signaling Technology, USA) or mouse α-beta-actin (Sigma-
Aldrich) and secondary donkey α-rabbit-HRP antibody or sheep α-mouse-HRP (GE 
Healthcare, USA). Membranes were incubated in EZ-ECL prior to image capture 
using a PXi multi-application gel imaging system (Syngene, UK). 
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2.14 Product enhanced reverse transcriptase (PERT) assay 
Lentiviral particle associated reverse transcriptase (RTase) activity was detected 
using the PERT assay as previously described (Pizzato et al., 2009; Vermeire et al., 
2012). Supernatant or whole cell samples lysed by equal volume of 2x lysis buffer 
(0.25% triton X-100, 50 mM KCl, 100 mM TrisHCl pH 7.4, 40% glycerol) was added 
to the reaction mix (QuantiTect SYBR green buffer; Qiagen, Germany) containing 
double distilled (ddH2O) RNase free water, forward and reverse MS2 primers 
(Thermo Fisher Scientific), MS2 RNA (Roche, Switzerland) and RNase inhibitor 
(Thermo Fisher Scientific) in a 96-well PCR plate. A standard curve was prepared 
using HIV-1 RTase (Abnova, Taiwan). Using a Mx3000P qPCR system (Agilent 
Technologies, USA), the thermal cycler conditions used were 10 min at 45°C, 15 min 
at 95°C and 50 cycles of amplification, consisting of 10 s at 95°C and 30s at 60°C. 
The PCR cycle ended with a melting curve cycle of 1 min at 95°C, 30 s at 55°C and 
30 s at 95°C. The standard curve was used to determine units (U) of RTase activity. 
 
2.15 HIV-1 generation and infection 
293T cells plated on poly-L-lysine coated plates and transfected with the pNL4.3 full-
length HIV-1 plasmid using fugene 6 and optimem. As mentioned in section 2.3, the 
cells were transfected for 6h at 37°C and the media replaced with 3% FBS/DMEM 
without P/S. Subsequently, virus collected at 48h and 60h post-transfection, the 
stocks were pooled, clarified by centrifugation at 2500 rpm for 10 min and stored at -
80°C. Cells infected in triplicate and incubated for 24h (TZM-bl cells) or 48h (1G5 and 
SupT1 cells) were lysed to assess luciferase activity. In parallel, the supernatant 
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collected from each well was clarified and stored at -80°C for PERT assay or titration 
on TZM-bl cells to quantify HIV-1 produced. 
 
2.16 Flagellin-pseudoparticle binding assay 
Flagellin was incubated with pseuodparticles for 1h at 37°C and Ni-NTA agarose 
beads (Qiagen) were added. This was mixed for 1h at r.t. on a rotary mixer and 
loaded into a propylene column (Sigma-Aldrich). The flow through was collected and 
the beads were PBS-washed 5x and samples collected. Flagellin was eluted using 
100 mM imidazole and samples were collected from all 5 elutions. The flow through, 
washes and elutions were assessed for pseudoparticles by PERT assay. 
 
2.17 Inhibitor panel assay 
Cytochalasin D (10 µM), jasplakinolide (1 µM), bafilomycin A1 (5 µM), chloroquine 
(50 µg/mL), blebbistatin (50 µM), 5-(N-ethyl-N-isopropyl) amiloride (EIPA; 50 µM) 
were kindly donated by Dr Dalan Bailey with data confirming the optimum 
concentration to use on A549 cells without cytotoxicity from Daniel Gonçalves-
Carneiro. Each inhibitor was added to cells at the concentration indicated for 30 min 
prior to flagellin and maintained throughout flagellin incubation for 1h and the 
subsequent addition of VSV-Gpp. After 1h virus infection, the cells were washed and 
fresh medium was added for the remaining 48h. Cells were lysed to determine 
luciferase activity and supernatant was stored at -20°C for quantification of IL-8 by 
ELISA. 
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2.18 Transferrin and dextran uptake assays 
To assess clathrin-mediated endocytosis a protocol previously reported by (Junutula 
et al., 2004) was modified. Two plates of A549 cells were treated with flagellin, while 
after 1h one plate was moved from 37°C to 4°C, the second plate was maintained at 
37°C. Cells in both plates were treated with 1 µg/mL human transferrin-Alexa Fluor 
488 conjugate in serum free medium. Cells were PBS washed, trypsinized and PFA 
fixed at indicated time points for flow cytometry using a CyAn ADP Analyzer. 
Background fluorescence from cells at 4°C, which would not allow internalization of 
transferrin, was removed from 37°C samples.  
 
Macropinocytosis was monitored by modifying a protocol previously reported by 
(Krzyzaniak et al., 2013). Briefly, A549 cells were treated with flagellin or phorbol 12-
myristate 13-acetate (PMA; kindly donated by Dr Dalan Bailey with data confirming 
the optimum concentration to use on A549 cells for macropinocytic uptake from 
Daniel Gonçalves-Carneiro) for 1h and 250 µg/mL of 10 kDa dextran Oregon green 
488 in serum free medium was added. At indicated time points, cells were washed 
with bleach buffer (10 mM sodium acetate, 50 mM NaCl, pH 5.5) to remove non-
internalized dextran and PBS, trypsinized and PFA fixed for flow cytometry using a 
CyAn ADP Analyzer.  
 
2.19 Isolation of primary CD4+ T cells 
CD4+ T cells were isolated using the EasySep human CD4+ T cell enrichment kit 
(Stemcell Technologies, Canada). Donated human blood was layered over 
lympholyte-H (Cedarlane, Canada) and centrifuged for 20 min at 800 g, r.t. 
 57 
Peripheral blood mononuclear cells were removed from the blood-lympholyte 
interface using a Pasteur pipette, resuspended in RPMI and centrifuged at 800 g for 
5 min to wash 3x using fresh RPMI. After the final wash, cells were resuspended in 
2% FBS/PBS containing 1 mM EDTA, enrichment cocktail was added and the cells 
were incubated for 10 min at r.t. Magnetic particles were added, incubated for 5 min 
at r.t. and the cells were placed into a magnet (Stemcell techinologies). After 5 min, 
the remaining cells in suspension were removed, centrifuged at 2000 rpm for 3 min 
and resuspended in 10% FBS/RPMI containing P/S and IL-2 for culture at 37°C until 
use.  
 
2.20 Statistical Analysis  
Statistical analyses were performed using Student t test for bar charts or linear 
regression for XY graphs in Prism 6.0 (GraphPad, USA) with P  <  0.05 being 
considered statistically significant.  
 
We use the term biological replicates to mean measurements of the same protocol 
run at different times with biologically distinct samples. These account for biological 
variation. We use the term technical replicates to mean repeated measurements of 
the same sample. These account for the variation associated with protocols or 
equipment. 
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3. DEVELOPMENT OF A MODEL TO STUDY BACTERIAL-VIRAL COINFECTION  
 
3.1 Introduction 
Virus entry into polarized epithelial cells can be restricted by the localization of host 
cell receptors, which can include TJ proteins (Bergelson, 2009; Fletcher et al., 2012). 
Pro-inflammatory mediators can increase epithelial permeability; this leads to a 
reorganization of these receptors that can increase virus internalization (Lütschg et 
al., 2011; Fletcher et al., 2014). Bacteria can also alter epithelial cell permeability to 
facilitate their own invasion, such as STm effectors SopB, SopE, SopE2 and SipA 
disrupting TJs (Boyle et al., 2006). Epithelial barriers are frequently colonized by 
bacteria and provide the first site in the host that viruses encounter. We hypothesized 
that bacterially induced changes in epithelial permeability promote virus entry.   
 
In this chapter, we present the development of a model system to investigate the 
effect of bacteria on virus infection. We selected to study virus entry as the first, and 
often rate-limiting, step in the life cycle and to use lentiviral pseudoparticles to 
quantify receptor-dependent virus internalization (Fig.3.1). This system produces 
particles comprising an HIV core, enveloped by cell membrane carrying heterologous 
envelope glycoproteins of the virus of interest that define receptor specific entry into 
the target cell via receptor-mediated interactions. Once the viral glycoprotein has 
enabled particle entry and fusion with host cell membranes, the HIV capsid uncoats  
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Figure 3.1 Pseudoparticles as a reporter system for virus entry. 
Pseudoparticles are produced by 293T producer cells transfected with a plasmid 
encoding the HIV genome; minus the env and rev genes, with a firefly luciferase 
reporter gene added; and a plasmid encoding the glycoprotein(s) of the virus of 
interest such as VSV-G. Assembly of the HIV core, containing HIV RNA with the 
luciferase gene, at the host cell membrane incorporates the glycoprotein(s) during 
release. Pseudoparticles are harvested from the supernatant of the producer cells. 
Pseudoparticle entry into target cells: 1. Pseudoparticles carrying the VSV 
glycoprotein enter the host cell through low-density lipoprotein (LDL) family receptors 
(Finkelshtein et al., 2013). Non-enveloped pseudoparticles (NEpp) are a control virus 
particle from producer cells that are not transfected with a viral envelope 
glycoprotein. NEpp can be taken up through non-specific routes and all quantification 
of background particle uptake in each cell line tested. 2. Once particles have entered 
the cell, the host and viral membranes fuse to release the HIV capsid core, which 
transports to the nucleus to allow the genome to integrate (3). 4. Expression of the 
reporter gene, luciferase, is driven by the HIV long-terminal repeat (LTR) promoter 
and luciferase is produced. To quantify virus entry, target cells are lysed and 
luciferase substrate is added, allowing measurement of relative light units (RLU) 
emitted. 
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and releases viral RNA that is transcribed and encodes a luciferase reporter gene to 
allow quantification of virus entry by luciferase activity. 
 
We decided to initially focus on VSV-Gpp and STm. VSV has a well-understood entry 
pathway and broad cell tropism, meaning is frequently used for developing gene 
therapies (Lévy et al., 2015). STm is a model Gram-negative organism that infects 
epithelial cells, for which there are many tools for genetic manipulation (Garai et al., 
2012). Importantly, STm is able to induce changes in epithelial cell permeability, as 
discussed above, within 4h (Boyle et al., 2006). However, it can kill cells in culture, 
reportedly after 12h (Fink and Cookson, 2007). Considering that pseudoparticles 
require 24h-72h to allow sufficient luciferase production, we chose to model short-
term exposure to STm for 1h and to include an antibiotic when adding VSV-Gpp, to 
prevent bacterial overgrowth and host cell death. In this chapter we present data on 
establishing and optimizing a model system to study the effects of STm-mediated 
changes in epithelial permeability on virus entry. 
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Results 
3.2 Modeling epithelial barriers 
We chose to study the effect of bacteria on virus entry into epithelial monolayers from 
the lung and gut, two sites of the body that are frequently colonized by bacteria and 
represent points of entry for many viruses. There are numerous epithelial cell lines 
that polarize in vitro and model these sites. We selected A549 human lung carcinoma 
cells and Calu-3 human lung adenocarcinoma cells. While Calu-3 cells are reported 
to polarize well, there are conflicting reports on the ability of TJs between A549 cells 
to develop transepithelial electrical resistance, one measure of the formation of 
barrier integrity required to allow polarization (Törmäkangas et al., 2010). Another 
technique to assess epithelial barrier integrity is to monitor the flux of a fluorescent 
molecule from apical to basolateral media using cells grown on transwells. Using this 
measurement, we demonstrate that both A549 and Calu-3 cells form a barrier within 
7 days of seeding on transwells and maintain this for 14 days (Fig.3.2a-b). 
 
We also selected to study Caco-2 cells, a well-characterized model of the gut 
epithelium (Natoli et al., 2012; Dean et al., 2013). Caco-2 cells were previously 
reported to polarize within 6 days of reaching confluence (Mee et al., 2008). 
However, our experiments showed that 14 days were required to reach optimal 
barrier integrity (Fig.3.2c). Furthermore, electron microscopy studies have shown 
that by 14 days an apical brush border forms, mimicking the structure of enterocytes 
in vivo (Hughson and Hopkins, 1990), making these cells a more physiological model 
than other intestinal cell lines. 
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Figure 3.2 Integrity of epithelial cell barriers over time. 
a-c) Barrier integrity developed per cell type was quantified by monitoring fluorescent 
dextran movement from the apical to basolateral medium of epithelial cells cultured 
on transwell inserts for the number of days indicated. The rate of dextran movement 
through each monolayer was calculated by collecting samples of basolateral medium 
at 5 min intervals for 30 min, following apical addition of 70 kDa FITC-dextran, and 
measuring fluorescence in each sample compared to a standard curve. The rate is 
represented as a permeability coefficient: the amount of dextran that will flow per min 
per cm of cells. Representative of 2 biological replicates, error bars show standard 
deviation (SD) of 2 technical replicates.  
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3.3 STm increases VSV-Gpp entry 
First, we assessed whether polarization limits VSV-Gpp infection of A549 and Caco-2 
cells. A549 cells supported significantly less virus entry when polarized and Caco-2 
cells showed a trend towards less entry (Fig.3.3a-b). These data represent the RLU 
values generated by VSV-Gpp infection of A549 and Caco-2 cells, with NEpp 
background values removed. Typical NEpp values were between 300 and 500 RLUs. 
Subsequent data assessing the effect of treatment on pseudoparticle entry will be 
presented as relative to the untreated control cells. 
 
Bacteria such as STm are often grown in LB broth. Before assessing the effect of 
bacteria on A549 or Caco-2 cells permissivity to support viral uptake, we assessed 
the effect of LB on VSV-Gpp infectivity (Fig.3.4a). We observed that LB reduced 
VSV-Gpp entry and in the following experiments bacteria were washed with PBS to 
remove LB broth and resuspended in cell culture media, prior to adding to epithelial 
cell cultures.  
 
Co-culturing bacteria and epithelial cells for 24h resulted in bacterial over-growth and 
cell death (data not shown). We therefore tested two bacteriostatic antibiotics that 
would halt growth of the bacteria without killing them (Rahal and Simberkoff, 1979; 
Chopra and Roberts, 2001). Preliminary tests showed that chloramphenicol affected 
A549 cell permissivity to VSV-Gpp to a lesser extent than tetracycline (Fig.3.4a) and 
we selected chloramphenicol for further experiments.  
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Figure 3.3 VSV-Gpp entry is restricted into epithelial cells.	   
a-b) VSV-Gpp entry into polarized cells compared to non-polarized was assessed by 
infecting cells with equal volumes of the same stock of VSV-Gpp and quantifying by 
luciferase assay at 48h. Data presented are net RLU minus RLU obtained for NEpp 
infection in each condition. Representative of 2 biological replicates, error bars show 
SD of 3 technical replicates, statistical comparison by Unpaired t test: n.s. = P > 0.05, 
* = P ≤ 0.05. 
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Figure 3.4 Optimization of conditions for bacterial addition to epithelial cells. 
a) Polarized cells were treated with 1:2 vol/vol LB broth, 34 µg/mL chloramphenicol 
or 20 µg/mL tetracycline for 1h prior to VSV-Gpp addition and entry was quantified by 
luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. b) Polarized A549 cells were incubated with stated MOI of STm 
(strain SL1344) for 1h prior to addition of 34 µg/mL chloramphenicol. Supernatant 
was collected at 24h to determine cytotoxicity by LDH assay. Positive control 
supernatant was generated by 2x freeze-thaw lysis of untreated cells and used to 
calculate 100% cytotoxicity. Data are presented as relative to positive control. 
Representative of 2 biological replicates, error bars show SD of 3 technical 
replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, *** = P ≤ 0.001. 
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To further assess the effect of bacteria on epithelial cell viability we used the LDH 
cytotoxicity assay, following 1h incubation of A549 cells with STm. We tested MOIs 
from one to 1000 bacteria per epithelial cell and found that 10 was the highest 
possible MOI that could be used without affecting cell viability (Fig.3.4b). Levels of 
bacterial invasion of epithelial cells will be discussed later in this chapter. 
 
These preliminary experiments allow us to assess the effect of short-term exposure 
to live STm on virus entry (Fig.3.5a). We included TNF, which has been previously 
reported to promote virus entry, as a positive control (Fletcher et al., 2014). Using 
this model system, we found that that STm significantly increased VSV-Gpp entry in 
all three epithelial cell lines tested (Fig.3.5b-d). We present data using pathogenic 
STm strain SL1344, but comparable data were observed with the attenuated STm 
strain, SL3261 (data not shown). These data support our hypothesis that bacteria 
can increase virus entry and may reveal a new mechanism for synergistic 
polymicrobial interactions in vivo. 
 
3.4 STm promotes VSV-Gpp entry independent of epithelial cell polarization 
We sought to determine whether the pro-viral effect of STm on polarized epithelial 
cells was mediated via bacterial alteration of cellular permeability. To assess this we 
used two different methods: flux of a fluorescent molecule from apical to basolateral 
media using epithelial cells polarized on a transwell, and TJ protein localization by 
immunofluorescence. Polarized A549 or Caco-2 cells were incubated with STm for  
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Figure 3.5 STm increases VSV-Gpp entry into epithelial cells. 
a) Schematic diagram of experimental setup showing timing of STm addition, VSV-
Gpp addition and epithelial cell lysis to determine pseudoparticle entry by measuring 
luciferase activity. b-d) Polarized cells were treated with STm (MOI 10) or TNF (100 
ng/mL) for 1h prior to addition of VSV-Gpp and chloramphenicol (34 µg/mL) and virus 
entry was quantified by luciferase assay at 48h. Data are presented as relative to 
VSV-Gpp entry into untreated cells. Representative of 3 biological replicates, error 
bars show SD of 3 technical replicates, statistical comparison by Unpaired t test: * = 
P ≤ 0.05, ** = P ≤ 0.01. 
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1h and 70 kDa FITC-dextran administered apically. We observed a minimal effect of 
STm on paracellular permeability (Fig.3.6a). 
 
We then stained for localization of TJ proteins ZO-1 and occludin, using cells fixed 
after 1h incubation with or without STm, and saw no changes in junctional patterns 
(Fig.3.6b). Caco-2 TJs showed a characteristic web-like pattern (Boyle et al., 2006) 
whereas TJs were less defined between A549 cells, as previously reported 
(Törmäkangas et al., 2010), suggesting no change in TJ integrity. Together these 
results indicate that that STm does not increase viral entry by altering epithelial cell 
permeability and we therefore designed experiments to explore the mechanism 
underlying STm pro-viral activity. 
 
3.5 STm increases entry of pseudoparticles with diverse viral glycoproteins  
Firstly, we determined whether the pro-viral activity of STm would be present in non-
polarized cells, since epithelial cell permeability was not affected by the presence of 
bacteria. Secondly, we investigated the impact of culturing STm in LB broth or cell 
culture media (DMEM) prior to adding bacteria to epithelial cells. It has been reported 
that STm grown in different media have varying phenotypes, due to altered 
transcription patterns (Blair et al., 2013). There was no difference between the 
bacteria grown in different media, but remarkably there was a much greater increase 
in virus entry into non-polarized A549 cells, around five-fold (Fig.3.7a), compared to 
two-fold for polarized A549 cells (Fig.3.5b). Using non-polarized Caco-2 cells there 
was a comparable boost in VSV-Gpp entry using DMEM grown STm, but no 
significant increase in entry using LB grown STm (Fig.3.7b).  
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Figure 3.6 The pro-viral effect of STm is not occurring through altered barrier 
integrity. 
U
nt
ST
m
N
on
-p
ol
U
nt
ST
m
N
on
-p
ol
0
1
2
3
4
5
Pe
rm
ea
bi
lit
y 
(c
m
/m
in
 x
10
-6
)
A549 Caco-2
n.s. n.s.
ZO-1 
occludin 
DAPI 
Untreated STm 
A
54
9 
C
ac
o-
2 
b) 
a) 
10 µm 
 70 
Figure 3.6 cont.  
a) Cells were cultured on transwells. Polarized cells were incubated with STm (MOI 
10) for 1h and movement of 70 kDa FITC-dextran from the apical to basolateral 
medium was monitored to determine the rate over 30 min. Data are presented as the 
permeability coefficient. Representative of 2 biological replicates, error bars show SD 
of 2 technical replicates. b) Cells were polarized on coverslips, incubated with STm 
(MOI 10) for 1h and fixed to visualize TJ proteins ZO-1 and occludin by 
immunofluorescence; nuclei were stained with DAPI. Cells were imaged using a 
Zeiss 510 Meta confocal microscope with 63x objective and LSM software. Scale bar 
indicates 10 µm. Images are representative of 2 biological replicate experiments. 
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Figure 3.7 STm increases VSV-Gpp entry into non-polarized cells. 
a-b) Non-polarized cells were treated with STm grown in bacterial culture broth and 
resuspended in DMEM (LB), or STm grown in cell culture medium (DMEM), both at 
MOI 10, for 1h prior to VSV-Gpp and chloramphenicol addition. Entry was quantified 
by luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 2 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 
0.01, *** = P ≤ 0.001. 
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There was a greater pro-viral effect using STm on non-polarized A549 cells 
compared to polarized cells, but no difference for Caco-2 cells. We investigated 
whether there was a difference in the response to STm in non-polarized cells 
compared to polarized cells by measuring IL-8 secretion, as a marker of an innate 
immune response (Eckmann et al., 1993). We found that in all conditions the 
epithelial cells secreted IL-8 following STm stimulation, although there was not a 
significant increase for polarized A549 cells (Fig.3.8). 
 
Additionally, we looked at the effect changing the antibiotic; comparing 
chloramphenicol to gentamicin. This antibiotic kills extracellular bacteria but cannot 
enter the epithelial cell to affect intracellular bacteria, allowing them to continue 
replicating within the cell (Elsinghorst, 1994). There was no difference in the pro-viral 
activity of STm depending on the type of antibiotic, and consequently the viability of 
bacteria within epithelial cells (Fig.3.9a-b).  
 
We next determined the MOI necessary for STm to promote VSV entry. As 
demonstrated in Fig.3.3b a high MOI of 100 had a detrimental effect on the cells, this 
led to a decreased effect of STm on VSV-Gpp (Fig.3.10). The initial MOI, 10, showed 
the greatest effect on VSV-Gpp entry with a dose-response effect indicating that one 
bacterium per 100 epithelial cells would be sufficient to increase virus entry. 
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Figure 3.8 Increased IL-8 secretion from epithelial cells exposed to STm. 
Cells were incubated with STm (MOI 10) for 1h prior to the addition of 
chloramphenicol. Supernatant was collected at 24h to measure IL-8 secretion by 
ELISA. Representative of 2 biological replicates, error bars show SD of 3 technical 
replicates, statistical comparison by Unpaired t test: ** = P ≤ 0.01, **** = P ≤ 0.0001. 
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Figure 3.9 Antibiotics with different modes of action allow STm to have 
comparable pro-viral effect. 
a-b) Non-polarized cells were incubated with STm (MOI 10) for 1h, prior to addition of 
VSV-Gpp and chloramphenicol and incubation for 48h, or to addition of VSV-Gpp 
and gentamicin (50 µg/mL) for 30 min, 1x wash with DMEM, addition of DMEM with 
gentamicin (5 µg/mL) and incubation for 48h. Entry was quantified by luciferase 
assay and data are represented as relative to VSV-Gpp entry into untreated cells. 
Representative of 2 biological replicates, error bars show SD of 3 technical 
replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01, *** = 
P ≤ 0.001. 
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Figure 3.10 STm pre-exposure has a dose response relationship on VSV-Gpp 
entry into epithelial cells.  
Non-polarized A549 cells were incubated with stated MOI of STm for 1h prior to 
addition of VSV-Gpp and 34 µg/mL chloramphenicol. Entry was quantified by 
luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 2 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison to untreated by Unpaired t test: ** = P ≤ 
0.01, **** = P ≤ 0.0001. 
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We then assessed whether STm would have comparable pro-viral activity using other 
cell lines. Detroit 562 cells are respiratory tract epithelial cells like A549 and Calu-3 
cells. However, they were isolated from the pharynx, therefore higher up in the 
respiratory tract than the lung. There was an increase in virus entry after STm 
infection of these cells of around two-fold (Fig.3.11a), as seen with the other 
epithelial cell lines. Hepatocytes in the liver represent another polarized epithelial cell 
within the body; we tested the hepatoma cell line Huh7 with STm and VSV-G but did 
not see a significant increase in virus entry (Fig.3.11b). 
 
Next, we assessed the entry of viral pseudoparticles bearing glycoproteins from 
Ebola, influenza, Lassa or MeV. These viruses enter cells using different host cell 
receptors, through a variety of pathways (Table 3.1). Remarkably, after STm 
treatment, A549 cells supported a four- to six-fold increase in entry for all 
pseudoparticles tested (Fig.3.12a) and Caco-2 cells a two-fold increase (Fig.3.12b). 
This suggests that the pro-viral activity of STm is broad and not specific to VSV-G. 
MeV does not readily infect A549 cells (Noyce et al., 2011). To assess the effect of 
STm on MeVpp entry into lung cells, we used A549 cells stably transfected to 
express the viral receptor SLAMF1. Overexpressing this protein did not affect the 
pro-viral activity of STm seen previously with VSV-Gpp and allowed MeVpp entry. 
STm pre-treatment increased MeVpp entry into A549-SLAMF1 cells three-fold 
(Fig.3.12c); comparable levels to the other pseudoparticles tested in A549 cells. 
Considering this data showing STm boosting virus entry through multiple pathways, 
and previous results ruling out the effect of STm requiring alteration of cell  
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Figure 3.11 STm has a variable effect on VSV-Gpp entry into other epithelial cell 
lines. 
a-b) Non-polarized lung (Detroit 562) and liver (Huh7) epithelial cells were incubated 
with STm (MOI 10) for 1h prior to addition of VSV-Gpp and chloramphenicol. Entry 
was quantified by luciferase assay at 48h. Data are presented as relative to VSV-
Gpp entry into untreated cells. Representative of 3 biological replicates, error bars 
show SD of 3 technical replicates, statistical comparison by Unpaired t test: ns = P > 
0.05, * = P ≤ 0.05. 	  
U
nt
ST
m
0
1
2
3
R
el
at
iv
e 
VS
V-
G
pp
 e
nt
ry
n.s.
U
nt
ST
m
0
1
2
3
R
el
at
iv
e 
VS
V-
G
pp
 e
nt
ry *
a) Detroit 562 b) Huh7 
 78 
	  
Virus Receptor(s) Entry pathway 
VSV LDL receptor and 
family
1 Clathrin-mediated endocytosis2 
Ebola C-type lectins, 
PtdSer receptors, 
NPC1
3 
Macropinocytosis
3 
Influenza Sialic acids4 Clathrin dependent and 
independent endocytosis
2 
Lassa α-dystroglycan5 Multivesicular bodies2 
MeV SLAMF1/Nectin-
4/CD46
6 Plasma membrane fusion
7 	  
Table 3.1 Summary of entry pathways and receptors used by the viral 
glycoproteins assessed in this study. 
Each viral pseudoparticle assessed in this study enters epithelial cells using a 
different receptor(s) and uptake pathway(s). 1(Finkelshtein et al., 2013; Cossart and 
Helenius, 2014; Moller-Tank and Maury, 2015; Skehel and Wiley, 2000; Cao et al., 
1998; Noyce et al., 2011; Palgen et al., 2015) 
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Figure 3.12 STm increases entry of diverse viral pseudoparticles. 
a-c) Cells were incubated with STm (MOI 10) for 1h prior to addition of 
pseudoparticles as stated and chloramphenicol. Entry was quantified by luciferase 
assay at 48h. Data are presented as relative to entry of each pseudoparticle into 
untreated cells. Representative of 3 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 
0.01. 
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permeability, we sought to investigate the mechanisms through which this was 
mediated. 
 
3.6 STm specifically increases viral glycoprotein-dependent particle uptake 
One potential pathway, other than glycoprotein-mediated entry, that could increase 
the luciferase production used to quantify virus entry by pseudoparticles would be a 
direct effect of STm on luciferase transcription or translation. To address this, we 
transfected cells with the plasmid used for pseudoparticle generation: pNL4.3env-rev-
luciferase, which encodes the HIV virus core competent for a single round of infection 
and the firefly luciferase gene. We used three different protocols to deliver the 
luciferase construct into cells without viral glycoprotein involvement. Firstly, A549 
cells were transfected 24h prior to the addition of STm for 1h, antibiotic treatment and 
24h incubation (Fig.3.13a). Using this method there was no difference in luciferase 
activity between STm-treated and untreated cells (Fig.3.14a). Secondly, STm was 
added to cells prior to transfection (Fig.3.13b), to imitate the pseudoparticle assay 
design in Fig.3.5a. This also showed a minimal difference in luciferase activity 
between untreated cells or STm treated cells (Fig.3.14b).  
 
Finally, when infecting cells with pseudoparticles, it is important to include a control 
virus that lacks any glycoproteins and is classified as NEpp (Fig.3.1). These particles 
may be non-specifically endocytosed by the target cell and provide a background 
luciferase signal. Viral glycoprotein-carrying pseudoparticles are often normalised to 
NEpp values, which can vary between cell types. We tested the effect of STm on 
NEpp to determine whether the presence of bacteria could increase baseline levels  
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Figure 3.13 Methods to assess the effect of STm on luciferase production. 
a-b) Schematic diagrams of two different experimental protocols used, showing 
timing of STm addition to and pNL4.3env-rev-luciferase transfection of epithelial 
cells. Transfection reagents were removed after 6h and fresh medium added to 
prevent cell death during the incubation time needed for luciferase production. 
Following 24h incubation, epithelial cells were lysed to quantify luciferase activity.  
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Figure 3.14 STm has no effect on luciferase production or non-specific particle 
uptake. 
a) Cells were transfected with pNL4.3env-rev-luc 24h prior to incubation with STm 
(MOI 10) for 1h, as described in Fig.3.13a. b) Cells were incubated with STm (MOI 
10) for 1h prior to transfection with pNL4.3env-rev-luc for 6h, as described in 
Fig.3.13b. pNL4.3env-rev-luc activity was determined by luciferase assay and data 
are presented as relative to untreated, transfected cells. c-d) Cells were incubated 
with STm (MOI 10) for 1h prior to addition of NEpp and chloramphenicol. Entry was 
quantified by luciferase assay at 48h. Data are presented as relative to NEpp entry 
into untreated cells. Representative of 3 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison by Unpaired t test: ns = P > 0.05.  	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of endocytosis. There was no increase in NEpp entry after STm in either cell line 
(Fig.3.14c-d). Together, these results support that STm promotes viral glycoprotein-
mediated entry. 
 
3.7 STm enhances the magnitude and kinetics of viral entry 
We were interested to define whether STm increased the number of virus infected 
cells or the number of virus particles entering each cell. We determined the rate of 
virus entry, by washing away unbound virus at specific time points after inoculation 
(Fig.3.15a), and found that 1h pre-treatment with STm significantly increased the rate 
of VSV-Gpp entry into both A549 and Caco-2 epithelial cells (Fig.3.15b-c). Another 
method to investigate virus infection is to use pseudoparticles expressing a 
fluorescent reporter in place of luciferase, allowing visualisation of infected cells. We 
used VSV-Gpp encoding GFP to measure infected A549 cells by flow cytometry. 
With STm pre-treatment there was a clear increase in the number of infected cells 
(Fig.3.15d) and an increased mean fluorescence in the GFP+ cell population (Table 
3.2). These results suggest that exposure of epithelial cells to STm increases their 
permissivity to virus entry, allowing more virus particles to bind per cell, and 
increases the rate of particle internalization. Furthermore, the effect of STm on the 
cell is long lasting. These experiments showed an increase in VSV-Gpp entry into 
A549 cells up to 4h post-STm exposure and up to 24h for Caco-2 cells (Fig.3.16). 
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Figure 3.15 STm increases rate and frequency of pseudoparticle entry. 
a) Schematic diagram of experimental setup showing timing of STm addition, VSV-
Gpp addition and washing of epithelial cells at different time points to remove 
unbound pp prior to 48hr incubation. Pseudoparticle entry was measured by 
luciferase activity.	  b-c) Cells were incubated with STm (MOI 10) for 1h, VSV-Gpp was 
added for the specified time and the cells washed to remove unbound pp. Following 
washing, cells were incubated with 34 µg/mL chloramphenicol. Entry was quantified 
by luciferase assay at 48h. Data are presented as RLU. Representative of 3 
biological replicates, error bars show SD of 3 technical replicates, statistical 
comparison by linear regression. c) Cells were incubated with STm (MOI 10) for 1h 
prior to addition of VSV-Gpp containing a GFP reporter gene and chloramphenicol. 
Cells were fixed at 48 hours and assessed by flow cytometry. The results are gated 
on live cells and presented as intensity of GFP expression versus number of events 
(% of max).	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Freq. of 
Parent  Mean 
Untreated  3.1 20.8 
VSV-Gpp 33.8 49.5 
VSV-Gpp 
+STm 60.5 101 
 
Table 3.2 STm increases virus infection per cell.  
Cells were incubated with STm (MOI 10) for 1h prior to addition of VSV-Gpp 
containing a GFP reporter gene and chloramphenicol. Cells were fixed at 48 hours 
and assessed by flow cytometry. The results are gated on live cells, then GFP+ cells, 
to determine the frequency of GFP+ cells in the live cell population and the mean 
fluorescence intensity of the GFP+ population. 
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Figure 3.16 STm increases VSV-Gpp entry for a prolonged time. 
a) Schematic diagram of experimental setup showing timing of VSV-Gpp addition 
during or after STm addition and subsequent high concentration gentamicin wash to 
kill extracellular bacteria. Gentamicin at a lower concentration was maintained for the 
remainder of the assay to prevent intracellular bacteria exiting epithelial cells and 
infecting new cells. VSV-Gpp was added for 1h and washed off to prevent new 
infections occurring throughout the incubation time. b) Cells were incubated with 
STm (MOI 10) for 30 min, washed and incubated with gentamicin (50 µg/mL) for 30 
min, washed and incubated with gentamicin (5 µg/mL). VSV-Gpp was added at the 
time indicated post-STm addition for 1h and washed off. Entry was quantified by 
luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 3 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 
0.01, *** = P ≤ 0.001. 
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3.8 STm invades A549 cells 
STm can enter intestinal epithelial cells to facilitate intracellular replication in SCV 
(Steele-Mortimer, 2008) and has been reported to invade Caco-2 cells via the apical 
surface and escape from the basolateral surface within 2h (Finlay and Falkow, 1990). 
We were interested to determine whether STm invaded A549 cells. Bacterial invasion 
into A549 and Caco-2 cells can be quantified by lysing the epithelial cells with the 
detergent triton X-100, serially diluting the lysate and plating on LB agar to determine 
CFU/mL. This method demonstrated that, while significantly more bacteria adhered 
to Caco-2 cells than A549 cells, comparable numbers of bacteria invaded both cell 
types (Fig.3.17). 
 
To determine whether cells infected with STm were more likely to be infected with 
VSV-Gpp, pseudoparticles were generated containing GFP as a reporter. 
Representative images of untreated and STm treated A549 cells infected with VSV-
Gpp expressing GFP are shown in Fig.3.18a. While there are virus-infected cells 
containing STm, an example of which is shown in Fig.3.18b, the majority of virus-
infected cells do not contain bacteria. This suggests that STm invasion is not 
required for its pro-viral effect. 
 
3.9 Bacterial invasion and pathogenicity islands are not required to promote 
virus entry 
STm has many effects on epithelial cells, including through the expression of MAMPs 
that can interact with cells. Nevertheless, the majority of effectors are encoded by 
two secretion systems located on genetic pathogenicity islands. SPI-1 facilitates  
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Figure 3.17 STm is internalized by epithelial cells. 
Epithelial cells were treated with STm (MOI 10) for 1h and lysed using Triton X-100, 
or washed and treated with gentamicin (50 µg/mL) for 30 min to kill extracellular 
bacteria then lysed. Cell lysates were plated on LB agar overnight and colonies 
counted to determine colony forming units (CFU) able to adhere to and invade cells. 
Invasion was calculated by removing number of adhered bacteria from total number 
of bacteria in whole cell lysate. Representative of 2 biological replicates, error bars 
show SD of 2 technical replicates, statistical comparison by Unpaired t test: ** = P ≤ 
0.01. 
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Figure 3.18 VSV-Gpp and STm localization in A549 cells. 
a) A549 cells were incubated with STM (MOI 10) for 1h prior to addition of VSV-Gpp 
containing a GFP reporter gene and chloramphenicol. At 48h, cells were fixed to 
determine levels of STm LPS by immunofluorescence; nuclei were stained with 
DAPI. Cells were imaged using a Zeiss 510 Meta confocal microscope with 40x 
objective and LSM software. There was no clear association between STm infected 
cells and VSV-Gpp infected cells. Scale bar indicates 50 µm. b) Zoom of orange box 
in top right hand image showing an example of a STm and VSV-Gpp infected cell, 
surrounded by solely VSV-Gpp infected cells. Scale bar indicates 10 µm. 
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invasion of host cells and can have effects such as altering TJ integrity (Boyle et al., 
2006; McGhie et al., 2009). As established in Fig.3.6, there was no effect on cell 
permeability or TJs during the 1h STm incubation prior to viral infection. However, 
SPI-1 effectors can have other effects. We assessed whether bacterial invasion was 
necessary for the pro-viral effect using an SPI-1 mutant strain of STm unable to 
secrete some of the effectors used for invasion. This mutant strain showed a 
comparable level of adhesion to epithelial cells as wild type STm, but reduced 
invasion (Fig.3.19). STm ΔSPI-1 increased VSV-Gpp entry into A549 cells with 
comparable levels to the wild type. However, it had slightly less pro-viral activity in 
Caco-2 cells (Fig.3.20a). SPI-2 effectors are released in the SCV to facilitate 
intracellular survival and can also affect actin dynamics (McGhie et al., 2009). We 
tested a SPI-2 mutant strain and saw no difference compared to the wild type strain 
in adhesion and invasion assays (Fig.3.19). Furthermore, there was comparable pro-
viral activity in A549 cells, although slightly lower than wild type in Caco-2 cells 
(Fig.3.20a). These data suggest that SPI-1 and SPI-2 effectors are not necessary to 
increase VSV-Gpp entry in A549 cells and may play a role in STm pro-viral activity in 
Caco-2 cells. 
 
Considering that invasion is not essential for STm to promote virus entry, we 
assessed whether live bacteria were required. STm was killed by heating to 100°C 
for 20 minutes and plated on agar to ensure no bacterial growth. Unexpectedly, heat-
killed bacteria promoted VSV-Gpp entry with comparable levels to live bacteria in 
both cell lines (Fig.3.20b). These results suggest that STm does not need to invade  
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Figure 3.19 Adhesion and invasion of mutant bacterial strains tested. 
Epithelial cells were treated with WT STm, STm ΔSPI-1 or STm ΔSPI-2 (MOI 10) for 
1h and lysed using Triton X-100, or washed and treated with gentamicin (50 µg/mL) 
for 30 min to kill extracellular bacteria then lysed. Cell lysates were plated on LB agar 
overnight and colonies counted to determine colony forming units (CFU) able to 
adhere to and invade cells. Invasion was calculated by removing number of adhered 
bacteria from total number of bacteria in whole cell lysate. STm ΔSPI-1 has 
comparable adhesion to but reduced invasion of epithelial cells. Representative of 2 
biological replicates 
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Figure 3.20 The effect of STm does not require invasive, live bacteria. 
a) Cells were treated with WT STm, STm ΔSPI-1 or STm ΔSPI-2 (MOI 10) for 1h 
prior to addition of VSV-Gpp and chloramphenicol. Entry was quantified by luciferase 
assay at 48h. Data are presented as relative to VSV-Gpp entry into untreated cells. 
b) Cells were treated with live STm or heat-killed STm (100 °C for 20 min; MOI 10) 
for 1h prior to addition of VSV-Gpp and chloramphenicol. Entry was quantified by 
luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 3 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 
0.01, *** = P ≤ 0.001. 
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cells or utilise any active processes, such as secretion of effectors that may alter the 
host cell TJs or cytoskeleton, to increase virus entry. 
 
3.10 Discussion 
We aimed to develop a model system to investigate the influence of bacterial 
exposure on virus infection of epithelial cells. The epithelial surfaces in the body are 
known to be colonised by bacteria, even the lung which was previously reported to 
be sterile (Dickson and Huffnagle, 2015). This suggests that an epithelial cell 
targeted for infection by a virus is likely to have bacterial cells, or their products, in 
close proximity. It has been reported that viral entry into polarized cells can be 
restricted (Walters et al., 2001; Mee et al., 2008) and that altering the monolayer 
permeability with cytokines counters this effect (Fletcher et al., 2014). We 
hypothesised that bacteria would increase virus entry because many bacterial 
species, and their effector molecules, have been shown to increase epithelial cell 
permeability (Boyle et al., 2006; Caron et al., 2015; Freedman et al., 2016). 
 
We established this model system using polarized cell lines (Fig.3.2) and observed 
that, when polarized, the cells supported lower levels of viral entry (Fig.3.3). We 
identified the highest bacterial MOI, added with an antibiotic, suitable to maintain 
viable epithelial cells during the course of the assay (Fig.3.4). Then, using this 
model, we saw that STm could increase viral entry into multiple epithelial cell types. 
Furthermore, this pro-viral activity was not limited by viral glycoprotein type or entry 
pathway (Fig.3.12). Interestingly, following STm pre-treatment, Huh7 hepatocyte-
derived cells did not support increased VSV-Gpp entry (Fig.3.11b). It is hard to 
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determine why this cell line would respond differently without knowing the 
mechanism of the bacterial effect, which will be explored in subsequent chapters. 
 
It was important to determine that the STm-induced increase in reporter activity was 
dependent on viral glycoprotein-mediated entry, rather than transcription or 
translation of the luciferase reporter. To do this we transfected cells with the 
luciferase reporter plasmid used to produce pseudoparticles and saw no increase 
after STm treatment (Fig.3.14). We also tested the effect of STm on control 
pseudoparticles without a viral glycoprotein and saw no increase in background 
particle uptake in either A549 or Caco-2 cells, confirming that a glycoprotein-receptor 
interaction is necessary. A general increase in non-specific uptake might have been 
an interesting mechanism for increased viral entry, considering that different viral 
entry pathways are increased. 
 
To reject our hypothesis that the effect of STm on virus entry would be through 
altered epithelial cell permeability we have collected data using different experimental 
methods. Initially, we assessed the effect of STm on the paracellular permeability of 
cells cultured on a transwell using a fluorescent dextran molecule. This technique 
showed no effect of STm treatment (Fig.3.6a) although it has previously been 
reported to show altered Caco-2 cell permeability after EGTA treatment to deplete 
calcium (Mee et al., 2008). We also imaged TJ proteins 1h after STm was added and 
saw no difference compared to untreated cells (Fig.3.6b). This result is in contrast to 
previous reports; Boyle et al. (2006) fixed the cells 4h after STm treatment using a 
MOI of 50, whereas we are using a MOI of 10 for 1h. It may be that we are not using 
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sufficient bacteria or allowing them enough time to target TJ proteins. However, it is 
remarkable that one bacterium per 10 epithelial cells can significantly increase virus 
entry. 
 
Further data supporting this conclusion are the results showing that STm increases 
viral entry into non-polarized cells (Fig.3.7) and the ability of STm ΔSPI-1 to increase 
VSV-Gpp entry (Fig.3.20a), given that the effect of STm on epithelial cell polarization 
is mediated by SPI-1 effectors (Boyle et al., 2006). The observation that growth 
medium does not alter the effect of bacteria on virus entry (Fig.3.7) may have 
predicted the finding that SPI-1 and SPI-2 are not necessary for the pro-viral effect, 
as it has been reported that growth media can affect SPI transcription (Blair et al., 
2013). Furthermore, heat-killed STm are as effective as live bacteria, supporting the 
conclusion that invasive bacteria are not required. 
 
Another possible mechanism for increased virus entry could have been through 
secondary messengers, secreted in response to STm and having an autocrine or 
paracrine effect on virus entry. The cytokines TNF and IL-1β have been reported to 
increase using many of these pseudoparticles (Fletcher et al., 2014). Analysis of 
epithelial cell supernatant after STm treatment by ELISA suggested that neither A549 
nor Caco-2 cells were secreting either cytokine (data not shown), ruling out this 
hypothesis for currently known cytokine mediators. 
 
It has been published that a non-typeable H. influenzae strain can increase rhinovirus 
entry by upregulating the virus receptor ICAM-1 (Sajjan et al., 2006). Interestingly, it 
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appears that the determining factor for how much STm boosts virus entry under 
these conditions is the cell line, rather than the virus type or pathway of entry. There 
was an approximate five-fold increase in virus entry into non-polarized A549 cells, 
however, only a two-fold increase into Caco-2 cells. Since these viruses use different 
cellular receptors and uptake pathways it is unlikely that STm would regulate all of 
these receptors. Alternatively, STm may target a host pathway downstream of 
receptors, allowing multiple receptor-mediated interactions to be regulated and the 
next step would be to look at internalization pathways. We will examine cellular 
signalling pathways more in the next chapter, but it is a fairly long-lived response, as 
determined in Fig.3.16.  
 
3.11 Summary 
We present results showing that epithelial cell exposure to STm, whether live or heat-
killed, increases host cell permissivity to allow more virus entry, faster, and using viral 
glycoproteins that enter the cell via multiple pathways. In the next chapter we will 
focus on how STm achieves this, given that it is not through altered host cell TJs or 
actin remodelling by SPI effectors. 
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4. IDENTIFICATION OF FLAGELLIN AS THE PRO-VIRAL FACTOR 
 
4.1 Introduction 
In the previous chapter we determined that short-term exposure to STm augments 
the ability of epithelial cells to support virus entry. To determine the mechanism(s) 
behind this pro-viral activity, since heat-killed bacteria gave comparable results to 
live, we were interested in secreted factors that may interact with epithelial cells. 
Bacteria can alter host cell biology through a number of distinct mechanisms, such as 
the release of virulence factors, toxins and outer membrane vesicles (OMVs; (Lee 
and Schneewind, 2001; Kaparakis-Liaskos and Ferrero, 2015). Many of these factors 
are recognized by the innate immune system, as indicated in Table 4.1. These 
include LPS, flagellin and outer membrane protein (Omp) porins that may be 
recognized by TLRs (McClure and Massari, 2014).  
 
LPS is composed of three regions: lipid A, core and O antigen (Fig.4.1a, (Maldonado 
et al., 2016) and is one of the most abundant bacterial molecules found on Gram-
negative bacteria. Lipid A is recognized by TLR4, using the accessory molecules lipid 
binding protein (LBP) and lipid A binding protein (CD14; (Miller et al., 2005). TLR4 
signaling leads to a potent pro-inflammatory response, which can aid in bacterial 
clearance and modulate host cell responses. However, elevated LPS levels can 
overwhelm the host and cause sepsis (Opal, 2007). On lung and gut epithelial 
surfaces, TLR4 may be expressed basolaterally or intracellularly  
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Ligand Receptor(s) 
CpG DNA TLR9 
Flagellin NAIP/Nlrc4 
TLR5 
Gram-negative PGN NOD1 
Gram-positive PGN NOD2 
Lipoproteins, cell wall 
components e.g. porins, PGN TLR2 (in complex with TLR1/TLR6) 
LPS TLR4 
 
Table 4.1 Bacterial factors recognized by host cell receptors.  
Ligands found in bacterial cells, including peptidoglycan (PGN) and 
lipopolysaccharide (LPS), can be detected by host cells such as epithelial cells 
through toll-like receptors (TLR) and nucleotide-binding oligomerization domain 
(NOD)-like receptors. 
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Figure 4.1 Components of the Gram-negative outer membrane. 
a) The structure of the outer membrane, from Maldonado et al., 2016. LPS is comprised of 
O-antigen repeats, the core region and lipid A, and forms the outer leaflet of the outer 
membrane (OM). Outer membrane proteins (OMP) such as porins can span the OM. 
Peptidoglycan and lipoproteins are found in the periplasm. Membrane proteins can also span 
the cytoplasmic membrane (CM). b) The structure of polymerized flagellin forming flagellar 
filaments, adapted from (Lu and Swartz, 2016) Flagellin contains four domains and each 
domain (D0-D3) is labeled by colour to demonstrate that D0 and D1 are inaccessible to host 
cell receptors when flagellin is polymerized. c) The flagellum is composed of three 
substructures, adapted from (Evans et al., 2014). A. The basal body and rod substructure 
spans the inner and outer membranes (IM, OM) and contains export machinery to move 
unfolded flagellin subunits through a channel in the flagellum. B. The main body of the 
flagellum is the filament, which can be up to 20 µm and is attached to the basal body via the 
hook section. C. Transported subunits are able to fold and incorporate into the tip, below the 
cap. 
 
a) 
b) c) 
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(McClure and Massari, 2014). This could avoid hyper-responsiveness due to 
constant exposure of epithelial cells to LPS during bacterial colonization of these 
sites.  
 
STm flagellin is a ~50 kDa protein that comprises the main structure of bacterial 
flagella, which enable bacterial cells to propel themselves and adhere to host cells 
(Fig.4.1b-c). Flagella can extend far from the bacterial surface and can be shed as 
monomeric flagellin during assembly (Lu and Swartz, 2016). The monomers can be 
recognized by TLR5, specifically in the D1 region of flagellin, and also by NLR 
apoptosis-inhibitory protein (NAIP), which is part of the NAIP/Nlrc4-inflammasome, in 
the D0 region (Rossez et al., 2015). TLR5 is expressed predominantly on the 
basolateral surface of intestinal epithelial cells to prevent hyper-responsiveness to 
commensal bacteria, but enables detection of bacteria escaping through a breach in 
barrier permeability (Vijay-Kumar and Gewirtz, 2009). Both Gram-positive and Gram-
negative bacteria can express flagellin. STm expresses two forms of flagellin, phase 
1: FliC and phase 2: FljB. Each bacterial cell alternates between the expression of 
these antigenically distinct proteins, a mechanism called flagellar phase variation, to 
escape immune recognition (Yamamoto and Kutsukake, 2006).  
 
Omps are trimeric proteins that form a pore through the outer membrane to allow 
nutrient transport into the periplasm (Fig.4.1a; (Galdiero et al., 2012). They can be 
recognized by TLR2/TLR6 (McClure and Massari, 2014). OmpC and OmpF can also 
be detected by the host via SLAM family members, leading to phagolysosomal 
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maturation and bacterial killing (Berger et al., 2010). However, these receptors are 
usually found on hematopoietic cells.  
 
PGN, found in both Gram-positive and Gram-negative cell walls, can be recognized 
by nucleotide-binding oligomerization domain-containing protein (NOD)1 and NOD2 
(Table.4.1; (Motta et al., 2015). PGN is composed of glycan strands, peptide 
subunits and interpeptide bridges and forms a layer around the bacterium to maintain 
its shape and protect from the environment (Bertsche et al., 2015). While Gram-
negative bacteria have a thin layer between the inner and outer membranes, Gram-
positive bacteria have a much thicker layer that comprises the outermost coating 
(Fig.4.1a). Both types of bacteria can shed PGN and Gram-negative PGN is 
detected by NOD1, whereas Gram-positive PGN is detected by NOD2 (Motta et al., 
2015). 
 
In the previous chapter we showed that STm can promote viral entry. We were 
interested in determining whether the pro-viral activity of STm is specific to this 
bacterial species, as we have already found that the effect is not through SPI-1 or 
SPI-2 (Fig.3.20a). We aimed to determine whether one bacterial factor is responsible 
for the pro-viral activity and if so could this factor be present on other species, or 
potentially specific to Gram-negative bacteria, as there are many common MAMPs 
that are recognized by host cells. 
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Results 
4.2 STm conditioned medium increases VSV entry 
After finding that heat-killed STm increase VSV-Gpp entry into epithelial cells to 
comparable levels seen with live bacteria (Fig.3.20b) and low multiplicities of 
infection are sufficient to stimulate viral entry (Fig.3.10), we hypothesized that 
secreted bacterial factors promote epithelial permissivity. To investigate this 
possibility, we evaluated the effect of conditioned media (CM) from STm cultures in 
mid-log phase for their effect on VSV-Gpp infection of A549 cells (Fig.4.2a). One 
hour pre-treatment of A549 cells with the CM increased VSV-Gpp entry in a dose 
responsive manner (Fig.4.2b). However, the CM had no effect on VSV-Gpp infection 
of Caco-2 cells. This result suggests a difference between lung and gut epithelial cell 
responses to bacterial products. It also highlights that bacterial cell presence is not 
necessary for secreted factors to influence host cell processes. 
 
4.3 Discovery of the secreted pro-viral factor  
During STm growth in high glucose media the pH can fall from pH 7 to as low as pH 
5 (Walker et al., 1997). Since mammalian cells can be reversibly altered by short-
term exposure to low pH (Taylor, 1962), and many cellular processes are pH-
dependent, we evaluated the pH of the CM. Using pH test strips we determined that 
STm CM had no significant effect on the pH of the media (Fig.4.3), allowing us to test 
for the presence of secreted bacterial pro-viral factors in the CM. 
 
To elucidate the composition of the secreted factor(s) in CM able to increase virus 
entry, the CM was boiled for 20 minutes to denature heat sensitive factors, or  
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Figure 4.2 VSV-Gpp entry can be increased using STm CM. 
a) Schematic diagram of experimental setup showing production of STm conditioned 
media (CM) and addition to epithelial cells. STm cultures were spin clarified and 
filtered to allow stimulation of epithelial cells with secreted bacterial products without 
the presence of whole bacteria, prior to pseudoparticle infection. b) A549 or Caco-2 
cells were treated with wild type STm CM diluted from 1 in 10 to 1 in 1000 for 1h and 
infected with VSV-Gpp. Entry was quantified by luciferase assay at 48h. Data are 
presented as relative to VSV-Gpp entry into untreated cells. Representative of 3 
biological replicates, error bars show SD of 3 technical replicates, statistical 
comparison by Unpaired t test: * = P ≤ 0.05, *** = P ≤ 0.001. 
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Figure 4.3 CM does not have an altered pH. 
Top panel of image: pH indicator paper strips were tested for efficacy with standard 
solution controls at pH 10, 7 and 4. Bottom panel of image: STm CM from strains 
SL1344 (top row) and SL3261 (middle row) cultured in DMEM were pH tested at 
indicated dilutions from neat to 1 in 1000. Control DMEM without bacterial culture 
was also pH tested (bottom row). 
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sonicated to disrupt OMVs. Sonication of cellular membranes is can be a harsh 
method and the CM was incubated on ice before, during and after sonication to 
prevent temperature rises leading to protein denaturation. Neither treatment method 
reduced the efficacy of CM to increase viral entry (Fig.4.4a), suggesting that the pro-
viral factor(s) are heat resistant and do not require intact OMV membranes to alter 
host cell permissivity. 
 
LPS is an abundant heat-stable component of the bacterial outer membrane that can 
induce cytokine expression at subnanogram quantities (Majde, 1993). Epithelial cells 
recognize LPS through TLR4 and activate downstream signaling pathways. We 
tested purified whether STm LPS could modulate VSV-Gpp infectivity and observed 
no detectable increase in host cell permissivity (Fig.4.4b). 
 
Given that LPS did not replicate results with STm or CM, we tested whether the heat 
resistant factor was proteinaceous by digesting the CM with proteinase K (PrK) for 30 
minutes, then heat inactivating the enzyme prior to treating A549 cells. This 
treatment abolished the pro-viral activity of the CM compared to control CM that was 
treated with PrK buffer and heated for the same amount of time (Fig.4.4c). 
Therefore, the factor is PrK sensitive, which makes it unlikely to be LPS or PGN. 
 
To characterise the STm-encoded proteins present in the CM we separated them 
using SDS-PAGE. CM was concentrated 300x using TCA and Coomassie staining of 
the gel showed two bands of around 50 kDa and less than 11 kDa (Fig.4.5a). To 
determine which band contained the pro-viral factor we used size fractionation.  
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Figure 4.4 The pro-viral factor(s) in CM are heat-stable proteins. 
A549 cells were treated with; (a) STm CM untreated, heated at 100 °C for 20 min or 
sonicated; (b) STm (MOI 10) or purified LPS from STm at indicated concentrations; 
(c) CM untreated or incubated with PrK for 30 min and heated to inactivate PrK at 
indicated dilutions. Each treatment was added for 1h prior to VSV-Gpp infection and 
entry was quantified by luciferase assay at 48h. Data are presented as relative to 
VSV-Gpp entry into untreated cells. Representative of 3 biological replicates, error 
bars show SD of 3 technical replicates, statistical comparison by Unpaired t test: * = 
P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001, **** = P ≤ 0.0001. 
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Figure 4.5 Size determination of pro-viral CM factor. 
b) 
a) 
0
2
4
6
R
el
at
iv
e 
VS
V-
G
pp
 e
nt
ry
U
nt
C
M
Retentate
Filtrate
100 50 30 10 5     kDa cutoff
**** **** ** *** * **** *** ****
 108 
Figure 4.5 cont. 
a) STm CM was concentrated by TCA precipitation and loaded into a 12% SDS gel 
for electrophoresis and Coomassie staining, identify two protein bands of ~50 and 
<10 kDa. b) CM was spin fractionated using molecular weight cut off columns of 
indicated sizes. Retentate and filtrate were collected from each column and added to 
A549 cells for 1h prior to VSV-Gpp infection and entry was quantified by luciferase 
assay at 48h. Data are presented as relative to VSV-Gpp entry into untreated cells. 
Filtrate >50 kDa shows reduced pro-viral activity. Collated results of 3 biological 
replicates, each with 3 technical replicates. Error bars show SD, statistical 
comparison to untreated by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 
0.001, **** = P ≤ 0.0001. 
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CM was passed through molecular weight cut-off columns of varying sizes and the 
resulting fractions assessed for their effect on VSV-Gpp infection of A549 cells. 
There was a loss of pro-viral activity in filtrates containing proteins smaller than 50 
kDa (Fig.4.5b). However, all of the retentates that contained proteins greater than 
100 kDa increased virus entry, although there were no bands larger than 50 kDa 
detected by SDS-PAGE. 
 
To identify candidate proteins in CM we performed mass spectrometric analysis of 
the CM fraction greater than 100 kDa. This semi-quantitative technique identified 
over 50 proteins in the CM for each independent run, the first 10 of which are shown 
in Table 4.2. Fragments of the protein flagellin, the major component of bacterial 
flagella, were highly represented in both runs. Another protein found in both samples 
was a membrane protein that we identified as siiE. This is a non-fimbrial adhesin 
protein secreted by a SPI-4 encoded type I secretion system that is reported to be 
necessary for STm invasion of polarized cells (Barlag and Hensel, 2015). It is a giant 
protein of 595 kDa, allowing it to protrude from the outer membrane and interact with 
the host cell, so did not fit the 50–100 kDa profile of our pro-viral factor. However, 
flagellin is approximately 50 kDa and polymerizes, but migrates through SDS gels as 
a monomer, which fits the profile (Smith et al., 2003). 
 
4.4 Flagellin increases VSV-Gpp entry  
Purified flagellin (phase I FliC) isolated from STm (Flores-Langarica et al., 2015) was 
assessed using the same pseudoparticle infection protocol developed for STm and 
CM. We observed an approximate two-fold increase in VSV-Gpp entry at all  
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Run 1 Accession Description Score Coverage # Proteins 
1 Q9R4Q8 Flagellin OS=Salmonella typhimurium PE=4 SV=1 - [Q9R4Q8_SALTM] 
224.45 71.60 23 
2 P06179 Flagellin OS=Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) GN=fliC PE=1 SV=4 - [FLIC_SALTY] 
204.27 66.67 72 
3 A0A023SY02 Membrane protein OS=Salmonella typhimurium GN=CY43_22240 PE=4 SV=1 - [A0A023SY02_SALTM] 
155.47 7.90 39 
4 
T5JUR5 Flagellin (Fragment) OS=Salmonella enterica subsp. enterica serovar Typhimurium str. STm5 GN=B581_33465 PE=4 SV=1 - 
[T5JUR5_SALTM] 
153.80 48.88 37 
5 
F2FXD3 Large repetitive protein OS=Salmonella enterica subsp. enterica serovar Gallinarum str. SG9 GN=SG9_4189 PE=4 SV=1 - 
[F2FXD3_SALGL] 
125.68 6.89 11 
6 
P0A1D3 60 kDa chaperonin OS=Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) GN=groL PE=3 SV=2 - 
[CH60_SALTY] 
113.09 35.77 6 
7 
T5K407 Large repetitive protein (Fragment) OS=Salmonella enterica subsp. enterica serovar Typhimurium str. STm5 GN=B581_35875 PE=4 
SV=1 - [T5K407_SALTM] 
86.07 8.90 11 
8 
A0A038EFQ2 Capsid protein OS=Salmonella enterica subsp. enterica serovar Typhimurium str. 108402 GN=N936_24625 PE=4 SV=1 - 
[A0A038EFQ2_SALTM] 
51.55 30.42 3 
9 Q8HAA2 Sb36 OS=Salmonella phage ST64B GN=sb36 PE=4 SV=1 - [Q8HAA2_9CAUD] 
41.74 39.64 6 
10 
F2FHV4 Enolase OS=Salmonella enterica subsp. enterica serovar Dublin str. SD3246 GN=eno PE=3 SV=1 - [F2FHV4_SALDU] 
40.96 16.67 2 
Run 2 Accession Description Score Coverage # Proteins 
1 Q9R4Q7 Flagellin OS=Salmonella typhimurium PE=4 SV=1 - [Q9R4Q7_SALTM] 
285.19 63.73 22 
2 A0FLJ5 Phase I flagellin middle domain variant C174 OS=Salmonella typhimurium GN=fliC PE=4 SV=1 - [A0FLJ5_SALTM] 
257.24 59.96 46 
3 
T5K278 Flagellin (Fragment) OS=Salmonella enterica subsp. enterica serovar Typhimurium str. STm3 GN=B573_24790 PE=4 SV=1 - 
[T5K278_SALTM] 
193.96 37.08 32 
4 
A0A038EDW8 Flagellin (Fragment) OS=Salmonella enterica subsp. enterica serovar Typhimurium str. 108402 GN=N936_02335 PE=4 SV=1 - 
[A0A038EDW8_SALTM] 
166.02 52.27 5 
5 A0A023SY02 Membrane protein OS=Salmonella typhimurium GN=CY43_22240 PE=4 SV=1 - [A0A023SY02_SALTM] 
132.33 7.38 37 
6 
F2FBE7 Phase-1 flagellin OS=Salmonella enterica subsp. enterica serovar Dublin str. SD3246 GN=SD3246_1252 PE=4 SV=1 - 
[F2FBE7_SALDU] 
130.93 14.65 11 
7 
F2FIW3 Putative Ig domain protein OS=Salmonella enterica subsp. enterica serovar Dublin str. SD3246 GN=SD3246_4515 PE=4 SV=1 - 
[F2FIW3_SALDU] 
117.63 6.62 21 
8 
A0A038EFQ2 Capsid protein OS=Salmonella enterica subsp. enterica serovar Typhimurium str. 108402 GN=N936_24625 PE=4 SV=1 - 
[A0A038EFQ2_SALTM] 
73.45 31.42 3 
9 
P0A1D3 60 kDa chaperonin OS=Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) GN=groL PE=3 SV=2 - 
[CH60_SALTY] 
55.89 29.38 6 
10 
H8M1H4 Phosphoglycerate kinase OS=Salmonella enterica subsp. enterica serovar Typhimurium str. 798 GN=pgk PE=3 SV=1 - 
[H8M1H4_SALTM] 
52.73 31.68 2 
Table 4.2 Flagellin is abundant in CM. 
The 10 most abundant proteins found in STm CM filtered through a 100 kDa 
molecular weight cut off column. The peptides present in CM were identified by semi-
quantitative mass spectrometry and the Sequest algorithm was used to determine 
the score: as a measure of the quality of protein identification, coverage of each 
protein and the number of proteins detected. Proteins identified are ranked by score. 
Data from two independent runs are presented. 
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concentrations tested (left hand side; Fig.4.6a). The absence of a dose-dependent 
relationship prompted us to review the protocol, to identify the minimum dose of 
flagellin able to increase virus entry. Cells were incubated with flagellin for one hour, 
unbound flagellin removed and the cells infected with VSV-Gpp. We observed a 
dose-response relationship, as shown on the right hand side of Fig.4.6a, for which 
the maximum boost in viral entry was approximately 3.5-fold; equivalent to that of 
CM. However, as seen with CM (Fig.4.2b), there was no effect of flagellin on VSV-
Gpp entry into Caco-2 cells (Fig.4.6b). These data highlight a new role for flagellin to 
increase lung epithelial cell permissivity to support virus infection. 
 
4.5 Flagellin is the pro-viral factor in CM 
To determine whether flagellin was the only pro-viral factor present in the CM, we 
used two methods. Firstly, we evaluated the effect of co-treating cells with CM and 
flagellin to identify whether they would be additive or synergistic. Using the CM and 
flagellin together at less than maximum doses achieved a comparable boost to either 
treatment alone, at their maximum dose, suggesting an additive mode of action 
consistent with both agents targeting the same pathway (Fig.4.7a). Secondly, we 
depleted flagellin from CM by affinity chromatography using a sepharose-anti-flagellin 
column (Bobat et al., 2011) and the flow-through collected and screened for its effect 
on VSV-Gpp infection. The pooled flow-through had a reduced effect on viral entry 
compared to untreated CM (Fig.4.7b). Together, these results point towards flagellin 
as the pro-viral factor in CM.  
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Figure 4.6 Flagellin increases VSV-Gpp entry into A549 cells. 
a) A549 cells were treated with CM or flagellin, at indicated concentrations, for 1h 
and either VSV-Gpp was added on top of the treatment (left hand side) or the 
flagellin was removed and VSV-Gpp added (right hand side). Entry was quantified by 
luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 3 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison to untreated by Unpaired t test: * = P ≤ 
0.05, ** = P ≤ 0.01, *** = P ≤ 0.001, **** = P ≤ 0.0001. b) Caco-2 cells were treated 
with flagellin and VSV-Gpp added. Entry was quantified by luciferase assay at 48h. 
Data are presented as relative to VSV-Gpp entry into untreated cells. Representative 
of 2 biological replicates, error bars show SD of 3 technical replicates, statistical 
comparison by Unpaired t test was n.s. (P > 0.05). 
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Figure 4.7 Flagellin is the factor in CM. 
A549 cells were treated with; (a) CM at a dilution that gave a full or 50% boost in viral 
infection with or without flagellin at indicated concentrations (µg/mL); (b) untreated 
CM or pooled flow-through (FT) from affinity chromatography using an anti-flagellin 
monoclonal antibody to deplete flagellin; for 1h prior to VSV-Gp. Entry was quantified 
by luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 3 biological replicates. Error bars show SD of 3 
technical replicates, statistical comparison to untreated by Unpaired t test: n.s. = P > 
0.05, * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001, **** = P ≤ 0.0001. 
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4.6 Variable epithelial responses to flagellin 
One observation during these experiments was variability in the pro-viral activity of 
flagellin, STm or CM. To demonstrate this, Fig.4.8 shows the results from every 
experiment using flagellin and VSV-Gpp, where each grey dot represents an infection 
value. While there was not always an increase in virus entry using 0.1 µg/mL 
flagellin, with 0.3-1 µg/mL flagellin we always observed a boost in infection and this 
could vary from two- to 14-fold. Since the same purified flagellin and VSV-Gpp 
preparations were used in aliquots stored at -80°C this result is likely to be 
attributable to variations in the epithelial cell response. We failed to observe an effect 
of flagellin on VSV-Gpp when using high passage A549 cells (data not shown) and 
used low passage cells for all experiments. 
 
4.7 Aflagellate STm fails to modulate virus entry 
STm encodes two flagellin genes that allow phase variation to avoid recognition by 
the host immune system (Yamamoto and Kutsukake, 2006). To determine whether 
flagellin is the sole factor secreted by bacterial cells to increase epithelial cell 
permissivity to viruses, an aflagellate STm mutant strain was produced. This fliC-fljB- 
strain had minimal effect on VSV-Gpp entry into A549 cells; independent of whether 
the whole bacterium or CM was added (Fig.4.9). This result strengthens the findings 
in Table 4.2 and Fig.4.7 that flagellin is the pro-viral factor present in the CM and 
identifies flagellin as the causative agent for STm to potentiate virus entry. 
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Figure 4.8 Variable epithelial cell responses to flagellin. 
Collated results from all experiments performed exposing non-polarized A549 cells to 
the stated concentrations of STm flagellin and subsequent VSV-Gpp addition to 
determine virus entry at 48 hours by luciferase assay. Data are presented as relative 
to VSV-Gpp entry into untreated cells. Error bars show SD, statistical comparison by 
Unpaired t test was **** (P ≤ 0.0001) for each flagellin-treated condition compared to 
untreated. 
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Figure 4.9 Aflagellate STm fails to modulate VSV-Gpp entry. 
A549 cells were treated with wild type or fliC-fljB- strains of STm (MOI 10), or CM 
produced from these strains, for 1h prior to VSV-Gpp addition. Entry was quantified 
by luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 2 biological replicates, error bars show SD of 3 
technical replicates, statistical comparison by Unpaired t test: *** = P ≤ 0.001, **** = 
P ≤ 0.0001. 
U
nt
W
ild
 ty
pe
Af
la
ge
lla
te
W
ild
 ty
pe
Af
la
ge
lla
te
0
2
4
6
R
el
at
iv
e 
VS
V-
G
pp
 e
nt
ry ***
****
STm CM
 117 
4.8 Other species of bacteria can increase VSV-Gpp entry 
Many species of bacteria express flagellin and we were interested to compare a 
panel of bacterial species, both Gram-negative and Gram-positive, to determine their 
effect on virus entry (Table 4.3). Interestingly, we found that all species of bacteria 
tested, except for S. aureus, increased VSV-Gpp infection of A549 and Caco-2 cells 
(Fig.4.10a & c). We also assessed CM from bacteria showing pro-viral activity and 
noted that CM from flagellated species increased virus entry (Fig.4.10b).  As seen 
previously using STm (Fig.3.7), there was a greater pro-viral activity in A549 cells 
than Caco-2 cells, with the exception being K. pneumoniae. These results suggest 
that the pro-viral activity of STm is not a species-specific mechanism and flagellin is 
the major factor driving increased A549 cell permissivity to virus infection. 
 
4.9 P. aeruginosa flagellin can increase virus entry 
To determine whether flagellin from a different bacterial species could increase virus 
entry, we assessed the effect of P. aeruginosa and its flagellin on virus uptake. 
Comparison of wild type and aflagellate strains confirmed that fliC expression was 
necessary for P. aeruginosa to increase VSV-Gpp infection (Fig.4.11a). Furthermore, 
purified P. aeruginosa flagellin increased virus entry in a dose-responsive manner 
(Fig.4.11b), as seen with STm flagellin (Fig.4.6a). These data demonstrate that the 
effect of STm flagellin on VSV-Gpp entry is not bacterial species specific. 
 
To determine whether flagellin from P. aeruginosa would also enhance entry of 
viruses other than VSV, A549 cells were pre-treated with flagellin and infected with 
influenza pseudoparticles. Influenza infection has previously been reported to  
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Bacterial species Gram stain Flagellum 
B. subtilis Positive Yes 
EP E. coli Negative Yes 
K. pneumoniae Negative No 
P. aeruginosa Negative Yes 
STm Negative Yes 
S. aureus Positive No 
  
Table 4.3 Characteristics of the bacterial species used in this study. 
The panel of bacteria assessed for pro-viral activity in this study contains both Gram 
negative and Gram positive species, with and without endogenous flagella. 
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Figure 4.10 Other species of bacteria can increase VSV-Gpp entry. 
(a) A549 or (c) Caco-2 cells were treated with the bacterial species stated (MOI 10) for 1h 
prior to VSV-Gpp and chloramphenicol addition. Entry was quantified by luciferase assay at 
48h. Data are presented as relative to VSV-Gpp entry into untreated cells. b) A549 cells were 
treated with CM from bacteria species stated for 1h prior to VSV-Gpp addition. Entry was 
quantified by luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Representative of 2 biological replicates, error bars show SD of 3 technical 
replicates, statistical comparison to untreated by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01, 
*** = P ≤ 0.001, **** = P ≤ 0.0001. 
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increase the chance of secondary bacterial infection, including P. aeruginosa (Renk 
et al., 2014; Lee et al., 2015). We report that the inverse of this relationship may also 
be true, as flagellin pre-treatment increased influenza entry (Fig.4.11c).  
 
4.10 Polyclonal antibody to flagellin has a negligible effect on the pro-viral 
activity of flagellin 
Flagellin elicits a humoral immune response in the host and anti-flagellin responses 
in serum are frequently used as a marker for bacterial translocation across the gut 
(Svärd et al., 2015). However, the role of anti-flagellin antibodies is unclear. While 
flagellin is an effective carrier antigen that increases the immune response to other 
antigens (Cunningham et al., 2004; Simon and Levine, 2012; Kim et al., 2015), 
antibody produced in response to flagellin does not necessarily control bacterial 
numbers (Bobat et al., 2011).  
 
We were interested to know whether the presence of anti-flagellin antibodies would 
modulate the pro-viral activity of flagellin on epithelial cells. To assess this, serum 
samples from four STm FliC or mock immunized mice were pooled and heat 
inactivated. We confirmed the presence of anti-flagellin antibodies by ELISA 
(Fig.4.12a). Flagellin was incubated with the pooled sera for 30 minutes incubated 
with A549 cells for one hour prior to infecting with VSV-Gpp. Incubating flagellin with 
sera had minimal effects on its pro-viral activity (Fig.4.12b), despite the high level of 
anti-flagellin antibodies present.  
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Figure 4.11 P. aeruginosa flagellin is able to increase virus entry. 
A549 cells were treated with; (a) wild type or aflagellate P. aeruginosa strains (MOI 
10) or (b) purified P. aeruginosa flagellin at indicated concentrations, for 1h prior to 
VSV-Gpp addition. Entry was quantified by luciferase assay at 48h. Data are 
presented as relative to VSV-Gpp entry into untreated cells. Representative of 3 
biological replicates. c) A549 cells were treated with purified P. aeruginosa flagellin 
for one hour prior to influenza (H7N1) pseudoparticle addition. Entry was quantified 
by luciferase assay at 48h. Data are presented as relative to VSV-Gpp entry into 
untreated cells. Error bars show SD of 3 technical replicates, statistical comparison 
by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001. 
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Figure 4.12 The effect of flagellin is not blocked by antibody. 
a) Mouse sera from four PBS-immunized and four STm FliC-immunized mice were 
analyzed by ELISA using a flagellin coated plate and OD405 measured to determine 
the presence of anti-flagellin antibodies. Data produced by Dr. Adriana Flores-
Langarica. b) Mouse serum samples were pooled, heat inactivated and incubated 
with flagellin (0.3 µg/mL) at 37°C for 30 min prior to treating A549 cells for 1h. VSV-
Gpp was added and entry was quantified by luciferase assay at 48h. Data are 
presented as relative to VSV-Gpp entry into untreated cells. Representative of 3 
biological replicates, error bars show SD of 3 technical replicates, statistical 
comparison to untreated by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01. 
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4.11 Discussion 
We were interested to define the bacterial component facilitating STm-mediated 
increase in viral entry and whether this effect was mediated by STm-specific secreted 
factors. We demonstrate that flagellin secreted by STm (Fig.4.6a) and other bacterial 
species such as P. aeruginosa (Fig.4.11) increases epithelial cell permeability to 
virus infection (Fig.4.13c) and this activity is not perturbed by anti-flagellin antibodies 
(Fig.4.12b). 
 
We found that neither CM nor flagellin alone was sufficient to increase virus entry into 
Caco-2 cells, but heat-killed STm potentiated infection (Fig.3.20b). It may be that 
more than one MAMP is necessary to prime a pro-inflammatory response in intestinal 
epithelial cells that can become tolerized through continuous bacterial exposure. 
Invasion of Caco-2 cells by STm, or uptake of heat-killed bacteria, may deliver 
flagellin to intracellular TLR5, where individual molecules may not be internalized. It 
would be interesting to test the effect of basolaterally-administered flagellin on virus 
entry, adding the virus to either apical or basolateral membranes.  
 
The immunostimulatory potential of secreted flagellin in bacterially conditioned 
medium has been reported elsewhere. Two independent studies used similar 
techniques to identify flagellin as the secreted factor from E. coli and STm. Both 
studies report stability following heat treatment, a proteinaceous molecule around 50 
kDa and minimal effect of aflagellate mutant strains (Gewirtz et al., 2001b; Schlee et 
al., 2007). Importantly, Gewirtz et al., 2001b, reported that their 50 kDa band purified 
by anion exchange column contained amino acid sequences from FliC and FljB, 
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suggesting that our STm CM may contain both isoforms. Strains deficient in either 
FliC or FljB induced IL-8 activity, however FljB expression was less stimulatory. 
 
One method to establish whether that flagellin was the sole pro-viral component in 
CM was to evaluate their combined mode of activity: to assess whether they would 
interact additively or synergistically. If two treatments target the same pathway then 
their combined activity will equal the sum of their individual activities. Whereas if the 
treatments work synergistically, their combined activity will be greater than the sum 
due to activation of multiple pathways (Singh et al., 2000a). In our assay, a 50% 
dilution of CM gave a three-fold increase in virus entry and 0.1 µg/mL flagellin gave a 
seven-fold increase. Combined they reached 10-fold, indicating an additive 
interaction and that flagellin is most likely the pro-viral factor in CM (Fig.4.7a).  
 
Interestingly, we observed a greater increase in viral entry when flagellin was added 
to A549 cells for a limited one hour period (Fig.4.6a). This could be due to negative 
feedback loops induced by flagellin stimulation. Flagellin signaling through TLR5 
uses myeloid differentiation factor 88 (MyD88) to activate the NF-κB pathway, but 
also the mitogen-activated protein kinase (MAPK) pathway (Yu et al., 2003; McClure 
and Massari, 2014). Yu et al. (2006) reported that flagellin-induced IL-8 was 
increased when cells were treated with the phosphoinositide 3-kinase (PI3K) 
inhibitor, wortmannin, through increased MAPK signaling. This was verified using 
PI3K deficient mice, which displayed increased KC expression (the murine equivalent 
of IL-8) after flagellin treatment compared to wild type (Yu et al., 2006). Interestingly, 
the level of KC in mouse serum peaked at the first time point of collection, two hours, 
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and declined by six hours, which is comparable to the pattern of flagellin-induced pro-
viral activity in our results (Fig.3.16). Prolonged expression of pro-inflammatory 
markers can be harmful to the host, leading to negative feedback mechanisms and 
this may explain why an excess of flagellin did not increase virus entry to comparable 
levels as a one hour exposure. 
 
Focusing on the flagellated bacterial species and their pro-viral activity, we found that 
exposure of A549 cells to STm or B. subtilis bacteria or their CM increased virus 
entry (Fig.4.10a-b). Previous reports suggest that, when using the same 
concentration, STm flagellin can induce A549 cells to express higher levels of IL-8 
than B. subtilis flagellin (Im et al., 2009). However, expression of monomeric flagellin 
by different bacterial species in vitro may vary, accounting for the comparable effect 
seen in our experiments. Furthermore, although the D0 (NAIP recognition) and D1 
(TLR5 recognition) domains are highly conserved between species, the D2 and D3 
regions can vary in sequence and glycosylation, which has been reported to affect 
their pro-inflammatory activity (Verma et al., 2005; Rossez et al., 2015).  
 
E. coli and STm are the most closely related bacterial species tested, so it could be 
predicted that they would boost virus entry to comparable levels, as observed with 
A549 cells (Fig.4.10a-b). Flagellin from EP E. coli strains, as used in this study, has 
been reported to play a role in adherence to intestinal epithelial cells (Rossez et al., 
2015), which may explain the increased pro-viral activity with EP E. coli compared to 
STm in Caco-2 cells (Fig.4.10c). Interestingly, using Caco-2 cells we observed a 
greater pro-viral effect with K. pneumoniae than B. subtilis, suggesting that there may 
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be more potentiation by Gram-negative bacteria than Gram-positive and minimal 
association for flagellate vs. aflagellate strains. Considering that the CM did not 
increase VSV-Gpp entry into Caco-2 cells, the effect of LPS or other factors was not 
tested. However, the concentration of LPS in CM was not measured and it may be 
informative to test LPS for pro-viral activity with Caco-2 cells. Additionally, there were 
no correlations between increased pro-viral activity using lung and gut pathogens on 
the cell type they would interact with in he host. 
 
P. aeruginosa increased virus entry into A549 cells to a lesser extent than other 
flagellated bacteria (Fig.4.11a). However, purified P. aeruginosa flagellin showed 
comparable activity to STm flagellin (Fig.4.11b). This could be explained by variable 
expression of flagella by different bacterial species. STm, B. subtilis and EP E. coli 
are peritrichous, meaning they can be covered in multiple flagella, whereas P. 
aeruginosa has a single flagellum (Guttenplan et al., 2013; Pfaller et al., 2015). It is 
known that the TLR5 binding site is hidden by the structure of flagella, so monomeric 
units of flagellin are necessary for host cell recognition (Eaves-Pyles et al., 2001). To 
avoid this, P. aeruginosa has been reported to degrade the monomeric flagellin it 
produces. (Bardoel et al., 2011) found that an alkaline protease, AprA, secreted by 
bacteria could prevent TLR5-mediated signaling, when administered to cells with 
flagellin, by cleaving the free flagellin monomers. However, it did not cleave flagellin 
within flagellar structures. A second, similar mechanism using an elastase to degrade 
flagellin has also been found in P. aeruginosa (Casilag et al., 2016). The presence of 
this immune evasion mechanism may also explain why CM from P. aeruginosa had a 
minimal effect on virus entry in our experiments (data not shown). AprA-mutant P. 
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aeruginosa, and CM produced for their study, induced TLR5 signaling over 100-fold 
higher than wild type P. aeruginosa (Bardoel et al., 2011). It would be interesting to 
test the activity of this strain or its CM on virus entry.  
 
While AprA-mutant P. aeruginosa could activate TLR5 signalling and promote virus 
entry, there are species of bacteria with flagellin that is not detected by TLR5: H. 
pylori and Campylobacter jejuni. These species still require flagellar motion for 
pathogenesis, but they can evade TLR5-mediated immune responses. This is 
achieved by alterations in a seven amino acid stretch of the D1 domain containing 
the area facilitating TLR5 recognition (Andersen-Nissen et al., 2005). Testing these 
flagellin monomers would determine whether the pro-viral effect requires TLR5 or 
can be mediated by NAIP signaling or a novel mechanism. Interestingly, the authors 
note that altering this region in STm FliC to prevent TLR5 activation reduced bacterial 
motility and compensatory mutations were necessary to restore polymerization. 
 
The role of flagellin-specific antibodies during STm infection is unclear. We report 
that polyclonal flagellin-specific sera had a negligible effect on flagellin pro-viral 
activity. This could be due to anti-FliC antibody recognizing the external domains of 
flagellin that are exposed when flagella are formed (Salazar-Gonzalez and McSorley, 
2005), therefore unable to block the TLR5 and NAIP recognition domains that are 
only accessible on monomers (Fig.4.1b). These results suggest that the effect of 
flagellin on host cell permissivity may be effective in environments that are naïve or 
pre-exposed to flagellated bacteria. 
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4.12 Summary 
In this chapter we have identified the pro-viral factor secreted by STm that increases 
lung epithelial cell permissivity to virus entry as flagellin. Furthermore this effect is not 
specific to STm, Pseudomonas aeruginosa flagellin increased influenza 
pseudoparticle entry. Pseudomonas aeruginosa colonization has been highlighted as 
a risk factor for increased susceptibility to influenza infection in individuals with CF 
(Renk et al., 2014). Our next aim was to determine the mechanism of flagellin 
activity. 
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5. DISSECTING THE PRO-VIRAL ACTIVITY OF FLAGELLIN AT A CELLULAR 
LEVEL 
 
5.1 Introduction  
In the previous chapter, we identified that bacterially encoded flagellin can increase 
virus entry into lung epithelial cells. Flagellin is abundantly expressed by a wide 
variety of bacterial species, making it a prominent target for recognition by host cells 
(Zhao and Shao, 2015). Extracellular flagellin can be bound by TLR5, leading to 
MyD88-dependent activation of NF-κB and AP-1, to induce cytokine, chemokine and 
IFN expression (Fig.5.1). This pro-inflammatory response recruits immune cells to 
sites of bacterial colonization to aid immune clearance (McClure and Massari, 2014). 
Flagellin is also detected by the NAIP/Nlrc4-inflammasome in the cytosol (Fig.5.2; 
(Khameneh and Mortellaro, 2014), which leads to caspase-dependent IL-1β 
production and cell death (Zhao and Shao, 2015).  
 
Flagellated bacteria in the lung have been reported to promote pulmonary fibrosis. 
(Kondo et al., 2012), found that flagellin increased NF-κB activity in A549 cells in a 
dose-responsive manner and the activity peaked between four and eight hours. The 
mechanism was reported to be via TLR5, based on the addition of purified flagellin 
extracellularly. In contrast, detection of flagellin by NAIP requires intact bacterial cells 
and can lead to host cell death (Sun et al., 2007). We therefore hypothesized that 
flagellin binding to TLR5 and signaling through NF-κB facilitated pro-viral activity.  
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Figure 5.1 TLR signaling activates NF-κB. 
From (Miller et al., 2005) Host cells can detect microbe associated molecular 
patterns (MAMP) through toll-like receptors (TLR). These are membrane-spanning 
proteins that, upon binding a ligand, recruit sequentially MyD88, interleukin-1 
receptor-associated kinase (IRAK) 1 and 4 and TNF-receptor-associated factor 
(TRAF) 6. This leads to phosphorylation of the IκB kinase (IKK) complex, which 
phosphorylates IκB. IκB phosphorylation releases it from the NF-κB subunits p50 and 
p65, allowing them to translocate to the nucleus and act as a transcription factor for a 
wide range of genes that regulate the immune response. 
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Figure 5.2 NAIP/Nlrc4-inflammasome activation by flagellin. 
Adapted from (Khameneh and Mortellaro, 2014) Flagellated bacteria that enter host 
cells and secrete flagellin into the cytoplasm can be detected by NLR apoptosis-
inhibitory protein (NAIP). NAIP interacts with NOD-like receptor (NLR)C4 and ASC to 
form an inflammasome that activates caspase-1. Caspase-1 converts pro-
interleukins (IL)-1β and -18 into cytokines IL-1β and IL-18, inducing an inflammatory 
response. 
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H. influenzae can potentiate rhinovirus infection of primary airway epithelial cells by 
increasing their cell surface expression of ICAM-1, enabling more virus to attach to 
the host cell (Sajjan et al., 2006). One route for flagellin to increase the entry of VSV, 
influenza, MeV, Ebola and Lassa is by upregulating host cell receptors. However, 
given the diversity of receptors used by these different viral glycoproteins (Table 3.1), 
this seems unlikely. Moreover, the observation that STm promotes MeV entry into 
A549 cells engineered to overexpress the viral receptor SLAMF1 (Fig.3.12) suggests 
that receptor modulation is an unlikely explanation for the pro-viral activity. 
 
To increase the entry of viruses using different pathways, flagellin may be 
potentiating multiple host cell processes and altering each virus pathway 
independently, or inducing diverse virus entry through the upregulation of one 
pathway. This could help all viruses to gain access into the host cell. For example, 
most cell types express heparin sulphate proteoglycans (HSPGs) that contain long 
polysaccharide chains, these bind viruses through electrostatic interactions and aid 
virus entry (Bishop et al., 2007). The upregulation of HSPGs on host cell membranes 
could augment virus entry using a variety of pathways (Zhang et al., 2016). 
Interestingly, influenza can enter cells via clathrin-dependent and independent 
pathways, and this can vary by cell type (Edinger et al., 2014). Conversely, an IFN-
stimulated gene has been identified, called ADAP2, that encodes a protein to restrict 
virus entry, including VSV, by altering the entry pathway to macropinocytosis and 
likely facilitating degradation of the particles (Shu et al., 2015). This suggests that 
innate immune signaling can modulate virus entry pathways. In this chapter, we will 
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design experiments to examine the mechanism underlying the pro-viral activity of 
flagellin. 
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Results 
5.2 Lentiviral pseudoparticles do not directly bind flagellin 
Although LPS had a modest ability to increase virus entry in this model system, it is 
known to bind to poliovirus particles, which can augment virus attachment to host 
cells (Robinson et al., 2014). LPS has also been reported to enhance transmission of 
MMTV in vivo by binding to virus particles (Wilks et al., 2015). It was important to 
determine whether flagellin increases pseudoparticle entry by direct binding to the 
viral particle.  
 
The recombinant STm flagellin used in these experiments contains a poly-histidine 
tag, to facilitate affinity purification using a nickel column (Bobat et al., 2011). VSVpp 
or NEpp were incubated with flagellin for one hour at 37°C, mixed with Ni-NTA 
agarose beads for one hour and allowed to settle in a column. The flow through was 
collected and the beads washed with PBS to remove unbound virus. Flagellin was 
then eluted using imidazole and the eluates collected to quantify viral particles.  
 
Lentiviral pseudoparticles were quantified using the PERT assay (Fig.5.3); which 
detects particle associated RTase that generates cDNA from exogenous, synthetic 
MS2 RNA (Pizzato et al., 2009; Vermeire et al., 2012). Although viral particles were 
eluted from the nickel beads by imidazole, we observed comparable levels of VSV or 
NE particles independent of pre-incubating with flagellin (Fig.5.4a-b). This result 
suggests that the pro-viral activity of flagellin is not mediated through direct 
association with virus particles, but through interactions with the epithelial cell or via a 
ternary complex with virus and cells. 
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Figure 5.3 Detection of virus particles by PERT assay. 
1:
30
00
1:
10
00
1:
30
0
1:
10
0
1:
30
1:
10 1:
310
-1
101
103
105
107
109
Vi
ru
s 
pa
rti
cl
es
 (n
U
 R
Ta
se
)
HIV dilution
	  	  
	  	  
	  
	  	   	  
	  	  
	   	  	  
	  
RTas
e 	   	  
Lysis 	  
	   	  
	  
+ MS2 RNA 
+ SYBR green mix 
+ MS2 primers 	  
cDNA synthesis step 
qPCR step 
b) 
a) 
 136 
Figure 5.3 cont. 
a) Schematic diagram of the product enhanced reverse transcriptase (PERT) assay 
used to detect reverse transcriptase (RTase) in virus particles. Following lysis of the 
particles, reagents are added to facilitate RTase-dependent generation of cDNA, 
which can be quantified by PCR. A standard curve can be produced using a 10-fold 
dilution series of recombinant HIV-1 RTase to determine units of RTase (Vermeire et 
al., 2012). b) A serial dilution of HIV-1 assessed by PERT assay. Data presented are 
viral particles as determined by units of RTase. 
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Figure 5.4 Pseudoparticles do not directly bind flagellin. 
a) Pseudoparticles were incubated with 0.3 µg/mL STm flagellin at 37°C for 1h prior 
to addition of Ni-NTA agarose beads for 1h at room temperature on a rotary mixer. 
The beads were loaded onto a column, flow through was collected and the beads 
were washed 5x with PBS. Flagellin was eluted by washing 5x with PBS containing 
100mM imidazole. Viral particles in all fractions were quantified by PERT assay. Data 
presented are viral particles as determined by units of RTase. b) The total number of 
viral particles eluted for each condition in (a). Representative of 2 biological 
replicates, error bars show SEM of 2-4 technical replicates, statistical comparison by 
Unpaired t test was n.s. (P > 0.05). 
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5.3 Flagellin does not modulate viral attachment to cells 
Since many of the viral pseudotypes we have studied can engage HSPGs as the first 
step in low affinity attachment we investigated the effect of flagellin on pseudoparticle 
attachment. Virus internalization can be prevented by cooling the cells to 4°C, which 
renders endocytosis or membrane fusion ineffective (Guyader et al., 2002).  
 
The PERT assay was used to assess the binding of VSV-Gpp at 4°C compared to 
37°C in the presence of flagellin. At 4°C, flagellin treatment had a modest effect on 
the number of bound virus particles, but it significantly increased the number of virus 
particles present in cells infected at 37°C (Fig.5.5). These data suggest that the pro-
viral activity of flagellin occurs after virus binding. To further examine this, the effect 
of flagellin treatment one hour prior to VSV-Gpp addition was compared to flagellin 
treatment one hour after VSV-Gpp addition at 4°C, with a washing step to remove 
any unbound virus particles. Although there was decreased virus entry at 4°C 
compared to 37°C, the effect of flagellin was comparable whether added before or 
after the virus (left-hand side; Fig.5.6). That the pro-viral activity of flagellin still 
occurs after virus binding has taken place suggests that this effect happens at a later 
step in the virus entry pathway. 
 
To assess internalization, we compared the effect of flagellin added before or after 
virus infection at 37°C. Again, the effect of flagellin was comparable whether added 
before or after virus pseudoparticles (right-hand side; Fig.5.6), suggesting that 
flagellin does not increase internalization but acts at a later stage of entry. 
Interestingly, the boost in virus entry with flagellin treatment was around five-fold at  
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Figure 5.5 Flagellin increases virus internalization at 37°C. 
Flagellin (0.3 µg/mL; removed after 1h) was added to non-polarized A549 cells 
before VSV-Gpp was added for 1h at 4°C or 37°C and the cells were lysed for 
quantification by PERT assay. Data presented are viral particles as determined by 
units of RTase, with background RTase activity in untreated cells removed. 
Representative of 2 biological replicates, error bars show SD of 4 technical 
replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01. 
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Figure 5.6 The pro-viral activity of flagellin is post-binding. 
a) Schematic diagram of experimental setup showing timing of flagellin (fla) addition, 
VSV-Gpp addition and epithelial cell lysis to determine pseudoparticle entry by 
measuring luciferase activity. b) Flagellin (0.3 µg/mL) was added to non-polarized 
A549 cells 1h before or immediately after VSV-Gpp was added for 1h at 4°C or 37°C 
and the cells were washed 3x with DMEM to remove unbound virus. Entry was 
quantified by luciferase assay at 72h. Data are presented as relative luciferase units 
(RLU). Representative of 2 biological replicates, error bars show SD of 4 technical 
replicates, statistical comparison by Unpaired t test: *** = P ≤ 0.001, **** = P ≤ 
0.0001. 
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both temperatures. Together, these data indicate that the pro-viral activity of flagellin 
occurs after virus binding and may be post-internalization. 
 
5.4 Inhibition of common virus entry pathways  
STm had a pro-viral effect on a wide range of virus entry pathways (Fig.3.12). We 
were interested to determine whether flagellin altered the route of virus internalization 
and evaluated a well-characterized panel of inhibitors that target actin polymerization, 
clathrin-mediated endocytosis and macropinocytosis. A549 cells were pre-treated 
with each drug for 30 min prior to incubating with flagellin for one hour and infecting 
with VSV-Gpp for a defined period of one hour. All of the treatments reduced 
untreated VSV-Gpp entry and bafilomycin A1 prevented infection (Fig.5.7a), 
consistent with reports that VSV infects cells via clathrin-mediated endocytosis. 
Importantly, flagellin treatment still boosted virus infection of drug-treated cells over 
to comparable levels as untreated virus, with the exception of the actin inhibitor, 
jasplakinolide (Fig.5.7b). As a control to examine the potential off-target effects of the 
inhibitors to modify flagellin signaling, we measured IL-8 expression at 48 hours. We 
noted a significant reduction in IL-8 expression following jasplakinolide treatment 
(Fig.5.7c), suggesting that this drug may affect IL-8 secretion or reduce NF-κB 
activation, rather than specifically affecting virus entry. None of the other treatments 
had any significant effect on flagellin-boosted VSV-Gpp entry or IL-8 secretion. 
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Figure 5.7 The effect of cell entry inhibitors. 
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Figure 5.7 cont. 
Non-polarized A549 cells were treated with inhibitors as stated for 30 minutes, for 
concentrations see methods. a) VSV-Gpp was added and entry was quantified by 
luciferase assay at 48h. Data are presented as relative luciferase units (RLU). b) 
Flagellin (0.3 µg/mL; removed prior to virus addition) was added for one hour prior to 
VSV-Gpp. Entry was quantified by luciferase assay at 48h. Data are presented as 
relative to VSV-Gpp entry into inhibitor treated cells without flagellin stimulation. c) 
Supernatant from (b) was collected at 48h to measure IL-8 secretion by ELISA. Error 
bars show SD of 3 technical replicates, statistical comparison by Unpaired t test: * = 
P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001, **** = P ≤ 0.0001. 
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5.5 Flagellin does not affect clathrin-mediated endocytic uptake of transferrin 
To investigate further whether flagellin increased the cellular uptake of ligands that 
utilize the clathrin-mediated endocytic pathway, we tested the well-characterized 
ligand transferrin. A549 cells were pre-treated with flagellin and incubated at 37°C 
with fluorescently labeled transferrin, which binds the transferrin receptor and is the 
archetypal cargo for clathrin-mediated endocytosis (Le Roy and Wrana, 2005). Cells 
were fixed at defined time points and uptake assessed by flow cytometry. As a 
control, cells were incubated at 4°C to determine background levels of transferrin 
binding to the host cell, since ligand uptake is temperature-dependent. To confirm 
that fluorescence detected after incubation at 37°C was due to intracellular 
transferrin; cells were fixed and co-stained for the plasma membrane located protein 
CD81 (Fig.5.8a), demonstrating intracellular transferrin localization. 
 
Representative flow cytometry plots are shown in Fig.5.8b and the kinetic results are 
collated in Fig.5.8c. While the background fluorescence at 4°C did not change over 
time, there was a peak in transferrin uptake at 15 minutes, which slowly declined. 
Treatment with flagellin did not affect either binding at 4°C or its uptake at 37°C 
(Fig.5.8c). These results, together with the result using an inhibitor of clathrin-
mediated endocytosis, chloroquine (Fig.5.7b), suggest that flagellin does not 
modulate this uptake pathway. 
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Figure 5.8 Flagellin does not have an effect on clathrin-mediated endocytosis. 
a) Non-polarized A549 cells were grown on coverslips, incubated with transferrin 
Alexa Fluor 488 (Tf; 10 µg/mL) for 1h and fixed to visualise CD81 by 
immunofluorescence; nuclei were stained with DAPI. Cells were imaged using a 
Zeiss 510 Meta confocal microscope with 10x objective and LSM software. Scale bar 
indicates 10 µm. (b) and (c) Non-polarized A549 cells were treated with flagellin (1 
µg/mL; removed prior to Tf addition) for 1h prior to Tf addition and incubated at 37°C 
or 4°C. Cells were fixed at stated time points and analyzed by flow cytometry. The 
results are gated on live cells and presented as intensity of fluorescent Tf uptake 
versus number of events (% of max), or median fluorescence of the population over 
time.	   Representative of 3 biological replicates, error bars show SD of 2 technical 
replicates.	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5.6 Flagellin does not affect macropinocytic uptake 
Macropinocytosis, also known as ‘cell drinking’, is a ligand-induced process allowing 
non-specific uptake of extracellular fluid and has emerged as another pathway for 
virus entry (Mercer and Helenius, 2012). Although the inhibitors blebbistatin and 
EIPA were unable to prevent the pro-viral effect of flagellin (Fig.5.7b), we assessed 
the effect of flagellin in a functional macropinocytosis assay using fluorescently 
labeled dextran and flow cytometry. To ensure that the fluorescence detected was 
intracellular and not bound on the surface of the cell, a bleach buffer that quenches 
extracellular fluorescence was used, as previously described (Aleksandrowicz et al., 
2011), and CD81 co-staining confirmed this (Fig.5.9a). 
 
Representative flow cytometry plots are shown in Fig.5.9b and the results collated in 
Fig.5.9c. PMA was used as a positive control to induce macropinocytosis 
(Aleksandrowicz et al., 2011). While PMA showed a steady increase in the uptake of 
the fluorescent dextran, there was no change following flagellin treatment (Fig.5.9c), 
confirming the results seen previously with inhibitors of macropinocytosis that this is 
not the mechanism for increased virus entry. 
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Figure 5.9 Flagellin does not have an effect on macropinocytosis. 
a) Non-polarized A549 cells were grown on coverslips, incubated with Oregon green 
10 kDa dextran (100 µg/mL) for 1h and fixed to visualise CD81 by 
immunofluorescence; nuclei were stained with DAPI. Cells were imaged using a 
Zeiss 510 Meta confocal microscope with 10x objective and LSM software. Scale bar 
indicates 10 µm. (b) and (c) Non-polarized A549 cells were treated with flagellin (1 
µg/mL; removed prior to dextran addition) for 1h prior to dextran addition and 
incubated at 37°C. Cells were washed with bleach buffer, fixed at stated time points 
and analyzed by flow cytometry. The results are gated on live cells and presented as 
intensity of fluorescent dextran uptake versus number of events (% of max), or 
median fluorescence of the population over time.	   Representative of 3 biological 
replicates, error bars show SD of 3 technical replicates. 
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5.7 The pro-viral activity of flagellin is NF-κB dependent  
To determine whether NF-κB activation contributes to the effect of flagellin on virus 
entry, we evaluated a small molecule inhibitor MLN4924. MLN4924 was designed as 
an anti-cancer treatment and has been reported to inhibit the RelA (p65) component 
of NF-κB translocating to the nucleus, thereby preventing activation (Milhollen et al., 
2010). This compound was reported to inhibit LPS-induced cytokine secretion by 
macrophages (Chang et al., 2012). Of note, MLN4924 was recently reported to have 
a negligible effect on VSV infection of HeLa epithelial cells, in line with our results 
(Song et al., 2016). 
 
Initially, we determined the concentration of MLN4924 required to prevent STm 
activation of NF-κB using the pConA reporter plasmid. This plasmid contains a 
luciferase reporter under the control of multiple NF-κB binding sites. STm induced a 
six-fold increase in NF-κB activity that was reduced by pretreating the cells with 
MLN4924 in a dose-dependent manner (Fig.5.10a).  
 
We assessed the effect of pre-treating cells with MLN4924 on STm, CM or flagellin 
priming of VSV-Gpp infection, as previously described. The drug was present 
throughout. This protocol blocked the effect of bacteria or secreted flagellin on virus 
entry (Fig.5.10b). We measured IL-8 expression using the supernatant from this 
experiment, demonstrating that MLN4924 significantly decreased the amount of IL-8 
released after STm stimulation (Fig.5.10c). Together these results identify NF-κB  
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Figure 5.10 MLN4924 prevents the effect of flagellin on VSV entry. 
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Figure 5.10 cont. 
a) A549 cells were transfected with the NF-κB reporter plasmid pConA-luciferase, 
incubated for 24 hours and pre-treated for 15 mins with MLN4924 at indicated 
concentrations. STm (MOI 10) was added for 1 hour prior to chloramphenicol 
addition. NF-κB activation was quantified by luciferase assay at 48h. Data are 
presented as relative to NF-κB activation in untreated cells. Representative of 3 
biological replicates, error bars show the standard error of the mean (SEM) of 3 
technical replicates, statistical comparison by Unpaired t test was n.s. (P > 0.05). b) 
Non-polarized A549 cells were pre-treated with MLN4924 (1 µM) for 15 mins. STm 
(MOI 10), CM or flagellin (0.3 µg/mL; removed prior to virus addition) were added for 
one hour prior to VSV-Gpp addition. Entry was quantified by luciferase assay at 48h. 
Data are presented as relative to VSV-Gpp entry into untreated cells. c) Supernatant 
from (b) was collected at 24h to measure IL-8 secretion by ELISA. Representative of 
3 biological replicates, error bars show SD of 2-6 technical replicates, statistical 
comparison by Unpaired t test: * = P ≤ 0.05, ** = P ≤ 0.01, **** = P ≤ 0.0001. 
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activation as a key pathway to facilitate the pro-viral activity of STm flagellin, or the 
whole bacterium, for lung epithelial cells. 
 
5.8 The pro-viral effect of flagellin through NF-κB signaling is TLR5 dependent 
To independently confirm a role for NF-κB in the pro-viral activity of flagellin, we used 
siRNA to silence RelA (Fig.5.11a) and observed a significant decrease in the effect 
of flagellin on VSV-Gpp infection (Fig.5.11c). Flagellin can be detected in epithelial 
cells by TLR5, leading to NF-κB activation, or NAIP, leading to inflammasome 
activation (López-Yglesias et al., 2014). To determine which was mediating the pro-
viral effect of flagellin, we evaluated the effect of siRNA silencing TLR5. Cells 
transfected with TLR5 siRNA were not as permissive to the pro-viral activity of 
flagellin (Fig.5.11c), suggesting a role for TLR5. However, given the limited 
availability of antibodies to detect TLR5 we were unable to validate the effect of the 
siRNA on protein expression levels and quantified TLR5 mRNA levels by RT-PCR 
(Fig.5.11b). There was a no significant effect on TLR5 mRNA levels in cells 
transfected with siRNA targeting TLR5. However, given there was a phenotypic 
difference compared to the control, it could be that the primer used detects a different 
isoform and is unsuitable for this assay. Earlier results showed that neither CM nor 
flagellin was able to increase VSV-Gpp entry into Caco-2 cells (Fig.4.2b, Fig.4.6b). 
We were interested to quantify TLR5 mRNA levels relative to A549 cells (Fig.5.12). 
We observed significantly higher levels of TLR5 mRNA in Caco-2 cells, suggesting 
that mRNA levels are not able to predict protein expression, or that the TLR5 
produced is not available for or responsive to flagellin stimulation. 
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Figure 5.11 The pro-viral effect of flagellin signals through TLR5. 
A549 cells were transfected with siRNA to target RelA, TLR5, or a control, and 
cultured for 24 hours. a) Cells were lysed to determine RelA or control β-actin 
expression by SDS-PAGE and western blotting b) Cells were lysed to determine 
TLR5 expression relative to control GAPDH by qRT-PCR. c) Flagellin (0.3 µg/mL; 
removed prior to virus addition) was added for 1h prior to VSV-Gpp addition. Entry 
was quantified by luciferase assay at 48h. Data are presented as relative luciferase 
units (RLU). Representative of 3 biological replicates, error bars show SD of 3-4 
technical replicates, statistical comparison by Unpaired t test: **** = P ≤ 0.0001. 
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Figure 5.12 TLR5 mRNA levels. 
A549 and Caco-2 cells were lysed to determine TLR5 mRNA relative to control 
GAPDH mRNA by qRT-PCR. Data are presented as relative to TLR5 mRNA levels in 
A549 cells. Error bars show SD of 3 technical replicates, statistical comparison by 
Unpaired t test: *** = P ≤ 0.001. 
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5.9 Discussion 
Our experiments to determine the mechanism of flagellin priming virus uptake into 
A549 cells showed that MLN4924, a small molecule inhibitor of NF-κB activation, 
reversed the pro-viral activity (Fig.5.10b). MLN4924 targets and inhibits the NEDD8-
activating enzyme to regulate the activity of cullin-ring ligases. These ligases are 
involved in the proteasomal degradation of many intracellular proteins (Soucy et al., 
2009). Given the broad activity of MLN4924, although it has been reported to hold 
RelA in the cytoplasm of cells (Milhollen et al., 2010), we confirmed that RelA was 
involved in the pro-viral activity of flagellin with siRNA silencing. The reduced pro-
viral activity of flagellin (Fig.5.11c), could be explained by incomplete silencing of 
RelA, or suggest a role for cullin-ring ligase targets in the pro-viral activity of flagellin.  
 
To further assess the effect of MLN4924 in A549 cells, cell supernatant was collected 
and showed decreased IL-8 secretion (Fig.5.10c). This is one downstream effect of 
NF-κB signaling by STm (Tallant et al., 2004) and strengthens the conclusion that 
MLN4924 is preventing NF-κB activation to block the activity of flagellin on virus 
entry. The observation that flagellin is sufficient to increase virus entry implies that 
epithelial barriers in the body that are sparsely colonized by flagellated bacteria may 
be affected, through a bystander effect. Interestingly, this phenotype was not 
observed with gut-derived Caco-2 cells, suggesting cell type selectivity. 
 
Flagellin can be recognized in host cells by TLR5 and NAIP (López-Yglesias et al., 
2014). We found that siRNA silencing of TLR5 decreased the effect of flagellin on 
VSV-Gpp entry, but did not abrogate the effect. This could be because the silencing 
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of TLR5 was not complete, as PCR results were inconclusive, or because the pro-
viral effect is also mediated by NAIP/Nlrc4-inflammasome signaling within the cell. It 
may be important to assess the whether inflammasome signaling can occur in A549 
cells, as they are reported to express low levels of NAIP (Vinzing et al., 2008). An 
alternative approach to determine the role of TLR5 signaling would be to evaluate 
mutant TLR5 proteins lacking either the extracellular binding region or the 
intracellular signaling region, or test mutant flagellin proteins unable to bind TLR5 for 
their effect on viral pseudoparticle uptake (Eaves-Pyles et al., 2001; Gewirtz et al., 
2001a).  
 
We assessed the possibility of his-tagged flagellin binding to the virus, using the 
PERT assay to detect virus particles, with a nickel affinity column. Interestingly, virus 
particles were eluted upon imidazole addition, although this was not increased in the 
presence of flagellin (Fig.5.4). HIV particles are derived from host cell membranes 
and are negatively charged (Lai et al., 2009), this could allow weak binding to 
positively charged nickel ions that would be disrupted by the addition of imidazole. 
Previous studies identifying that LPS binds to MMTV assessed this by ELISA, using 
both anti-envelope glycoprotein antibodies and biotinylated LPS (Wilks et al., 2015). 
A similar method could be used to eliminate the background signal of non-specific 
virus binding to nickel. 
 
We defined the role of flagellin in virus binding and internalization by studying 
pseudoparticle attachment at 4°C and quantifying virus particles bound or 
internalized after a one hour incubation. VSV-Gpp entry into A549 cells is reduced at 
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4°C (Fig.5.6). This is likely due to a disruption in the recycling of endocytic receptors 
to the plasma membrane when cells are at a low temperature (Maxfield and McGraw, 
2004), allowing less availability of receptors for virus particles to bind to. Interestingly, 
a previous study has reported that after binding host cells at 4°C, around one third of 
VSV particles are internalized and this happens within five minutes of increasing the 
temperature to 37°C. The pH-dependent fusion step occurs within 30 minutes for the 
majority of internalized particles (Johannsdottir et al., 2009). We found that flagellin 
was able to increase virus entry when added after a one hour infection at 37°C 
(Fig.5.6), during which the majority of virus particles should have internalized and 
fused. One limitation to this finding is that we are using retroviral pseudoparticles 
rather than full-length VSV, as used by Johannsdottir et al., 2009, and this could be 
altering virus entry kinetics.  
 
It would be informative to assess the effect of flagellin on VSV-Gpp entry expressing 
a GFP reporter while using NH4Cl to prevent endosomal acidification. Comparing the 
results to the kinetic profile reported by Johannsdottir et al., 2009, could determine 
whether flagellin promotes virus fusion in the endosome. It is also reported that three 
times more VSV binds to the cell surface than is internalized, when cells are 
untreated (Johannsdottir et al., 2009). Flagellin could be affecting this stage of the 
viral entry process to allow a higher proportion of virus into the cell. The PERT assay 
suggests that cells incubated at 37°C for one hour have increased virus 
internalization after flagellin treatment (Fig.5.5), which could support this hypothesis. 
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While investigating the mechanism through which flagellin increases lung epithelial 
cell permissivity to viruses, we assessed a panel of cellular uptake inhibitors, 
alongside measuring the uptake of soluble ligands transferrin and dextran. Using 
these techniques we observed a minimal effect for altered virus uptake pathways 
following flagellin treatment. Transferrin uptake increased over the first 20 min as 
previously reported (Junutula et al., 2004), however the decline noted after the first 
20 min was not previously reported and is likely to reflect cell-type specific 
differences and saturation of the pathway. Using this extended time course we failed 
to detect any effect of flagellin on transferrin uptake kinetics (Fig.5.8c).  
 
Previous studies have reported that, following dextran addition, macropinosome 
formation increases over time (Falcone et al., 2006) as we observed. However, there 
was no change with flagellin treatment (Fig.5.9c). Falcone et al., 2006, reported 
comparable macropinocytic uptake of FITC-labeled 20 nm latex beads to 70 kDa 
dextran. As our dextran molecules were only 10 kDa it may be informative to test 
higher molecular weight structures that may mimic virus particles, such as latex 
beads. Another inhibitor that would be interesting to test with flagellin and 
pseudoparticles is nystatin. One study reports that nystatin, a lipid raft inhibitor, can 
reduce flagellin-induced IL-8 secretion by A549 cells (Im et al., 2009). It is known that 
non-enveloped viruses utilize lipid rafts to enter cells (Pelkmans, 2005). Although the 
role of lipid rafts in enveloped virus entry is still to be determined, influenza may also 
use this area of the plasma membrane to internalize (Ohkura et al., 2014).  
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VSV-G mediated, acid-dependent fusion of virus particles in the endosome is an 
inefficient process and many virus particles internalized are degraded prior to fusion 
by proteases (Hastie et al., 2013). A genome-wide functional analysis of the human 
kinome used siRNA to target 590 kinases and identified a small number that 
enhanced VSV entry when they were silenced through altered endocytosis 
(Pelkmans, 2005). To determine whether flagellin increases virus escape from the 
endosome, the proteases involved in degradation of attached and internalized VSV-
G particles could be targeted with siRNAs and further experiments could determine 
whether any kinases involved in endocytosis are affected downstream of NF-κB 
activation by flagellin. Furthermore, it would be important to confirm that the effect of 
flagellin on VSV-G-dependent entry is present in full-length VSV infection. 
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5.10 Summary 
In this chapter, we present that the pro-viral activity of flagellin occurs via TLR5 and 
NF-κB signaling (Fig.5.11c), to increase virus internalization post-binding (Fig.5.5). 
While attempting to define the mechanism of increased virus entry we found that 
flagellin had a minimal effect on clathrin-mediated endocytosis of transferrin 
(Fig.5.8c) or macropinocytosis of dextran molecules (Fig.5.9c), suggesting a 
requirement for particulate or multi-valent structures. In future experiments it will be 
important to determine whether the effect of flagellin occurs during VSV-G mediated 
membrane fusion in the endosome and to assess the effect of flagellin on the entry of 
other viruses to determine whether the same mechanism applies. These findings 
highlight a new role for flagellin, although more work is needed to define the 
mechanism leading from NF-κB activation to increased virus entry. 
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6. THE EFFECT OF FLAGELLIN ON HIV-1 REPLICATION 
 
6.1 Introduction 
To extend our earlier findings that flagellin promotes epithelial permissivity to support 
the entry of a panel of viruses; we selected to study the effect of flagellin on HIV-1 
infection. 
 
HIV-1 can infect T cells and macrophages using the primary attachment receptor 
CD4 and chemokine receptors CXCR4 or CCR5 (Clapham and McKnight, 2001). 
Entry is mediated by the virally encoded glycoproteins gp120 and gp41 (Fig.6.1a) 
and is mediated via the fusion of viral and host cell membranes (Fig.6.1b; reviewed 
by (Aiamkitsumrit et al., 2014). The early phase of HIV-1 replication includes RTase-
mediated conversion of viral RNA into a dsDNA pro-viral genome whilst the capsid 
core is released into the cytoplasm. The virus uncoats and the DNA is imported into 
the nucleus, where it can integrate via the activity of a virally encoded integrase. The 
late phase of the life cycle comprises transcription of the integrated proviral genome, 
expression of viral proteins and the assembly of nascent viral particles that are 
secreted from the cell (reviewed by (Freed, 2015). 
 
HIV-1 transcription is regulated by LTRs that contain an enhancer element 
comprising two binding sites for NF-κB, which can initiate transcription in concert with 
with other cellular transcription factors. The virally encoded transactivator of 
transcription (Tat) protein is expressed early in the HIV-1 life cycle and has many  
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Figure 6.1 The HIV genome and lifecycle. 
a) The HIV genome, from Thomas Splettstoesser (www.scistyle.com). The envelope 
glycoproteins, gp41 and gp120, are encoded by env late in the viral life cycle. 
Expression of Tat requires splicing early in the viral life cycle to create tat transcripts. 
b) The HIV lifecycle, adapted from (Laskey and Siliciano, 2014). Fusion occurs at the 
plasma membrane, following attachment using CD4 and CXCR4 or CCR5. Reverse 
transcription of viral RNA allows integration and viral gene expression to assemble 
new viral particles and bud from the host cell. 
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roles including enhancement of transcription, between 10- and 100-times higher than 
levels using host cell transcription factors alone (Li et al., 2012). This virally encoded 
transactivator forms the basis of LTR-reporter cell lines that are sensitive to HIV-
dependent Tat expression (Aguilar-Cordova et al., 1994, Wei et al., 2002). 
 
As well as being present on epithelial cell barriers colonized by bacteria, flagellin can 
be detected in the blood when gut barrier integrity is compromised. Indeed, HIV-1 
infection may be associated with increased flagellin levels in the serum (Svärd et al., 
2015). Previous studies assessing the role of TLR agonists on HIV replication have 
shown that flagellin increases LTR activity (Ferreira et al., 2011). Thibault et al., 
2009, reported that flagellin could reactivate latent HIV-1 in a model cell line, J-Lat, 
derived from Jurkat cells. Treatment with an NF-κB inhibitor, weledolactone, reduced 
this reactivation, suggesting an NF-κB dependent process. Brichacek et al., 2010, 
reported that flagellin induced a two-fold increase in the replication of CXCR4- or 
CCR5-tropic HIV-1 strains infecting ex vivo lymphoid tissue. Furthermore, HIV-1 LTR 
activity can be promoted by flagellin, using a reporter T cell line, 1G5 (Ferreira et al., 
2011).  
 
Given our earlier studies showing a role for flagellin to promote viral entry through 
NF-κB signaling, we were interested to determine whether flagellin could modulate 
HIV-1 entry into T cells and whether the reported effects of flagellin on LTR-
transcription could augment infectious virus production. 
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Results 
6.2 Flagellin increases HIVpp entry  
We were interested to determine whether flagellin could increase HIV-1 entry into T 
cells. Our initial experiments assessed the sensitivity of the PM1 T cell line to support 
VSV-Gpp infection and its response to flagellin. We observed a modest increase in 
VSV-Gpp entry (Fig.6.2a), demonstrating that the pro-viral activity of flagellin 
signaling observed in epithelial cells is present in T cells. 
 
We generated HIVpp using the pNL4.3e-r-luciferase plasmid used for all previous 
single-round pseudoparticle infections and a plasmid encoding HIV-1 env from the 
LAI strain, which uses the CXCR4 co-receptor (Aiamkitsumrit et al., 2015). Flagellin 
increased HIVpp dependent reporter activity three-fold (Fig.6.2a). Primary CD4+ T 
cells were isolated to confirm the pro-viral activity of flagellin on HIVpp entry and two 
concentrations of flagellin were assessed. Treating primary cells with flagellin (10 
µg/mL) increased HIVpp and VSV-Gpp infection (Fig.6.2b). However, the increase 
was not statistically significant. This result supported the finding in PM1 cells that 
flagellin can increase HIV-1 entry into T cells. 
 
6.3 Flagellin promotes HIV-1 replication  
After demonstrating that flagellin promotes HIV-1 entry, we were interested to 
investigate its effect on the full-length HIV-1 replicative life cycle. Two LTR-reporter 
cell lines were available to us: TZM-bl cells are derived from HeLa cervical epithelial 
cells and are engineered to express the viral receptors CD4/CXCR4/CCR5 and a 
luciferase reporter under transcriptional control of the HIV-1 LTR promoter  
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Figure 6.2 Flagellin increases HIVpp entry into T cells. 
a-b) Cells were incubated with flagellin at stated concentration for 1h prior to infecting 
with VSV-G or HIV pseudoparticles. Entry was quantified by luciferase assay at 48h. 
Data are presented as relative to pseudoparticle entry into untreated cells. Error bars 
show SD of 3 technical replicates, statistical comparison by Unpaired t test: * = P ≤ 
0.05, ** = P ≤ 0.01. 
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(Wei et al., 2002); 1G5 cells are derived from the Jurkat CD4 and CXCR4 expressing 
T cell line and also LTR-luciferase (Aguilar-Cordova et al., 1994). 
 
Initial studies compared the sensitivity of the TZM-bl and 1G5 reporter cells to 
support HIV-1 infection. Both cell lines were infected with a dilution series of HIV-1 
NL4.3 and the data are presented as net luciferase values, where the uninfected 
basal LTR activity is annotated using a dotted line. We noted a linear relationship 
between virus dose and reporter activity in both cell lines. TZM-bl cells are more 
sensitive than 1G5 cells, yielding higher luciferase values and detecting infectivity 
with a lower viral inoculum (Fig.6.3a-b). However, TZM-bl cells have high basal LTR 
activity. We assessed the effect of media on LTR activity and determined that lower 
serum concentrations reduced basal levels (data not shown). To maintain low basal 
levels, TZM-bl cells experiments were carried out with 3% FBS/DMEM. To generate 
maximum luciferase output from 1G5 cells they were incubated for 48h. However, 
incubation with HIV-1 for longer than 48h affected cell viability (data not shown). 
These data demonstrate that both reporter cell lines are valuable but may be used for 
different experimental protocols: TZM-bl cells are able to detect low quantities of HIV-
1, whereas 1G5 cells are T cells and a more physiological cell type. 
 
We then confirmed that flagellin increases HIV-1 infectivity in 1G5 cells as previously 
reported (Ferreira et al., 2011) and tested the effect of flagellin on HIV-1 infectivity in 
TZM-bl cells. As determined in previous chapters, flagellin can modulate virus 
infection through NF-κB signaling and we hypothesized that this would increase LTR-
reporter activity. TNF was included as a positive control for NF-κB mediated  
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Figure 6.3 Sensitivity of HIV-1 reporter cell lines. 
a-b) A serial dilution of HIV-1 (strain NL4.3) was added to cells. TZM-bl cells were 
lysed at 24h, 1G5 cells were lysed at 48h and HIV-1 infectivity was quantified by 
luciferase assay. Data are presented as relative luciferase units (RLU). Error bars 
show SD of 3 technical replicates. Dotted lines show the mean RLU of uninfected 
cells +2 SD. 
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upregulation of virus infectivity (Li et al., 2012) and this was observed in both cell 
lines (Fig.6.4a-b). Interestingly, flagellin has different effects depending on the cell 
line. While the basal levels of transcription are increased by flagellin treatment of 
both TZM-bl and 1G5 cells, it has a negligible effect on HIV-1 infection in TZM-bl 
cells. However, flagellin increases HIV-1 infection 30-fold in 1G5 cells. These data 
suggest that TZM-bl cells and 1G5 cells respond differently to flagellin stimulation 
and we chose to focus on 1G5 cells as a more physiologically relevant model. We 
determined that the pro-viral activity of flagellin in 1G5 cells occurs in a dose-
responsive manner (Fig.6.5a) as seen previously. 
 
While our results and previous studies show increased HIV-1 infectivity after flagellin 
treatment of T cells, we were interested to determine whether this lead to increased 
infectious virus particle production. To quantify this, 1G5 cells were pre-treated with 
flagellin, infected with HIV-1 and extracellular media containing newly generated 
virus particles was collected for titration on TZM-bl cells and lysis for analysis of 
RTase activity by PERT assay. Flagellin increased extracellular HIV-1 infectivity as 
determined by titration on TZM-bl cells in a dose-responsive manner, up to eight-fold 
(Fig.6.5b). This pattern is comparable to the effect of flagellin on HIV-1 infectivity in 
1G5 cells (Fig.6.5a), suggesting that increased transcription does lead to increased 
production of infectious virus particles. This result is supported by the PERT assay 
results, which show a 17-fold increase in RTase activity for particles produced by 
1G5 cells pre-treated with flagellin (Fig.6.4c). Interestingly, although TNF increases 
HIV-1 infectivity, this does not lead to an augmentation of infectious virus particle 
production. Together, the data in Fig.6.4 and Fig.6.5 demonstrate that increased  
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Figure 6.4 The effect of flagellin on HIV-1 infection of reporter cell lines. 
a-b) Cells were incubated with flagellin (1 µg/mL) or TNF (10 ng/mL) for 1h prior to 
infection with HIV-1 (NL4.3) and lysed at 24h (TZM-bl) or 48h (1G5). HIV-1 infectivity 
was quantified by luciferase assay. Data are presented as relative luciferase units 
(RLU). Representative of 3 biological replicates, error bars show SD of 4 technical 
replicates, statistical comparison by Unpaired t test: ** = P ≤ 0.01, *** = P ≤ 0.001, 
**** = P ≤ 0.0001. c) Extracellular media from HIV-1 infected 1G5 cells treated as in 
(b) was collected and assessed for RTase activity by PERT assay. Data presented 
are viral particles as determined by units of RTase. Error bars show SD of 3 technical 
replicates, statistical comparison by Unpaired t test: ** = P ≤ 0.01. 
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Figure 6.5 Flagellin increases de novo HIV-1 particle production. 
a) 1G5 cells were treated with flagellin at stated concentrations for 1h prior to 
infection with HIV-1 (NL4.3) for 3h. Cells were washed to remove unbound virus, 
incubated for 48h. HIV-1 infectivity was quantified by luciferase assay. Data are 
presented as relative to untreated HIV-1 infectivity. b) Infectivity of the extracellular 
medium from infected 1G5 cells treated as in (a) when titrated on TZM-bl cells. Data 
are presented as RLU. Representative of 3 biological replicates, error bars show SD 
of 3 technical replicates, statistical comparison by Unpaired t test: * = P ≤ 0.05, ** = P 
≤ 0.01, *** = P ≤ 0.001, **** = P ≤ 0.0001.  
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Tat-dependent transcription in the presence of flagellin augments virus particle 
production from T cells, which has not been previously reported and suggests that 
flagellin can modulate virus spread. 
 
Given the different responses of TZM-bl and 1G5 HIV-1 reporter cells to flagellin, we 
confirmed the pro-viral activity seen in the T cell reporter line using another T cell 
line, SupT1 cells. In support of the results seen with 1G5 cells, there is a significant 
increase in extracellular virus infectivity with flagellin treatment when supernatant 
from SupT1 cells is titred on TZM-bl cells (Fig.6.6a) and there is augmented RTase 
activity by PERT assay (Fig.6.6b). Using these data we calculated the specific 
infectivity and see a 10-fold change (Table 6.1), which demonstrates that while more 
particles are produced, they may be less infectious. 
 
Finally, we assessed the effect of the NF-κB inhibitor, MLN4924, which blocks the 
pro-viral activity of flagellin in A549 cells (Fig.5.10b). Pre-treating 1G5 cells with a 
concentration of MLN4924 previously reported to inhibit T cell signaling without 
inducing cell death (Jin et al., 2013) had a minimal effect on the pro-viral activity of 
flagellin on HIV-1 infectivity (Fig.6.7). This suggests that the pro-viral activity of 
flagellin in T cells may use a different signaling pathway or other factors may be at 
play. 
 171 
 
 
Figure 6.6 Flagellin increases infectious HIV-1 secretion. 
SupT1 cells were treated with flagellin (0.3 µg/mL) for 1h prior to infection with HIV-1 
(NL4.3) and extracellular media was collected at 48h to determine (a) virus infectivity 
by titration on TZM-bl cells, data are presented as relative luciferase units (RLU), and 
(b) RTase activity by PERT assay, data presented are viral particles as determined 
by units of RTase. Error bars show SD of 3 technical replicates, statistical 
comparison by Unpaired t test: * = P ≤ 0.05. 
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Sample Specific infectivity 
(RLU x104/µU) 
Unt 0.30 
Fla 0.03 
 
Table 6.1 Specific infectivity of HIV-1 particles produced by SupT1 cells. 
Specific infectivity was calculated by dividing luciferase activity, as demonstrated in 
Fig.6.6a, by RTase activity, as demonstrated in Fig.6.6b. 
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Figure 6.7 The pro-viral activity of flagellin on HIV-1 transcription is not blocked 
by MLN4924. 
1G5 cells were treated with MLN4924 (100 nM) for 15 min prior to flagellin addition 
(10 µg/mL) for 1h. Flagellin was removed and cells were infected with HIV-1 (NL4.3) 
for 3h. MLN4924 concentration was kept constant throughout this time. Cells were 
washed to remove unbound virus and incubated for 48h. HIV-1 infectivity was 
quantified by luciferase assay. Data are presented as relative luciferase units (RLU). 
Error bars show SD of 3 technical replicates, statistical comparison by Unpaired t 
test: **** = P ≤ 0.0001. 
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6.4 Discussion 
In this chapter we aimed to expand the model system we have used to identify a role 
for flagellin in viral entry, by investigating the role of flagellin in full-length virus 
infection. Firstly, we observed that flagellin has pro-viral activity in T cells. It can 
increase HIV-1 entry (Fig.6.2), infection of reporter cells (Fig.6.4) and the production 
of infectious virus particles (Fig.6.6). Interestingly, this may not be through the same 
NF-κB signaling mechanism we identified for A549 lung epithelial cells (Fig.6.7). 
However, further experiments are needed to define the mechanism of flagellin pro-
viral activity in the HIV-1 replicative lifecycle. 
 
We chose to assess the effect of flagellin on HIV-1 infection, as there were well-
characterized reagents available to study at different stages of the viral lifecycle. 
Initial experiments focused on whether flagellin has pro-viral activity in CD4+ T cells, 
the main reservoir of HIV-1 infection. As seen with epithelial cells, flagellin can 
increase virus entry into T cells using the pseudoparticle system (Fig.6.2). The HIVpp 
tested uses the CXCR4 receptor. It will be important to determine the effect of 
flagellin on CCR5-tropic HIV-1 strains that are involved in the early transmission 
stages of HIV-1 infection (Aiamkitsumrit et al., 2015). Furthermore, we tested one 
primary cell donor. There is wide variation in permissivity to HIV-1 infection between 
primary CD4+ T cell donors (Ciuffi et al., 2004) and it is important to use many 
different donors to draw conclusions. The effect of flagellin on primary T cells is also 
likely to vary between donors and TLR responses can be affected by differences in 
cell purity (Lancioni et al., 2009). The pro-viral activity of flagellin in primary cells 
required a higher concentration than in the PM1 T cell line. 
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Another factor to consider when using T cells is their activation status, as the HIV 
lifecycle may differ depending on whether CD4+ cells are active or quiescent, with 
activated T cells allowing more productive HIV-1 infection (Zack et al., 2013). We 
saw higher levels of HIV-1 infection in resting primary CD4+ T cells than in anti-
CD3/anti-CD28 activated cells (data not shown) and used resting cells for the 
flagellin treatment experiment. However, TLRs can act as co-stimulators for TCR 
signaling, although TLR ligands such as flagellin cannot activate T cells alone (Caron 
et al., 2005; Rahman et al., 2009). It would be interesting to assess the effect of 
flagellin alongside TCR-activating anti-CD3 prior to HIV-1 infection, as flagellin and 
anti-CD3 can increase proliferation of CD4+ T cells (Caron et al., 2005) potentially 
giving the HIV-1 more target cells to infect. However, Caron et al., 2005, also 
reported increased cytokine production following flagellin stimulation, including IFNγ. 
 
The effect of flagellin on HIV-1 infectivity in 1G5 cells shows a comparable boost to 
that reported by Ferreira et al., 2011, of around seven-fold, using 10 µg/mL, after 24 
hours. Depending on the concentration of flagellin and whether the experimental 
protocol required leaving flagellin and HIV-1 on the cells throughout the assay, or 
removal after 4 hours, we saw an increase between two- and 30-fold after 48 hours 
(Fig.6.4b, Fig.6.5a). Previous reports have identified increased HIV p24 (capsid 
protein) release after flagellin treatment and HIV-1 infection of tonsil explants 
(Brichacek et al., 2010). P24 release signifies that the virus has reached the late 
stage of its lifecycle, viral genes have been transcribed and new virus particles have 
been formed to exit the cell (Freed, 2015). However, p24 can also be released 
independent of particle formation. We report that there is increased virus particle 
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release from flagellin pre-treated T cells, using titration on TZM-bl cells and the PERT 
assay (Fig.6.4c, Fig.6.5b, Fig.6.6). However, the particles released may not be as 
infectious and more investigation is needed to determine the effect of flagellin. 
 
Surprisingly, preliminary results suggest that the ability of flagellin to increase HIV-1 
infectivity is not through NF-κB signaling (Fig.6.7), although flagellin can increase 
both NF-κB promoter activity and HIV-1 promoter activity in T cells (Thibault et al., 
2009). There are also differences in the effect of flagellin or TNF pre-treatment on 
HIV-1 particle production from 1G5 (Fig.6.4c) and SupT1 cells (Fig.6.6), although 
TNF activates NF-κB signaling. Previous studies have found an anti-viral effect of 
TNF on HIV-1 infection of various cell types (Herbein et al., 1996; Lane et al., 1999) 
but it is also able to activate HIV-1 in chronically infected T cells and this is through 
NF-κB-mediated activation of the HIV-1 LTR (Kumar et al., 2013). It will be important 
to investigate the role of NF-κB in flagellin-associated HIV-1 infection further. 
 
HIV-1 infection can occur through two pathways: cell-free virus encountering a target 
cell, or cell-cell transmission from an infected cell to a target cell. The second 
pathway of cell-associated transmission is between 10 and 1000 times more effective 
than cell-free transmission (Anderson, 2014). We have found that flagellin can 
increase HIV-1 infection and with the experimental design we used this could be via 
cell-free or cell-cell transmission routes. Interestingly, flagellin pre-treatment of DCs 
incubated with HIV-1 prior to co-culture with T cells increased cell-associated 
transmission, as measured by p24 release (Côté et al., 2013). It would be interesting 
to investigate further whether flagellin could increase cell-associated transmission, as 
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it is one pathway thought to contribute to HIV-1 persistence (Kulpa et al., 2013). 
Flagellin has been reported to reactivate latent HIV-1 (Thibault et al., 2009). To 
investigate a role for flagellin in cell-associated transmission, it could be added to co-
cultures of HIV-infected and uninfected, target CD4+ T cells.  
 
6.5 Summary 
Together, these data suggest multiple ways for flagellin to increase virus infection in 
different cell types throughout the body that may be exposed to flagellin during 
coinfection or microbial translocation. More experiments are necessary to determine 
the mechanisms involved. However, it will also be important to expand this model 
system to include the innate immune cells that will be present in vivo. Flagellin can 
be used as an effective adjuvant, inducing an innate immune response (Lu and 
Swartz, 2016; Porte et al., 2015). Thus, its role in coinfection may be complex.  
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7. DISCUSSION 
 
The data presented in this thesis highlight a new role for bacteria to promote 
enveloped virus infection of epithelial cells, in the presence a low-dose of bacteria. In 
lung epithelial cells this can be specifically mediated by a single bacterial protein; 
flagellin. We observed the pro-viral activity of STm to be long lasting, which may be 
explained by continued host cell signaling or the release of flagellin, suggesting that 
sparsely bacterially colonized areas of the body may replicate this effect and 
enhance the infectivity of incoming viruses. We noted that flagellin increased the 
ability of T cells to support HIV entry and the secretion of infectious particles, 
demonstrating additional roles in the HIV replicative life cycle beyond entry. These 
studies implicate a role for flagellin to enhance HIV transmission and infection of new 
target cells.  
 
The biological relevance of our observations with flagellin may be reflected in the 
observation that no common bacterial pathogen of the healthy lung is flagellated. P. 
aeruginosa, though flagellated, is a pathogen of immunocompromised individuals, 
such as those with bronchiectasis or CF (Pfaller et al., 2015, Elborn, 2016). In an 
individual with bronchiectasis, the burden of P. aeruginosa in the lung can often 
reach >108 bacteria/mL of sputum (Tunney et al., 2013), providing a reservoir of 
flagellin production that could contribute to the increased burden of viral infections 
seen in the immunocompromised lung (Renk et al., 2014; Gao et al., 2015). 
Furthermore, P. aeruginosa has been reported to express low levels of flagellin in the 
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chronically infected lung (Wolfgang et al., 2004). This is thought to occur because 
aflagellate bacteria survive longer in the host than flagellated bacteria, most likely 
mediated by reduced immune recognition, such that many bacterial species down-
regulate flagellin expression during infection (Rossez et al., 2015).  
 
Our data suggest a role for TLR5 in the pro-viral activity of flagellin. This receptor has 
been reported to facilitate flagellin antigen presentation, from DCs to T cells, through 
MHCII, to induce an adaptive immune response (Letran et al., 2011). Interestingly, 
MyD88 is not involved in this mechanism, suggesting that there is no involvement of 
NF-κB signaling. However, this finding led the authors to suggest that increased 
internalization of the antigen by TLR5 enhances the processing of flagellin into 
epitopes, to deliver to MHCII. The A549 lung epithelial cells we used are type II 
alveolar epithelial cells and express both MHCI and MHCII, although expression of 
the latter is minimal compared to primary cells (Corbière et al., 2011). Relating this 
theory to our model may be of interest, as this function of TLR5 could allow increased 
internalization of adhered virus particles into the cell.  
 
The epithelial model system we have used thus far only comprises one host cell type. 
However, to fully define the effect of flagellin on virus infection it will be important to 
assess the role of innate immune cells that are also present on epithelial barriers. In 
vivo studies report that the administration of flagellin can limit influenza or rotavirus 
infection via the increased recruitment and cytokine activity of innate immune cells 
(Zhang et al., 2014; Porte et al., 2015). Furthermore, flagellin is known to be a potent 
adjuvant and can enhance the efficacy of viral vaccines, including influenza (Kim et 
 180 
al., 2015). However, all of these studies used supra-physiological doses of flagellin to 
enhance the anti-viral immune response. We have found that low doses of flagellin 
promote virus infection of epithelial cells and T cells, suggesting that the outcome 
from flagellin challenge will be cell-type and context dependent. Our observations 
highlight the need for further studies to assess the impact of flagellin on the viral 
lifecycle in vivo, where it has the potential to induce particle uptake into epithelial 
cells and thereby promote viral spread as well as induce uptake into innate immune 
cells that may mount an anti-viral response. 
 
Flagellin is an unusual TLR ligand that can elicit responses from both the innate and 
adaptive immune systems (Letran et al., 2011). We observed a pro-viral effect of 
flagellin in T cells that may contribute to cell-free HIV-1 infectivity during infection with 
flagellated pathogens, or microbial translocation. Flagellin has been reported to 
augment cell-cell transmission (Côté et al., 2013) and reactivate latent HIV-1 in a 
cellular population that is insensitive to ART, quiescent central memory CD4+ T cells 
(Thibault et al., 2009). Interestingly, this effect on reactivation can be used to the 
host’s advantage; HIV latency is now being targeted to clear these viral reservoirs 
during treatment, by reactivating the virus with cytokines or TLR agonists (Sebastian 
and Collins, 2014).  
 
If the pro-viral activity of flagellin is solely mediated through TLR5, its effect(s) may 
be most prominent in the aged, where there is a relative decrease in the functionality 
of TLRs with the exception of TLR5 (Kollmann et al., 2012). It could be that flagellin 
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enhances susceptibility to viral uptake in individuals who have a reduced capacity to 
mount an immune response due to age related immune senescence. Our data 
suggest a dual role of flagellin in enveloped virus entry: while previous studies report 
a reduction in virus infection (Porte et al., 2015), the cell type that encounters both a 
virus and flagellin may determine the infection outcome. In conclusion, coinfection 
research has determined that our past infection history, but also the microbes that we 
currently carry, can alter the course of incoming infections. By detecting and 
understanding these interactions better, we may reduce the burden of infectious 
disease on human health. 
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7.1 Future work  
While these data have uncovered a novel role for flagellin, more investigation is 
necessary to validate that flagellin has pro-viral activity in primary human cells, using 
both epithelial and T cells, which may vary in their responses between donors (Ciuffi 
et al., 2004). Furthermore, there is a need to increase our understanding of 
coinfection using complex models (Rall and Knoll, 2016) and previous experiments 
have identified that flagellin can increase HIV cell-cell transmission (Côté et al., 
2013). It would be interesting to explore the role of innate immune cell recognition of 
flagellin in co-culture with epithelial cells, to determine whether virus infection 
increases or the anti-viral response is augmented. As well as complex in vitro 
models, the role of flagellated vs aflagellate bacteria using in vivo virus infection 
could be assessed, to examine whether the flagellin produced alters the outcome of 
coinfection.  
 
When considering immune cells to examine in this model, the highest expression of 
TLR5 mRNA in the mouse is in intestinal DCs (Uematsu et al., 2006). DCs can be 
targeted by viruses, including HIV-1, to enter the body (Rinaldo and Piazza, 2004). 
However, this also allows the cells to present viral antigens to the adaptive immune 
system. By incubating DCs with both flagellin and enveloped viruses, the pro-viral 
activity of flagellin could be assessed as well as whether viral antigen presentation is 
increased, to determine the potential role of DCs in vivo. Furthermore, the anti-viral 
effect of flagellin during rotavirus infection in mice is mediated by DC secretion of 
anti-viral cytokines (Zhang et al., 2014), which may counteract the pro-viral effect of 
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flagellin. Interestingly, during P. aeruginosa infection of individuals with CF, TLR5 is 
upregulated on neutrophils (Koller et al., 2008). TLR5 upregulation, together with the 
presence of flagellin, could increase virus entry into neutrophils and it would be 
interesting to determine whether this results in increased virus infection or increased 
viral clearance.  
 
Although we observed decreased pro-viral activity in TLR5-silenced epithelial cells, 
the role of this receptor could be further studied using non-functioning TLR5 (Gewirtz 
et al., 2001) or flagellin from bacterial species such as H. pylori, which does not 
interact with TLR5 (Eaves-Pyles, 2001). Furthermore, TLR5 is reported to be 
expressed on the basolateral surface of gut epithelial cells (Gewirtz, 2001a). It would 
be informative to assess whether basolaterally-administered flagellin can increase 
the entry of viruses into the apical, or basolateral, surface of polarized gut epithelial 
monolayers, which have been thus far unresponsive to flagellin. If flagellin addition to 
the basolateral surface of gut epithelia does not promote virus entry, we could assess 
whether the addition of multiple MAMPs replicates the pro-viral activity seen with 
whole bacteria. 
 
We found that the pro-viral activity of flagellin and whole bacteria occurs through NF-
κB signalling in epithelial cells. The difference between flagellin being sufficient for 
lung epithelial cells but the presence of whole bacteria being necessary for pro-viral 
activity in gut epithelial cells could suggest that the gut cells require more MAMPs to 
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allow pro-inflammatory activation, which may be predicted given their increased 
burden of bacteria and need for tolerance.  
 
Through NF-κB signaling, epithelial cells allow more virus particles to enter cells. 
However, this is not mediated via increased adhesion of particles, as determined by 
measuring viral particles with the PERT assay following 4°C incubation, leading us to 
propose that either more virus particles are internalized post-attachment, or more 
virus particles are able to escape from the endosome. To determine whether adhered 
particle uptake, or endosomal fusion, is increased we could assess the role of 
flagellin on GFP-labelled virus trafficking with NH4Cl to block endosomal acidification. 
After NH4Cl is added on a time course, virus uptake can be determined by flow 
cytometry to create a kinetic profile (Johannsdottir et al., 2009). These techniques 
are optimized for VSV-G mediated entry, but we see an effect on various virus entry 
pathways. The effect of flagellin on other viral entry pathways could be investigated 
by using the PERT adhesion assay to assess the full panel of viral pseudoparticles 
available. It would also be interesting to examine the role of TLR5 internalization in 
the context of MHCII expression. However, there are currently no reliable reagents to 
visualize TLR5 that are readily available. 
 
The pro-viral effect of flagellin on HIV-1 replication is considered to be through NF-κB 
signaling (Brichacek et al., 2010; Ferreira et al., 2011). We observed a negligible 
effect of the inhibitor, MLN4924, reported to prevent RelA translocation to the 
nucleus (Milhollen et al., 2010). Further work is necessary to determine whether 
MLN4924 has this effect in T cells and the role of NF-κB signaling could be 
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determined by silencing RelA. Flagellin may also help to activate T cells, which could 
induce proliferation and enhance HIV-1 spread (Caron et al.; 2005, Zack et al., 
2013). We could combine flagellin with anti-CD3 to activate T cells prior to HIV-1 
infection and assess whether virus infection is increased, or whether activation 
induced anti-viral responses such as IFN. 
 
We tested an HIV-1 strain with CXCR4 co-receptor usage. As the shift from CCR5 to 
CXCR4 is associated with the loss of CD4+ T cells, this suggests that the pro-viral 
activity of flagellin could speed up progression to the low T cell numbers associated 
with AIDS by promoting infection with CXCR4-tropic particles (Aiamkitsumrit et al., 
2014). CXCR4 and CCR5 tropic viruses can be differentially modulated by the 
presence other microbes (Kannangara et al., 2005). Although Brichacek el al., 2010, 
reported that replication was increased for both CCR5 and CXCR4 virus strains 
following flagellin treatment of ex vivo lymphoid tissue, it would be interesting to 
assess the effect of flagellin on a CCR5 tropic virus, to determine whether flagellin 
may increase the production of the viral strain associated with HIV-1 transmission 
(Aiamkitsumrit et al., 2014).  
 
Finally, this study has addressed the role of flagellin on enveloped virus entry and 
found that flagellin has pro-viral activity on a range of entry pathways. It will be 
important to test flagellin with non-enveloped viruses, which can enter cells through 
similar pathways, to determine whether the effect of flagellin is pan-viral.  
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